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Abstract 
This thesis focuses on empirical investigations and refinements of 
immunohistochemical marker chemistry, to (1) gain insights into the rational 
design of novel amplifiable markers at the light microscopic level for (ultimately) 
single molecule detection, and (2) develop element-rich markers for use in 
analytical electron microscopical tomography (AEMT) to facilitate the 3-
dimensional localisation of multiple target molecules at the ultrastructural level. 
In Chapter 2, incorporation of d-block metals into polymerised 3,3′,4,4′-
tetraaminobiphenyl (polyDAB) was investigated; Ni(II), Pt(II), Pt(IV) and Au(III) 
complexes were shown to be the most effective catalysts of silver reduction from 
physical developers in membrane and tissue model systems. Treatment of d-block 
metal-polyDAB complexes with Na2S(aq) increased both the range of catalytic 
complexes and catalytic activity. The most effective technique, employing Au(III) 
in combination with Na2S, allowed previously invisible immunohistochemical 
deposits of polyDAB to be clearly seen in diagnostically relevant samples. 
Chapter 3 refined this technique by manipulating reagent concentrations whilst 
suppressing tissue argyrophilia with La(III)/H2O2, increasing 
immunohistochemical sensitivity by an order of magnitude. Marker deposition and 
thus the degree of amplification were dependent on reagent quality and conjugate 
coupling method. 
In Chapter 4, scanning  and transmission electron microscopical examination 
of d-block metal-polyDAB complexes identified 8 that were demonstrable by back-
scattered electron imaging of immunohistochemically stained tissue sections, 
including those of W(VI), Os(VIII), Pt(II) and Au(III). The majority were 
xviii 
 
detectable by energy dispersive X-ray analysis (EDX), but d-block metals were 
present in insufficient quantities for use in AEMT. 
In Chapter 5, polymerised halogenated aromatic diamines and bis-diamines as 
markers for AEMT were investigated. Immunohistochemical polymerisation of 
these compounds resulted in deposits of varying properties and compositions. Of 
the 16 compounds studied, morphological criteria identified polymers of 1,2-
diamino-4-bromobenzene and 1,2-diamino-4,5-diiodobenzene as suitable 
candidates; EDX indicated that the latter might be applicable to AEMT. 
Chapter 6 investigated silver deposition from a physical developer by 
photoconversion, a process used to visualise fluorescent markers in the electron 
microscope. Photo-excitation of immunofluorescently-stained tissue sections in the 
presence of physical developer resulted in the selective deposition of silver at the 
immunopositive sites. This novel method, in combination with the traditional 
photoconversion techniques, has the potential to permit discrimination of multiple 
live-cell fluorescent markers by AEMT. 
In Chapter 7, characterisation of polyDAB revealed the molecular weight to 
range from 600 to over 100,000; IR spectra were consistent with both indamine- or 
phenazine-like polymer structures. Poor solubility restricted further 
characterisation. 
In Chapter 8, a fibrillary form of poly-1,2-diamino-4,5-dichlorobenzene 
demonstrated a dramatic improvement over polyDAB for immunohistochemistry, 
and indicated that novel markers based on living polymer technology would be of 
considerable benefit in biological/biomedical research and clinical diagnosis. 
1 
 
 
Chapter 1 
Introduction 
  
2 
 
1  Introduction 
The identification and analysis of specific molecules in a variety of settings is 
an essential aspect of biological research and clinical diagnosis. One of the principle 
approaches for detecting biological molecules is the use of ‘reporter/marker’ 
systems; reporters detect them and markers visualise them. 
Analytical techniques that employ such systems can be broadly divided into 
two categories; those that localise molecules of interest within whole organisms, 
slices of tissue (sections), or cultured cells, and those that analyse extracts thereof. 
The former includes light and electron microscopy, X-ray imaging, magnetic 
resonance imaging and positron emission tomography. The latter includes 
analytical biochemistry, molecular biology and the various ‘-omic’ sciences such as 
genomics, proteomics, glycomics etc. 
 
1.1 An Apology from Biology 
Biological specimens, be they whole organisms, slices of tissue, or cultured 
cells, are extremely complex and delicate and thus present special challenges to the 
analytical scientist. From the physicist’s point of view, their properties are far from 
ideal; biological tissue is optically heterogeneous and cells, when in the living state, 
must be viewed in aqueous solution, thus limiting the resolution that can be 
obtained with the high quality lenses that optical physicists have spent so long 
perfecting. In addition, they are poor conductors of heat and electricity which puts 
constraints on certain aspects of tissue processing and the resolution that can be 
obtained in the electron microscope. The chemist, in turn, is faced with different 
problems; analytical techniques are frequently restricted by the requirement for 
aqueous solutions of (preferably) neutral pH and mild conditions. In addition, the 
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complexity of biological systems necessitates a large amount of empiricism once an 
analytical technique has been developed. To compound these problems, living cells 
react to their environment; the introduction of probably any substance into a living 
biological system will elicit a response, even though this may go unnoticed. In spite 
of these restrictions, considerable ingenuity has resulted in the accumulation of an 
enormous amount of knowledge regarding biological structure and function. 
Microscopy represents part of a spectrum of imaging technologies whose 
resolution covers millimetres (positron emission tomography), tens of micrometres 
(X-ray and magnetic resonance imaging), micrometres ( m) (light microscopy), 
nanometres (nm) (electron microscopy) and picometres (pm) (atomic force and 
scanning tunnelling microscopy). 
With the development of ever more sophisticated technologies and the 
integration of existing ones for examining biological systems in their living, as well 
as their preserved state, considerable opportunities exist for developing novel 
chemistries to meet the new challenges. 
 
1.2 A Brief History of Microscopy 
1.2.1 Early Lenses 
The earliest examples of convex lenses are rock crystal artefacts, discovered at 
Nineveh in Egypt, which have been dated to 2,600BCE (Barker, 1930). The ancient 
Greeks and Romans also possessed such artefacts but, like those of the Egyptians, it 
is uncertain whether they were used specifically for magnification, although it is 
unlikely that this property would have been overlooked. 
The earliest known written description of the action of lenses is the 7 volume 
treatise, Kitab al-Manazir (Optics). Written in 1038 by the Arabian scholar Alhazen 
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Abu Ali al-Hasan Ibn Al-Haitham (figure 1.1), it described, amongst other subjects, 
the optical action of the eye and the mechanism of refraction. Its translation into 
Latin in 1270 greatly influenced the likes of Frances Bacon and Johannes Kepler. 
 
1.2.2 Development of the Light Microscope 
The microscope can be defined as “a device by which one can make visible 
details of structure too minute to be seen with the unaided eye” (Hartley, 1993). Its 
invention, in about 1590, has been generally attributed to the Dutch spectacle 
makers, Hans and Zaccharias Janssen (figure 1.2). Early microscopes comprised 
either single, highly curved glass lenses or compound microscopes composed of 
several lenses. The former were small, portable and powerful whilst the latter 
afforded a much greater working distance, thus allowing specimens to be 
manipulated or dissected.  
In 1665 Robert Hooke (figure 1.3) published Micrographia, a collection of 38 
illustrations of specimens he had observed and in which he coined the term ‘cell’ 
(Hooke, 1665). Micrographia prompted the Dutch tradesman, Anthon van 
Leeuwenhoek (figure 1.4) to make his own simple, but powerful microscopes and 
thus to discover, for example, bacteria, free-living and parasitic microscopic 
protists, sperm cells and blood cells.  
There followed an explosion of interest in the microscopical world that these 
instruments revealed, and over the following 200 years considerable improvements 
were made in microscope optics and design, such as the achromatic (1824), 
aplanatic (1827) and apochromatic (1879) lenses, and the water (1855) and 
homogeneous (1878) immersion lenses. Microscope design underwent similar 
developments, such as fine focus adjustment (1673), the concave illuminating
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Figure 1.1. Alhazen Abu Ali al-Hasan 
Ibn Al-Haitham. 
  Zaccharias Jannsen 
 
 
 
Figure 1.3. Robert Hooke. 
   
 
Figure 1.2. Zaccharias Janssen. 
 
 
 
 
 
Figure 1.4. Anthon van 
Leeuwenhoek. 
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mirror (1727), the substage condenser (1831) and the binocular eyepiece (1860) 
(Hartley, 1993). 
In 1834, George Airy, the director of the Cambridge Observatory, published his 
observations on the diffraction of light from a point source (stars) (Airy, 1834) 
(figure 1.5). He observed that light did not produce a single point image, but a series 
of concentric rings, the Airy disc (figures 1.6). 
In 1873, Ernst Abbe (figure 1.7) published the formal mathematical basis for 
optical microscopy and showed the diameter of the central peak of the Airy disc to 
be: 
sin
22.1
n
 
where  is the wavelength of light,  is the half angle of acceptance of the lens and 
n is the refractive index of the medium between the object and the lens. Most 
importantly, he recognised that the limit to resolution was imposed, not by the 
design of lenses, but by the wavelength of light (Abbe, 1873). 
When two point sources are brought closer and closer together such that their 
Airy discs overlap, there comes a point when they are so close that it may not be 
possible to state whether they are indeed separate objects i.e. that they can be 
resolved.  
Lord Rayleigh established the arbitrary criterion that the point where the first 
minimum of one Airy disc coincided with the central maximum of the other should 
represent the resolving power of a lens system (Strutt, 1879) (figure 1.8). This 
distance, d, is thus: 
sin
61.0
n
d  
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Figure 1.5. George Airy. 
 
 
  
  
 
Figure 1.7. Ernst Abby. 
 
Figure 1.6. The Airy disc. 
 
 
 
 
 
Figure 1.8. The Rayleigh Criterion. 
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Since visible light has a wavelength between 390 nm and 750 nm, using the shortest 
wavelength and the highest numerical aperture (n sin ) lens, a theoretical resolution 
of 170 nm is possible. In practice, this is rarely, if ever, achieved. 
With the resolution limit of the light microscope firmly established, attention 
was more fruitfully directed towards the production of image contrast and the 
optimisation of specimen preparation. 
The invention of the phase contrast microscope, by Frits Zernike (figure 1.9) in 
1935, permitted the high resolution examination of living, unstained biological 
tissue (which has little inherent contrast) by displaying phase differences in the light 
transmitted through the specimen as differences in amplitude (Zernike, 1935). 
Optical restrictions of the condenser and objective lenses, halo-like artefacts and 
specimen thickness limited resolution, but these problems were overcome by the 
development of differential interference contrast that exploited differences in the 
specimen’s thickness and refractive index to produce differences in amplitude and 
colour (Normaski and Weill, 1954) (figure 1.10). 
A lens’s depth of field (the depth of sample that is in focus at any given time) is 
inversely proportional to (n sin )
2
, which places constraints on high resolution light 
microscopy; typically 0.2 m for a x100 oil-immersion objective lens. Thus, for a 
conventional 4 m thick section viewed under these conditions, 95% of the 
specimen is out of focus. This out of focus light contributes to the final image and 
compromises the spatial resolution that can be achieved.  
Two techniques exits that overcome this problem, namely (1) thin sectioning 
and (2) confocal microscopy. 
Cutting sections thinner than 0.5 m normally requires samples to be 
embedded in a hard resin, which restricts sample size for various practical reasons.
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Figure 1.9. Fritz Zernike. 
 
Figure 1.10. Georges Normaski. 
 
 
Figure 1.11. The principle of confocal microscopy. 
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In confocal microscopy, out of focus light is excluded with confocal pinholes (figure 
1.11). The restricted view that this technique engenders is overcome by scanning 
the specimen with a point source of illumination. Scanning was originally achieved 
by moving either the specimen (Minsky, 1957) or the light source with a perforated 
spinning disc (Nipkow, 1884) in the tandem scanning microscope (Petran et al., 
1968). Since most light is excluded with this technique, extremely bright sources are 
required such as mercury arc lamps as in later designs of the spinning disc system 
(Petran et al., 1985) or lasers in the confocal laser scanning microscope which uses 
mirrors to control beam movement (Brakenhoff 1979). These optical techniques 
have an absolute requirement for light derived from the specimen itself, and cannot 
exploit transmitted light, which puts constraints on their application. In the 
confocal’s original manifestation, reflected light from the specimen itself formed the 
image, but modern biological confocal microscopy frequently collects light from 
fluorescent markers. 
The most significant aspect of confocal microscopy is the facility for 3-
dimensional reconstruction (figure 1.12) which is achieved by combining x-y 
scanning with controlled vertical movement of either the microscope stage or the 
objective lens (z-axis). It is this, in combination with rapid scanning technologies, 
which has been of particular importance for the study of dynamic events in living 
cells. Additional optical techniques are frequently incorporated into live cell studies, 
such as the determination of intramolecular conformational alterations or changes 
in intermolecular distance by Förster resonance energy transfer (Förster, 1948) or 
the measurement of diffusion rates within membranes using fluorescence recovery 
after photobleaching (Axelrod et al., 1976). More recently, fluorescent markers 
within cells have been localised at sub-diffraction resolutions using a variety of
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Figure 1.12. Red/green anaglyph reconstructed from a confocal image z-stack, 
collected in reflection mode, of a 90 m thick section of rat lung 
immunohistochemically stained for caveolin-1 and visualised with colloidal 
gold/silver. Requires red/green glasses.
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techniques such as stimulated emission depletion microscopy (Donnert et al., 2006; 
Willig et al., 2006; Westphal et al., 2008), structured illumination microscopy 
(Gustafsson, 2000; 2005; Carlton et al., 2010), photoactivated localization 
microscopy (Betzig et al., 2006) and stochastic optical reconstruction microscopy 
(Rust et al., 2006). In none of these techniques, however, is it possible to directly 
visualise cellular structure at the same resolution. 
Modern light microscopy, while allowing spectacular results to be achieved, is 
ultimately limited, in the broader sense, by the resolution limit imposed by visible 
light. 
 
1.2.3 Development of the Electron Microscope 
The theoretical description of the quantum nature of light by Max Plank in 
1900, together with Niels Bohr’s model of the atom in 1922, led Louis de Broglie 
(figure 1.13) to theorise that electrons also had wave-like characteristics (de Broglie, 
1923), and that the wavelength was considerably less than that of light (de Broglie, 
1925). If electrons, instead of light, could be used to form images, the resolution 
would be limited by the energy of the electron which is given by the equation: 
mv
h
 
where h is Plank’s constant, m is the mass of the electron, and v is the electron’s 
velocity. The accelerating voltage (V) of the electron microscope, which determines 
the electron’s momentum (mv), is related to the wavelength of the electron 
according to the equation: 
2
1
)2( mV
h
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Using this reasoning, Ernst Ruska (figure 1.14) and Max Knoll (figure 1.15) 
elaborated the first electron lens in 1931 and suggested the potential resolution of 
the electron microscope (Knoll and Ruska, 1932) which they subsequently 
constructed in 1933 (figure 1.16). The first practical transmission electron 
microscope (TEM), with a theoretical resolving power of 10 nm, was constructed at 
the University of Toronto by James Hillier and Albert F. Prebus in 1938, the same 
year as the first commercial machine was built by Siemens. Modern TEMs can 
easily achieve sub-nanometre resolution and the most advanced instruments have 
achieved a spatial resolution of 40 pm (Alem et al., 2011). 
Since only the central area of the magnetic lens of the TEM is used, the 
instrument has a very small numerical aperture, typically 0.01 (compared to 1.4 for 
a x100 objective of a light microscope), resulting in a large depth of field; up to 1 
mm at 80 kV. Aberration-corrected microscopes and scanning transmission electron 
microscopes (STEM) have much higher numerical apertures, and thus the depth of 
field is greatly reduced, often to a few nanometres. In the conventional TEM, the 
large depth of field is exploited in electron tomography, where relatively thick 
sections (500 nm or more) are rotated orthogonally to the beam axis to produce a 
series of images, and the 3-dimensional structure of the sample is reconstructed by 
back-projection (Crowther et al., 1970). In high resolution instruments, the small 
depth of field is exploited in an analogous way to confocal microscopy with the 
exception that out-of-focus information is removed from the through-focus series of 
digital images by various algorithms (Borisevich et al., 2006; Hovden et al., 2011). 
The concept of the scanning electron microscope (SEM) was first proposed in 
1935 (Knoll, 1935) and the first use of such an instrument for examining the surface 
of a solid object occurred in 1942 (Zworykin et al., 1942). 
14 
 
 
Figure 1.13. Louis de Broglie. 
 
 
 
Figure 1.15. Max Knoll. 
 
 
Figure 1.14. Ernst Ruska. 
 
 
 
Figure 1.16. Knoll and Ruska’s electron 
microscope.
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The most remarkable aspect of the SEM was its ability to show three-
dimensional structure (McMullan, 1953). Unlike the TEM, no image is formed 
anywhere within the SEM. Instead, the instrument employs lenses to de-magnify 
the electron beam to a finely focussed point which is scanned across the specimen. 
Electrons derived from the sample are detected, and the signal synchronised with a 
display screen. Spatial resolution is determined by both the diameter of the focussed 
beam, which is dependent upon the electron source, and the interaction volume 
from which signal-generating electrons are derived, the size of which is proportional 
to the energy of the electron beam and also to the composition of the material under 
observation (Goldstein et al., 2003). 
Recently, scanning microscopes that use helium ions, rather than electrons, 
have been developed. The advantages of this technology are the small probe size, 
small interaction volume and brightness of the source (Ward et al., 2006; Postek 
and Vladar, 2008). The instrument has been used primarily in the examination of 
materials (Rodenburg et al., 2010). 
 
1.2.4 Interaction of Electrons with Matter 
The interaction of high energy electrons with matter results in the production of 
a variety of signals that can give considerable information regarding the specimen’s 
structure and composition. Electrons from the beam can undergo elastic scattering 
to provide specimen contrast in the TEM and also impart information regarding 
both the structure (electron diffraction) and atomic number contrast (back 
scattering). Inelastically scattered electrons that travel through the specimen in the 
TEM can provide information regarding both elemental composition and chemical
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Figure 1.17. Interaction of high energy electrons 
with a thin specimen. 
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bonding (figure 1.17) (Williams and Carter, 1996; Goldstein et al., 2003). In 
addition, Bremstrahlung X-rays (from the deceleration of electrons entering the 
sample) and characteristic X-rays (due to electron shell transitions following 
ejection of core electrons) are produced, the latter providing information regarding 
elemental composition. By scanning the beam across the specimen and analysing 
either characteristic X-rays or the energy loss of inelastically scattered electrons 
(Mekler et al., 1964), elemental maps can be produced. In the SEM, beam electrons 
impart some of their energy to eject low energy electrons (secondary electrons) from 
the conductance layer to provide information regarding surface topology. 
 
1.3 Biological Sample Preparation 
 
Judged by the quality of the preparations used as basis for many investigations, 
the importance of technical process is not fully appreciated. The value of the 
results obtained from any microscopical study is directly dependent upon the 
quality of the techniques employed in preparing the material (McClung, 1929). 
 
Living cells can be observed from smears on glass-slides or from tissue culture 
in Petri dishes, but resolution is poor. It is much improved if the tissue has the same 
refractive index (n) as that of the glass lens with which it is viewed. In order to 
achieve this, the tissue or cells are placed on glass slides and mounted under thin 
slivers of glass (coverslips) in a clear substance (mountant) with the same refractive 
index as glass. The highest resolution is achieved when the air gap between the 
coverslip and the microscope lens is excluded with a drop of fluid (immersion oil) 
again having the same refractive index as glass. 
18 
 
One of the earliest mountants was the resinous plant extract, Canada Balsam. 
Its use required cells and tissue to be dehydrated and ‘cleared’ (clearing is the 
increase in refractive index that results from many commonly employed solvents 
that are miscible with both dehydrating solvents and mountants and which results 
in the tissue becoming more transparent). Live cells reacted very badly to such 
treatment, becoming shrunken and severely distorted. It became clear that tissue, 
cells and their contents required preservation by ‘fixation’, a method designed to 
stop all cellular processes immediately before they can react to subsequent 
treatments. In theory, fixation may be defined as the instantaneous, perfect 
preservation of tissue structure and chemistry. Further, the perfectly preserved cell 
structure should be prevented from changing whilst the tissue is processed for 
microscopic examination. In practice, this ideal is rarely achieved, and, in some 
cases, undesirable. 
Even when mounted correctly, whole cells and tissues still lack clarity because 
of the limited depth of focus of glass lenses, and thin sections are often required to 
study the interior cellular structure. Before sectioning can be achieved the tissue 
must be embedded in a suitable matrix to provide mechanical support; the harder 
the matrix, the thinner the sections that can be prepared. 
 
1.3.1 Fixation 
Fixation of tissue is a vast and complicated subject. Innumerable techniques 
have been devised, many of which have their own specialised applications and 
devotees. By 1958 it was estimated that over 200 chemical fixatives containing 
formaldehyde existed (Baker, 1958). Two broad approaches to fixation have 
predominated. Chemical fixation precipitates or cross-links native constituents into 
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insoluble derivatives whilst physical fixation, usually very rapid freezing, 
immobilises cell constituents without causing chemical change. 
 
1.3.1.1 Chemical Fixation 
Common precipitating fixatives include organic solvents such as acetone, 
chloroform, methanol and ethanol that rapidly precipitate protein and some other 
cellular constituents. Organic solvents may damage cells by contortion of structures 
and extraction of substances. Lipids are especially at risk of extraction, in particular 
from cell membranes that are rich in saturated and unsaturated lipid. 
Cross-linking fixatives include the low molecular weight aldehydes, such as 
formaldehyde and glutaraldehyde, which cross-link proteins without precipitating 
them, and certain heavy metal compounds. Formaldehyde in neutral buffered 
aqueous solution (usually 4% w/v) is the most commonly used fixative for light 
microscopy. Its fixative properties were first noted in 1893 during assessment of its 
potential as a bactericide (Blum, 1893). Formaldehyde penetrates rapidly into tissue 
and cross-links mainly proteins. Much of the understanding of formaldehyde 
fixation is based on model systems (Fraenkel-Conrat et al., 1947; Fraenkel-Conrat 
and Olcott, 1948a; 1948b), and there remains considerable uncertainty as to its 
exact mechanism of action in tissue. Fixation must continue for at least 22 hours 
before permanent methylene bridges are formed (Fox et al., 1985) and the great 
histologist, Lillie, insisted that 48 hours was the minimum requirement for 
adequate fixation (Lillie, 1965).  
There is, unfortunately, considerable confusion in the literature regarding the 
preparation of formaldehyde solutions. Traditionally, such solutions were prepared 
by simple dilution of formalin (water saturated with formaldehyde gas) in neutral 
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buffer, 100 mM phosphate being the most common. Alternatively, 
paraformaldehyde (PFA) was dissolved in water by reflux and the diluted solution 
stored over marble chips (to remove formic acid), often for many months, to ensure 
depolymerisation (Dr. Geoff Newman, Medical Microscopy Sciences, Cardiff 
University, personal communication). More recently, the use of freshly prepared 
dilute solutions of PFA has become commonplace, based on the belief that 
depolymerisation is immediate and complete. Indeed, simple solution has been 
used as a judge of this (Helander, 2000). This practice appears to have arisen from 
the preparation of formalin from trioxane (Richardson, 1961), its subsequent 
misnaming as PFA (Robertson et al., 1963; Glauert, 1975), and the unsupported 
assertion that solution of PFA leads to immediate depolymerisation (Glauert, 
1975). Studies regarding the depolymerisation of PFA in aqueous solution are few, 
but suggest that the concentration of formaldehyde (as methylene glycol) in freshly 
prepared solutions is quite low (Hallbeck, 1957) and that equilibration times 
following dilution of concentrated solutions can be many hours (Le Botlan et al., 
1983). 
In 1963 glutaraldehyde was identified as the best primary fixative for electron 
microscopy (Sabatini et al., 1963). In contrast to formaldehyde, glutaraldehyde 
penetrates tissue slowly (approximately 0.5 mm in 3 hours at room temperature) 
but irreversibly cross-links almost instantaneously. Further studies introduced 
mixtures of aldehydes, the most popular being formaldehyde and glutaraldehyde 
(Karnovsky, 1965).  
Another popular chemical fixative is osmium tetroxide, which is used almost 
exclusively for electron microscopy. Its value as a fixative was noted in 1927 
(Strangeways and Canti, 1927) and it was used as the sole fixative in early electron 
21 
 
microscopic studies (Palade, 1952). Osmium tetroxide, like glutaraldehyde, 
penetrates tissue slowly. Now it is usually employed as a secondary fixative 
following aldehyde fixation. Its main value has been to improve the preservation of 
unsaturated lipids (Riemersma, 1968) and to increase tissue contrast in the electron 
microscope. 
Uranyl acetate is a less frequently employed, though no less useful, fixative 
than osmium tetroxide. It is used either as a secondary fixative after primary 
aldehyde fixation (Ryter et al., 1958) or as a tertiary fixative/pre-embedding stain 
after aldehyde and osmium (Farquhar and Palade, 1965) and probably acts by 
stabilising the phospholipids of cell membranes (Silva et al., 1968). 
Chemical fixation, while allowing a broad range of staining techniques to be 
employed, has a number of undesirable side effects, such as tissue shrinkage 
(Sabatini et al., 1963; Eisenberg and Mobley, 1975), the lowering or loss of 
biological activity (Sabatini et al., 1963; Ericsson and Biberfel, 1967) and/or 
antigenic reactivity (Hancock et al., 1982) and the rearrangement of cellular 
structure (Hobot et al., 1985) following loss of membrane permeability (Woldringh, 
1973). 
 
1.3.1.2 Physical Fixation 
 
Even when good vitreous samples are available, however, there remains a major 
difficulty in locating and unequivocally identifying specific areas of interest for 
study in the cryo-EM. The inherently low contrast of frozen-hydrated samples, 
combined with their beam sensitivity, makes it difficult to find regions of interest 
without destroying them; this severely limits the benefit of an otherwise powerful 
technique for answering biological questions (Schwartz, 2007). 
22 
 
Rapid freezing techniques are not strictly acts of fixation but rather physical 
immobilisation. Freezing generates its own artefacts which usually revolve around 
the formation of ice crystals, resulting in loss of structure and cellular content. For 
light microscopy, such artefacts are tolerable if histology is urgently required e.g. 
diagnosis during surgery or if tissue reactivity is paramount such as the 
demonstration of enzyme activity. In these circumstances, freezing is achieved by 
plunging the specimen into isopentane cooled with dry ice. 
For high resolution light microscopy, or electron microscopy, more elaborate 
techniques are required, namely the formation of vitreous ice i.e. ice which has no 
discernable crystalline structure in the electron microscope. Specimens must be very 
small, typically 0.1 – 0.2 mm
3
 due to the poor thermal conductivity of biological 
material. Freezing can be achieved by slamming the specimen onto a liquid 
nitrogen pre-cooled polished copper block or plunging it into liquid nitrogen pre-
cooled liquid propane. Vitreous ice, and thus good ultrastructural preservation, is 
achieved to a depth of approximately 6 m. Proprietary high pressure freezing 
systems are also available which claim to produce vitreous ice to a depth of 200 m, 
but 30 m is probably more realistic (Dr. Jan Hobot, Medical Microscopy Sciences, 
Cardiff University, personal communication) and such systems are very expensive. 
The water content of the tissue now acts as the embedding matrix, allowing 
sections to be cut in the micrometre range, for light microscopy, or in the 
nanometre range for transmission electron microscopy. Frozen sections still require 
chemical fixation to prevent loss of structure or substance when the section is 
thawed for subsequent staining. Frozen, hydrated sections may be observed directly 
in the transmission electron microscope if a suitable freeze-stage is available to keep 
them frozen in the heat of the electron beam, but contrast is very poor and the 
23 
 
thickness of the specimen is restricted, usually to a maximum of about 0.5 m, 
limiting their use in electron tomography. 
 
1.3.2 Dehydration and Infiltration 
The majority of embedding media are insoluble in water and dehydration is 
usually required. This is achieved by passing the specimen through a gradient of 
organic solvents, usually ethanol or acetone (typically 30%, 50%, 70%, 90% and 
finally 100%), the intention being to gently remove the water and avoid osmotic 
shock (distortion and contraction of cells that occurs if tissue is plunged into high 
concentrations of organic solvents). 
The dehydrating solvent is often replaced with a suitable intermediate solvent 
which is miscible with both the dehydrating solvent and the embedding medium. 
An alternative to full dehydration is partial dehydration to 70% organic solvent 
which markedly increases the tissue’s sensitivity to reporters (Newman et al., 1982; 
1983a) and can be employed with certain hydrophilic embedding media. 
Once suitably dehydrated, the sample is infiltrated with several changes of the 
embedding medium to ensure complete removal of the dehydrating agent.   
 
1.3.3 Embedding Media 
Paraffin wax, which was introduced in the late 19
th
 century by Edwin Klebs, 
remains the most popular tissue embedding medium for light microscopy. The 
intermediate solvent is usually xylene. Other embedding media have been used 
including celloidin (Peterfi 1921), gelatine (Oakley, 1937) agar (Friedland, 1951) 
and ester waxes (Steedman, 1960).  
For TEM, much thinner sections are required (typically 70 nm) and harder 
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embedding substances are essential. The early embedding resins were based on 
methacrylate (Newman et al., 1949), but these were unstable in the electron beam 
and prone to uneven polymerisation and shrinkage. By the time that these problems 
had been addressed (Kushida, 1961a; 1961b), the beam stable epoxy resins (Craig et 
al., 1962; Glauert, 1965; Spurr, 1969) had become firmly established and remain 
the most popular embedding media today. The epoxy resins are hydrophobic and 
almost impervious to aqueous stains unless these are strongly alkaline. Sections can 
be ‘etched’ for immunohistochemistry (Bendayan and Zollinger, 1983), but the 
procedures are deleterious to tissue reactivity and staining is often poor with high, 
non-specific background staining. In many cases, specific staining techniques are 
applied pre-embedding, which can limit the specimen’s usefulness for other 
applications. 
 The problems associated with epoxy resins have been largely circumvented by 
the introduction of acrylic resins such as the lowicryls (Kellenberger et al., 1980) 
and the LR resins (Newman et al., 1983a). These resins are beam stable and, most 
importantly, hydrophilic. This latter property not only allows partial dehydration of 
tissue but also post-embedding staining with almost any technique without the need 
to etch. The lowicryls have the added advantage of permitting low temperature 
(below -35
o
C) embedding techniques for cryoimmobilised or very lightly fixed 
tissue (Newman and Hobot, 2001). In addition, their composition is published and 
thus their properties can be manipulated to meet specific requirements (Carlemalm 
et al., 1982; Acetarin et al., 1986). 
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1.3.4 SEM Sample Preparation 
Preparation for scanning electron microscopy rarely requires embedding, since 
biological SEM is primarily concerned with surface features. The specimen is fully 
dehydrated as above and an additional step of critical point drying (CPD) is 
introduced (Anderson, 1951). CPD replaces the dehydrating solvent with liquid 
carbon dioxide under high pressure. Once exchange is complete, the temperature is 
raised above the critical point and gaseous carbon dioxide is slowly withdrawn. 
Hexamethyldisilazane has been proposed as a cheap alternative to CPD (Nation, 
1983), since it requires no specialised high pressure equipment, relying solely on 
solvent evaporation. Since biological tissue has poor thermal and electrical 
conductivity, the specimen is finally coated in a thin (5-50 nm) layer of metal (e.g. 
gold, platinum, chromium) to minimise beam damage and accumulation of 
electrical charge which impairs image quality. It is this layer of metal that provides 
secondary electrons for imaging. Alternatively, the specimen may be coated in 
carbon to allow X-ray microanalysis or back-scattered electron imaging to be 
performed. 
The invention of the environmental SEM (Danilatos, 1981), which employed 
differential pumping to achieve an hydrated atmosphere within the specimen 
chamber of the instrument, obviated the need to dehydrate and coat samples. Its 
principle biological application has been the observation of unfixed samples in their 
hydrated state, such as plant cells (Pope and Scheetz, 1990), carrots (Thiel and 
Donald, 1998), bacteria (Bergmans et al., 2005) and yeast (Ren et al., 2008). All 
these organisms, however, possess cell walls that confer protection to the adverse 
effects of the electron beam. In contrast, considerable damage occurs to animal cells 
when they are subjected to similar conditions (Kirk et al., 2009). 
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1.3.5 Sectioning 
Tissue sections are cut on a microtome or cryostat, for paraffin embedded or 
frozen sections respectively, and collected onto glass slides. 4 m thick sections are 
usually preferred since this ensures that the internal structures of all but the smallest 
cells are available for staining and examination. For subsequent staining, wax is 
removed by simply reversing the dehydration process (rehydration). Epoxy resin 
sections require etching if anything other than the simplest staining technique is 
required, but acrylic sections can be stained directly. For electron microscopy, 
ultramicrotomes (for resin-embedded samples) and cryoultramicrotomes (for frozen 
samples) are used and the specimen is collected on a thin metal grid which confers 
mechanical support as well as thermal and electrical conductivity. 
 
1.4 Staining 
 
The method of staining, once having taken root in the animal histologist, grew 
and grew, till to be an histologist became practically synonymous with being a 
dyer, with the difference, that the professional dyer knew what he was about, 
while the histologist, with few exceptions, did not know, nor does he to the 
present day (Mann, 1902). 
 
This rather caustic remark may perhaps have been true in the latter part of the 
19
th
 century, but innumerable publications concerning the mechanism of staining 
since that time attest to the detailed understanding of the vast majority of staining 
techniques. With the widespread introduction of high throughput, automated 
staining systems and staining kits, the latter part of Mann’s comment may well 
become true once again, since it is no longer necessary to understand the 
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mechanism of staining, nor indeed the function of the individual components. All 
that is required is to mix solution A with solution B. 
Most biological tissue has insufficient inherent colour or electron opacity 
(capacity to scatter beam electrons) to allow it to be conveniently examined in the 
light or electron microscope respectively. To overcome these limitations, the 
inherent optical properties of biological tissue have been exploited to great effect, 
but it is not only more convenient to impart colour/electron opacity to biological 
tissue but often considerably more useful, since additional information regarding 
morphology and composition can be elucidated.  
Staining at the light microscopic level has been traditionally regarded as a 
variety of dyeing using natural or synthetic coloured organic reagents. The 
development of increasingly sophisticated staining techniques has led to a revision 
of this perception such that it may now be defined as “any means of conferring a 
colour reaction on tissue elements and their stainable contents, metabolic, 
functional or pathological” (Conn, 1977). Its application to electron microscopy 
merely requires the substitution of ‘differential electron opacity’ for ‘colour’. 
The first deliberate use of stains for microscopical examination dates back to 
1714 when van Leeuwenhoek used saffron to improve the visibility of muscle fibres, 
but it was not until the 1860’s that staining with, for example, the boxwood extract 
haematoxylin, and aniline dyes became widespread. Today, a vast number of stains 
and staining techniques are available for illustrating various tissue components 
(Conn, 1977; Drury and Wallington, 1980; Culling et al., 1985; Hayat, 1993). 
Staining can be performed before embedding (pre-embedding) or after (post-
embedding). 
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1.4.1 Staining, Cytochemistry and Histochemistry 
General staining techniques are those where the underlying mechanism of 
staining was not known, or at least poorly understood, at the time of their 
invention. In contrast, cytochemical and histochemical techniques employ a 
specific chemical reaction to illustrate a particular cellular component or process. 
The definitions for these two major cellular analytical techniques, cytochemistry 
and histochemistry, have changed over the preceding century as technologies have 
advanced, and new disciplines developed. Even today, considerable confusion 
exists regarding exact definitions, particularly when applied to immunostaining 
techniques. Cytochemistry originally referred to the biochemical analysis of cells, 
and included such techniques as morphometry, electrophoresis and quantitative 
estimation of enzyme activity from tissue extracts (Glick, 1961), but these 
techniques developed into separate subjects e.g. cytometry and biochemistry. 
Histochemistry has been defined as “a borderline field between histology, analytical 
chemistry or biochemistry” (Gomori, 1952) or “the identification, localisation and 
quantification, in cells and tissues and by chemical or physical tests, of specific 
substances, reactive groups and enzyme catalysed activities” (Pearse, 1972). A 
practical distinction might be based on whether whole cells/tissues or sections are 
being examined, but this becomes imprecise when thick sections (>20 m thick) 
containing whole cells are the subject of investigation. 
For the purpose of this thesis, cytochemistry and histochemistry will be defined 
as the performance of chemical reactions on whole cells/tissue and on sections 
(irrespective of their thickness) respectively. 
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1.4.1.1 General Staining 
By far the most popular general staining technique, at least in animal tissue, is 
haematoxylin and eosin (H&E) (figure 1.18). Haematoxylin is one of the earliest 
histological stains (Waldeyer, 1863) and is used, principally, to illustrate cell nuclei 
by virtue of its affinity for the basic histone proteins of chromatin. A vast array of 
formulations have been developed to improve intensity and fastness of colour, and 
by 1954 over 120 had been catalogued (Gray, 1954). Toluidine blue is frequently 
employed as a morphological stain for thin (0.35 µm) sections of resin embedded 
material for light microscopy (figure 1.19) (Richardson et al., 1960). In cytology, 
the polychromatic Papanicolaou's stain is widely used to discriminate a variety of 
cell types in smear preparations, and is of particular value in screening for cervical 
cancer (Papanicolaou and Traut, 1941). 
 
1.4.1.2 Cytochemistry 
Living cells present special challenges for the microscopist since the plasma 
membrane represents a significant barrier to the introduction of reporters and 
markers into the cell’s interior. Low molecular weight dyes can often freely 
penetrate living cells for tracking cell movement (Merrilees et al., 1995) and 
illustrating the distribution of organelles (Plasek and Sigler, 1996) and ion-sensitive 
proteins have been internalised using liposomes (Dormer et al., 1977). For the 
detection of proteins, this problem has been largely overcome by molecular 
biological techniques. These techniques frequently use viral vectors to introduce 
genes into the target cell or organism that encode the protein of interest, with an 
additional amino acid sequence that encodes either a fluorescent protein tag, or acts 
as a reporter. Expression of this hybrid protein is believed to reflect the behaviour
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Figure 1.18. 4 m thick section of paraffin wax-embedded kidney stained with 
haematoxylin and eosin. 
 
Figure 1.19. 0.35 m thick section of LR White-embedded abdominal muscle 
stained with toluidine blue. 
31 
 
and distribution of its native counterpart. Fluorescent proteins include green 
fluorescent protein (GFP) (Chalfie et al., 1994) and its derivatives. Concern 
regarding the size of GFP and its potential to interfere with the normal functioning 
of the protein has led to the development of short peptide tags that act as 
coordination hosts for fluorogenic ligands e.g. tetracyseine and its respective 
biarsenical ligand (Adams et al., 2002). 
At the electron microscopic level, very few cytochemical techniques have been 
employed, since it is rare that whole cells are examined, principally because of their 
thickness. In the SEM, the distribution of cellular peroxidase and acid phosphatase 
has been successfully demonstrated (Soligo et al., 1983). Techniques for visualising 
fluorochromes in the electron microscope exploit the early observation that they 
can, upon excitation, induce the polymerisation of biphenyl-3,3′,4,4′-tetramine 
(3,3′-diaminobenzidine, or DAB) which is then rendered electron-opaque by 
treatment with osmium tetroxide (Maranto, 1982). Such preparations are invariably 
examined by thin section following either resin embedding or rapid freezing. 
 
1.4.1.3 Histochemistry 
The complexity and specificity of these methods range from the staining of 
broad classes of compounds with similar physicochemical properties to highly 
specific and complex techniques that illustrate single molecular species. 
Anionic sites, such as the complex acidic polysaccharides of gut secretory cells, 
can be visualised with cationic dyes such as the copper phthalocyanin, Alcian blue 
(figure 1.20) (Steedman, 1950). In this case, the reporter and marker are the same. 
Tissue carbohydrates can be demonstrated by selective oxidation with periodic 
acid to yield dialdehydes (reporter) and visualised with Schiff stain (pararosaniline) 
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(marker) in the periodic acid-Schiff (PAS) stain (figure 1.21) (Hotchkiss, 1948). The 
electron microscopical equivalent of this technique uses a secondary reporter, 
thiocarbohydrazide, to form an electron-opaque marker complex with osmium 
(Seligman et al., 1965) or silver (Theiry, 1967; Neiss, 1988). The latter technique 
has also been modified for light microscopic examination of thin resin sections 
(figure 1.22) (von Ruhland and Newman, 2001). 
More specific techniques for demonstrating carbohydrates exploit the affinity of 
a group of (predominantly) plant proteins called lectins for specific complex 
carbohydrate residues. Ricin, for example, is derived from the seed of the castor oil 
plant Ricinus communis and occurs in two forms, designated RCA60 and RCA120, 
which bind strongly to N-acetyl-D-galactosamine and terminal -D-galactosyl 
residues respectively (Nicholson et al., 1974). Highly specific carbohydrate binding 
proteins exist that can identify single complex carbohydrates, such as hyaluronic 
acid binding protein (HABP) (figure 1.23) (Dsouza and Datta, 1985).  
The high specificity of other reporter/target interactions have been exploited 
such as the detection of tissue antibodies by their respective antigens (Coons et al., 
1955) and the localisation of enzyme substrates by using the enzyme as the reporter. 
These reporters can be visualised by linking them to a variety of markers such 
as fluorochromes or colloidal gold, or marker generating systems such as enzymes. 
Enzymes may be visualised directly by their action upon a substrate analogue, 
which results in the production of a marker. More frequently, however, the product 
of the enzyme catalysed reaction is linked to a separate marker generating reaction; 
the demonstration of tissue alkaline phosphatase serves to illustrate this principle.
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Figure 1.20. 4 m thick section of paraffin wax-embedded colon. Goblet cells 
stained with Alcian blue. Eosin counterstain. 
 
 
Figure 1.21. 4 m thick section of paraffin wax-embedded peritoneum. Basement 
membrane of blood vessels stained with PAS. Cell nuclei stained with 
haematoxylin. 
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Figure 1.22. 0.35 m thick section of LR White-embedded peritoneum. Sclerotic 
blood vessels stained with periodic acid-thiocarbohydrazide-silver proteinate-silver 
enhancement. 
 
Figure 1.23. 0.35 m thick section of LR White-embedded fibrotic peritoneum 
stained for hyaluronic acid with HABP-colloidal gold conjugate and silver 
amplification. Sirius red counterstain. 
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Early techniques, using phosphate esters of simple organic compounds such as -
glycerphosphate as the enzyme substrate, employed calcium salts to precipitate the 
phosphate (reporter) that was released following enzymatic hydrolysis. The 
precipitate was visualised by substitution with either silver(I) and subsequent 
photoreduction to metallic silver (marker), or with cobalt(II) followed by 
conversion to black cobalt sulfide (marker) (Gomori, 1939). Later techniques 
employed reactions that formed insoluble azo dyes with the organic product, such 
as -naphthyl phosphate (substrate) with -naphthyl diazonium chloride (Menten 
et al., 1944) or with -naphthyl diazonium naphthalene-1,5-disulphonate 
(Manheimer and Seligman, 1948), or exploited the chromogenic dimerisation of 
indolyl (Seligman et al., 1954) or its halogenated derivatives (Horowitz et al., 1966), 
either alone or coupled to the reduction of tetrazoliums (McGadey, 1970). More 
recently, the early techniques of phosphate precipitation have been revisited and 
modified, such as conversion of cobalt phosphate to its ferricyanide followed by 
intensification with osmium (Hanker, 1979) or precipitation of phosphate with 
cerium, conversion to the perhydroxide followed by catalytic polymerisation and 
deposition of DAB for light (Halbhuber et al., 1988) or electron microscopy 
(Halbhuber et al., 1991). Recently, fluorogenic substrates have become available for 
increasing signal strength (Huang et al., 1993). 
The application of these principles together with considerable ingenuity has 
allowed a vast range of tissue enzymes to be visualised and localised at both the 
light and electron microscopic levels (Pearce, 1972; Hanker, 1979). 
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1.4.1.4 Immuno-techniques 
Immuno-techniques are specialised histochemical methods which exploit the 
high specificity of antibodies for their respective antigens. These techniques 
overcome the fact that different proteins, with a few notable exceptions, e.g 
amyloid and reticulin, react in an identical manner with conventional histochemical 
staining techniques. Antibodies are proteins, and thus no different. They can be 
visualised indirectly, however, by attaching a marker to them (labelling or 
conjugating). The enormous number of antibodies now available makes this 
approach impractical, since application dictates the choice of marker. It is more 
efficient and convenient to use indirect methods. The simplest technique uses a 
labelled secondary antibody (secondary reporter). More complex techniques use 
bridge systems and polymeric secondary reporters. 
 
1.4.1.4.1 Immunocytochemistry (ICC) 
Antibodies, labelled with R salt (2,3,6- -naphtholdisulphonate) coupled via 
diazotised benzidine, were first used at the London Hospital, U.K. in 1934, 
demonstrating that they could be indirectly visualised without adversely 
compromising their immunoreactivity. Importantly, the significance of diluting the 
antibody to overcome non-specific staining was also noted (Marrack, 1934). 
Marrack labelled the surface of his cells, but nowadays, it is often desirable to 
visualise internal cellular components. Since antibodies are large molecules 
(150kD), they do not penetrate the cell membrane and it is necessary to permeablise 
cells by treating them with organic solvents (Fujiwara and Pollard, 1976) or 
detergents such as saponin (Ohtsuki et al., 1978), but structural preservation is 
severely  compromised (Wassler et al., 1987). 
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Given the poor structural preservation that inevitably accompanies techniques 
that facilitate ICC of whole cells, it is not surprising that no TEM studies appear to 
have been conducted on these preparations. In contrast, many studies have 
exploited the SEM where interest is centred primarily on surface phenomena. 
Given the complex topography of cell surfaces, ease of identification, rather than 
electron opacity, has determined the choice of markers (Molday and Maher, 1980). 
The earliest markers were latex spheres (Lo Buglio et al.; 1972, Molday et al., 
1974), but these have been superseded by colloidal gold (Horisberger et al., 1975) 
since it is easily visualised using backscattered electron imaging. The possibility of 
using marker generating systems, particularly enzymes, has also been suggested. 
Horseradish peroxidase (HRP) has been used to polymerise DAB, which has been 
subsequently identified based on morphological criteria (Ward et al., 1973). A 
refinement of this idea, involving the modification of DAB with a suitable element 
to facilitate identification using analytical electron microscopy has also been 
suggested (Chandler, 1973) but this was never examined, probably because of the 
success of the colloidal gold technique. 
 
1.4.1.4.2 Immunohistochemistry (IHC) 
In 1941, Marrack’s seminal work was repeated by Albert Coons who increased 
signal strength by labelling antibodies with the fluorochrome, anthracene (Coons et 
al., 1941) and subsequently with fluorescein to detect antigens in tissue sections for 
the first time (Coons et al., 1942). The simultaneous detection of several antigens 
was achieved with the multiple immunofluorescence technique in which each 
antibody was labelled with a different fluorochrome (Clayton, 1954). Problems with 
tissue autofluorescence prompted the development of an alternative to fluorescein, 
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tetramethylrhodamine (Hiramoto et al., 1958). Both fluorescein and 
tetramethylrhodamine remained the most popular fluorochromes until the 
development of more photostable compounds such as the cyanine dyes (Mujumdar 
et al., 1989), Alexa dyes (Panchuk–Voloshina et al., 1999) (figure 1.24) and 
semiconductor Quantum Dots (Bruchez et al., 1998). The major advantages of 
fluorochromes over the products of enzyme-catalysed reactions are the ease of 
multiple labelling and their applicability to confocal microscopy. With the 
exception of Quantum Dots (Giepmans et al., 2005), the low electron opacity of 
fluorochromes has restricted their application to light microscopy. 
Early studies examining the applicability of enzymes to deposit markers in an 
IHC setting focussed on HRP and acid phosphatase conjugates. The latter gave 
better localisation, but were unstable and difficult to prepare. In addition, unwanted 
affinity of acid phosphatase for cell nuclei was also observed (Nakane and Pierce, 
1967).  HRP conjugates, although producing less well defined staining, were much 
more stable (Avrameas and Uriel, 1966; Nakane and Pierce, 1967).  
Alkaline phosphatase conjugates were introduced in 1971 (Engvall and 
Perlman, 1971). The most commonly used substrate is the halogenated indolyl 
phosphate, 5-bromo-4-chloro-3-indolyl phosphate (BCIP) which, following 
hydrolysis, undergoes tautomerization and oxidative dimerisation to indigo white 
(in alkaline solution). This is coupled to the reduction of nitro blue tetrazolium 
(NBT) to its formazan (figures 1.25 and 1.26). Fluorescent substrates have also been 
synthesised (Larison et al., 1993; 1994; 1995). 
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Figure 1.24. 4 m thick section of paraffin wax-embedded arteriole 
immunohistochemically stained for smooth muscle actin 
and visualised with Alexa 488. 
 
Figure 1.25. 4 m thick section of paraffin wax-embedded tonsil. Lymphocytes 
immunohistochemically stained for CD45RO and visualised with alkaline 
phosphatase conjugate and BCIP/NBT.
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Figure 1.26. Mechanism underlying the histochemical demonstration of alkaline 
phosphatase using BCIP/NBT 
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The most popular enzyme conjugate for IHC, however, is HRP. The enzyme 
has been extensively studied and the catalytic mechanism, involving an unusual 
Fe(IV) oxyferryl intermediate, has been elucidated (Veitch, 2004) (figure 1.27).
In immunohistochemical staining, reduction of the substrate, hydrogen peroxide, is 
coupled to the oxidative polymerisation of DAB (Seligman et al., 1968) to yield a 
red-brown deposit (figure 1.28). This marker, polyDAB, is permanent and insoluble 
in all solvents used in histological preparation. The poor solubility of polyDAB, 
while being one of its great strengths in immunohistochemistry, has hindered its 
characterisation.  The few attempts that have been performed have yielded limited 
data, and both the mechanism of polymerisation and the nature of the final polymer 
remain speculative (Seligman et al., 1968; Cammer and Moore, 1973; Litwin, 1979) 
(figure 1.29). Like alkaline phosphatase, fluorescent HRP substrates have also been 
developed (Krieg and Halbhuber, 2004). 
Other enzyme conjugates have been advocated where endogenous phosphatase 
or peroxidase activity is problematic, namely glucose oxidase (Stage and Avrameas, 
1976) and -galactosidase (Tanimori et al., 1983). These have not received 
significant interest because of their limited commercial availability. The use of 
colloidal gold labelled antibodies was suggested for light microscopical IHC (Gu et 
al., 1981) but the cost of reagents made this approach impractical. 
A number of strategies have been employed to impart electron opacity to 
antibodies for IHC in the TEM, including. labelling with ferritin (Singer, 1959), 
mercury (Pepe, 1961), uranium (Sternberger et al., 1963) and iodine (Mekler et al., 
1964), but these have been superseded by metal particles, principally colloidal gold 
(Faulk and Taylor, 1971) (figure 1.30) which can be prepared in a number of sizes, 
allowing multiple immunolabelling (Horisberger and Rosset, 1977) (figure 1.31). 
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Figure 1.27. The horseradish peroxidase catalytic cycle. 
 
Figure 1.28. 4 m thick section of paraffin wax-embedded tonsil. Lymphocytes 
immunohistochemically stained for CD45RO using HRP conjugate and 
H2O2/DAB. 
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Figure 1.29. Suggested mechanism for the polymerisation of DAB. 
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Figure 1.30. 80 nm thick section of LR White-embedded pleural mesothelial cell 
immunohistochemically stained for caveolin-1 using 10 nm colloidal gold. Uranyl 
acetate counterstain. 
 
Figure 1.31. 80 nm thick section of LR White-embedded blood vessel. Vascular 
endothelial cell immunohistochemically stained for caveolin-1 (5 nm) and vimentin 
(20 nm) using colloidal gold. Uranyl acetate counterstain. 
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More recently, Nanogold™, a 1.4 nm gold particle, (Hainfeld, 1992; Hainfeld and 
Furuya, 1992) has been developed to overcome the tissue-penetration problem of 
traditional preparations of colloidal gold, which are usually produced between 5 nm 
and 20 nm. 
The potential of horseradish peroxidase for IHC in the TEM has received some 
interest, since polyDAB is easily made electron-opaque with osmium (Graham and 
Karnovsky, 1966) and gold salts (Newman et al., 1983b) (figure 1.32).
In addition, polyDAB-gold can be demonstrated using X-ray microanalysis 
(Siegesmund et al., 1979), suggesting the possibility of multiple labelling using 
different enzyme conjugates. It has also been suggested that HRP conjugates can 
penetrate resin sections (Newman and Hobot, 1987), raising the intriguing 
possibility of applying this technology to electron tomography. 
Attempts to visualise alkaline phosphatase products in the electron microscope 
have met with little interest because of their obscurity (Hanker, 1979) or complexity 
(Halbhuber et al., 1991). 
The requirement for markers that could be visualised at both the light and 
electron microscopic levels was recognised early on, and led to the development of 
antibodies that were doubly labelled with mercury and fluorescein (Pepe, 1961) or 
ferritin and fluorescein (Hsu et al., 1963). The modern equivalent is Nanogold™ 
and fluorescein (Powell et al., 1997; 1998). 
 
1.4.2 Fluorescence in-situ Hybridisation 
Nucleic acid in tissue is often double stranded but can be denatured to single 
strands. A complementary single stranded nucleic acid polymer will therefore act as
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Figure 1.32. 80 nm thick section of LR White-embedded pituitary. Corticotroph 
immunohistochemically stained for adrenocorticotropic hormone and visualised with 
HRP and H2O2/DAB followed by gold(III) chloride. No counterstain. 
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a reporter. The marker system, when attached to the reporter sequence, is usually 
either an enzyme, shown by a histochemical reaction, or a fluorochrome. 
Immunohistochemical techniques are frequently used to localise labels attached to 
single stranded probes. 
 
1.4.3 Biochemical Techniques 
Biochemical analysis of cell and tissue extracts can involve techniques that are 
analogous to immunohistochemistry. Extracts are separated and immobilised 
electrophoretically (Western blotting) and the components identified with immuno-
techniques. The most frequently employed reporter/marker system was alkaline 
phosphatase and BCIP (Knecht and Dimond, 1984) or BCIP and NBT (Blake et al., 
1984). This system has been largely superseded by chemiluminescent technologies. 
 
1.4.4 Molecular Biology 
Separation and analysis of specific nucleic acid sequences is performed in an 
analogous process to Western blotting. The reporter molecules are not antibodies, 
as in Western blotting, but complementary nucleic acid sequences that bind with 
very high specificity. The molecular biological equivalent of Western blotting is 
Southern blotting (for DNA) (Southern, 1974; 1975) and Northern blotting for 
(RNA) (Alwine et al., 1979). Markers are similar to those used for Western blotting. 
 
1.4.5 Amplification Systems 
The theoretical ideal of any reporter/marker system is single molecule 
detection. In reality, this would require considerable signal amplification, even for 
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macromolecules. A number of approaches have been developed that are by no 
means mutually exclusive. 
 
1.4.5.1 Primary Probe Amplification 
This is the selection and/or production of primary probes that have a greater 
affinity or avidity for their respective target molecules. This has been particularly 
important in the immunohistochemical staining of aldehyde-fixed samples, since 
antibodies are raised against unmodified antigens or their fragments, and it is thus 
serendipitous that they recognise fixed antigens. 
 
1.4.5.2 Target Retrieval 
Many target molecules in a solid sample, such as a tissue section, are 
inaccessible to primary probes due to the presence of surrounding tissue structures, 
or are unrecognisable as a result of covalent modification by chemical fixatives. 
These restrictions have been largely overcome, by enzymatic digestion (Huang et 
al., 1976) and microwave heating (Shi et al., 1991) respectively. Microwave 
treatment of tissue sections has been particularly beneficial in rendering antigens 
more recognisable by their respective antibodies and thus increasing the range of 
substances that can be visualised. 
 
1.4.5.3 Reporter Amplification 
The simplest form of reporter amplification is the use of secondary antibodies 
since more than one can attach to each primary antibody. Successive layers could 
potentially be constructed, but such a technique would rapidly become prohibitively 
expensive. A more efficient technique is the introduction of multidentate bridging 
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molecules such as the avidin-biotin complex (ABC). This technique uses the protein 
avidin (from egg white) or, more commonly, streptavidin (from Streptomyces 
avidinii) which can bind up to four biotin molecules. Biotinylated markers or 
enzymes form the final layer (Guesdon et al., 1979; Hsu et al., 1981).  
Catalysed reporter deposition (CARD) employs labelled (e.g. biotinylated) 
enzyme substrates as binding sites for additional reporters (e.g. ABC). This 
technique was originally developed for biochemical analysis in immunoassays 
(Bobrow et al., 1989) and membrane (dot blot) immunoassays (Bobrow et al., 1991) 
using soluble or insoluble chromogenic markers respectively. 
Immunocytochemical/histochemical applications frequently use biotinylated 
tyramide (Hunyady et al., 1996). Recent techniques include deposition of 
fluorochromes such as europium chelates (de Haas et al., 1996). Proprietary 
polymeric systems increase signal strength by covalently attaching numerous 
markers or enzymes to a polymer backbone which is, in turn, attached to a reporter 
molecule (figure 1.33). 
Reporter amplification has the capacity to generate very large quantities of 
signal. Problems arise where multilayered systems are employed since reagents are 
applied in excess to ensure saturation of all available specific sites. Non-specific 
background staining inevitably results and this increases with each successive layer. 
Additional problems include the limited tissue penetration of polymeric systems, 
steric hindrance, and the presence of ‘specific-unwanted’ sites within tissue such as 
endogenous biotin. To overcome these problems, the complexity of the reporter 
system can be reduced to just the primary reporter and secondary reporter 
conjugate followed by marker amplification. 
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Figure 1.33. Principles of reporter amplification.  
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1.4.5.4 Marker Amplification 
One of the most successful techniques for amplifying markers is physical 
development (Newman and Jasani, 1998b). This process is analogous to 
photographic development where the photo-reduced silver grains in the 
undeveloped negative or photographic paper catalyse the reduction of silver ions, 
derived from the photographic emulsion, in the presence of a reducing agent (the 
photographic developer). Physical development combines ionic silver and the 
reducing agent in the same final solution. Light insensitive physical developers, 
which are convenient for laboratory use, prevent light catalysed reduction of silver 
by colloidal protection (Gallyas, 1979) or complexing (Newman and Jasani, 
1998a). There are a number of commercial physical developers available as well as 
published formulations (Gallyas, 1979; Danscher, 1981; Newman and Jasani, 
1998a). 
Colloidal gold can be seen directly in the light microscope, but it is more usual 
to amplify this poor signal by exploiting its capacity to reduce silver from physical 
developers (Danscher, 1981; Holgate et al., 1983). A similar principle is used to 
visualise Nanogold™ particles (Hainfeld and Furuya, 1992). 
PolyDAB can also be amplified by physical developers, either alone (Gallyas et 
al., 1982), or following complexing with d-block metals (Przepiorka and Myerson, 
1986; Gallyas and Merchenthaler, 1988; Green et al., 1989; Mullink et al., 1992) 
and their sulfides (Newman et al., 1983c) (figure 1.34). Halhuber’s technique for 
alkaline phosphatase (Halbhuber et al., 1988), which ultimately results in the 
polymerisation of DAB, could be amplified by techniques that are applied to 
peroxidase but the method is extremely complicated and has received little interest. 
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Figure 1.34. Principle of marker amplification. 
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1.4.6 Advantages and Disadvantages of Existing Markers 
1.4.6.1 Fluorochromes 
Fluorochromes offer high signal to noise and are of considerable importance 
in live cell studies. In addition, they can be easily visualised by confocal microscopy 
allowing 3-dimensional and 4-dimensional (+ time) studies. Their main drawback 
has been the instability of fluorescently labelled preparation which was first 
observed in 1942 (Coons et al., 1942), although modern developments such as 
quantum dots has largely overcome this. In addition, no conventional fluorescent 
counterstains exist and fluorescence produces free radicals that can damage cells. 
Furthermore, autofluorescence is a serious problem of aldehyde-fixed tissue and, 
with the exception of the quantum dots, fluorochromes are not directly visible in 
the electron microscope. 
 
1.4.6.2 Metal Particles 
The particulate nature of colloidal gold facilitates its recognition in the EM and 
it is easily amplified with physical developers. Tissue penetration is poor and 
labelling density varies inversely with particle size. This latter feature renders any 
attempt at quantitation highly dubious. 
Nanogold™ particles were developed to overcome the penetration problems of 
colloidal gold but they difficult to see, even in the electron microscope, are hard to 
amplify and are expensive. 
 
1.4.6.3 Products of Enzyme Catalysed Reactions 
PolyDAB is permanent and easily intensified with certain d-block metals. It can 
be easily made electron-opaque and amplified with physical developers. In 
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addition, its allegedly diffuse nature (compared with metal particles) has been 
exploited in electron tomography (Geuze et al., 2003). There are, however, 
numerous disadvantages of the peroxidase/DAB system. Peroxidases and pseudo-
peroxidases (e.g. catalase) are endogenous to many tissues and the substrate, 
hydrogen peroxide, is common to many biological systems. In addition, a number 
of non-enzymatic catalysts of the reaction exist, such as endogenous metals (Sayre 
et al., 2000) and haem proteins (Schmid et al., 1989). Suppression of endogenous 
enzymatic activity is frequently detrimental to tissue reactivity and suppression of 
endogenous non-enzymatic activity is extremely difficult (Schmid et al., 1989). 
Furthermore, the reaction does not proceed beyond approximately 3 minutes due to 
deposition of the product, making quantitation difficult, the substrates are 
hazardous, poorly defined regarding impurities (DAB) and unstable. Finally, as has 
been mentioned earlier, little is known about the polymerisation of DAB, nor of the 
co-ordination chemistry of the product, polyDAB. 
Alkaline phosphatase is not significantly affected by product inhibition hence 
quantitation is a possibility. Endogenous activity is easily suppressed (van Belle, 
1972) and the enzyme’s wide substrate specificity allows considerable opportunities 
for novel chemistry. Current products (mainly formazans) have a tendency to 
diffuse during tissue dehydration and mounting, and are completely dissolved by 
prolonged exposure to organic solvents such as ethanol. They cannot be amplified 
at present, nor easily made electron-opaque. 
 
1.4.7 Properties of an Ideal Marker 
An ideal marker should be finely localised and strongly adherent to the target, 
clearly visible, even at low concentrations, and be stoichiometrically related to 
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primary reporter density. It should be specific to the reporter system and have no 
affinity for non-target substances. It should be compatible with biological systems 
and insoluble in aqueous solution and/or organic solvents such as ethanol, xylene 
and histological mountants. The marker should be chemically stable, amplifiable 
and electron-opaque, or easily rendered so. None of the currently available marker 
systems fulfil all the above criteria. 
 
1.5 Summary 
Marker chemistry has been developed on a largely empirical basis and the 
occurrence of additional properties, such as the capacity to facilitate amplification, 
or electron opacity is often serendipitous. Modern requirements, such as the 
demonstration of biological molecules in low copy number at the light microscopic 
level and the 3-D visualisation of multiple markers in a tomographic EM setting, 
present exciting new challenges. 
Of the various amplification systems, outlined above, enzymes are currently the 
most suitable, since they provide a mechanism for generating large amounts of 
marker. The choice is restricted, however, by their high quality commercial 
availability. While alkaline phosphatase offers the greatest opportunity for novel 
marker chemistry, the properties of the HRP reaction product, polyDAB, have 
much to commend it. Unfortunately, almost nothing is known about its chemistry; 
the description of its structure is based solely on infrared spectroscopy (Seligman et 
al., 1968) and little is known about its behaviour as a coordination host. The 
elucidation of this information could provide useful insights into the design of novel 
enzyme substrates that will ultimately be of benefit to diagnostic histopathology. 
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The visualisation of multiple markers in tomographic electron microscopy can, 
in principle, be realised by exploiting the analytical capabilities of the instrument 
and employing markers that contain sufficient quantities of specific element to 
facilitate ease of discrimination by energy filtering techniques, or that minimise X-
ray signal acquisition time.  
Paradoxically, the requirement for high resolution microscopy has come, not 
from pathologists and cell biologists, but from molecular biologists and 
biochemists, who have finally recognised the limitations of the light microscope and 
require the higher resolution that is afforded by the electron microscope.  
Unfortunately, the prominence of molecular biology and the ‘-omic’ sciences 
over the last few decades has been accompanied by a concomitant reduction in 
interest in electron microscopy. As a result, much expertise has been lost and 
considerable confusion and ignorance exists. For example, the technology that is 
frequently employed for electron microscopy is either outdated (1960s) e.g. pre-
embedding immunocytochemistry/histochemistry, osmium post-fixation and epoxy 
resin embedding, or is perceived to require the most complex procedures and 
expensive equipment i.e. the various cryo techniques.  
Novel markers should, ideally, be simple to use and not require complex 
preparative procedures or expensive equipment to observe them, and thus be as 
broadly applicable as possible. 
 
1.6 Structure and Aims of the Thesis 
This thesis is divided into two parts. Part 1 examines the amplification of 
polyDAB with physical developers at the light microscopic level and comprises 
Chapter 2, an empirical investigation of the interaction of d-block metal salts with 
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polyDAB in both a pre- and post-polymerisation setting, with a view to determining 
which combinations are powerful catalysts of silver reduction and thus which might 
have some utility in diagnostic histopathology, and Chapter 3, in which these 
studies are further refined to determine the practical limits of sensitivity of the 
peroxidase/DAB system.  
In Part 2 the investigation focuses on the development of markers for use in 
analytical electron microscopical tomography. Chapter 4 applies the results of 
chapter 2 in an electron microscopical setting with a view to developing 
immunohistochemical markers based on polyDAB-metal complexes. These studies 
are extended to halogenated aromatic diamines and bis-diamines as enzyme 
substrates in Chapter 5, and techniques for visualising fluorochromes in the electron 
microscope are explored in Chapter 6. Chapter 7 describes a limited 
characterisation of polyDAB with a view to understanding its behaviour and thus 
indicating fruitful directions for rational marker design. Chapter 8 briefly explores 
alternative applications of halogenated aromatic diamines, and Chapter 9 is a 
general discussion of the results of the experimental chapters. 
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2.1 Introduction 
The requirement for demonstrating ever smaller quantities of target molecules 
in biological research and clinical diagnosis has led to the development of a number 
of powerful techniques, namely (1) primary probe amplification, (2) target retrieval, 
(3) reporter amplification and (4) marker amplification.  
The first three have been much more easily incorporated into high throughput, 
automated laboratories since standardisation, and hence quality control, are easily 
achieved by manipulating concentrations of reagents or staining times. Marker 
amplification, in contrast, requires observation of the final staining procedure to 
identify the appropriate endpoint of the reaction i.e. where background staining just 
starts to arise. 
Intensification and amplification are two terms that have been used 
interchangeably for describing techniques that increase marker visibility. For the 
purpose of this thesis, a distinction will be drawn between the two, namely that 
intensification involves manipulation of the marker’s optical properties (usually 
extinction coefficient and/or absorption spectrum), whereas amplification involves 
the deposition of additional marker at the site of the initial reaction.  
The former is usually achieved by either modifying the marker once it has been 
deposited e.g. the conversion of the pale blue cobalt phosphate substitution product 
of tissue alkaline phosphatase activity to black cobalt sulfide (Gomori, 1939) or by 
incorporating additional chromogenic components into the reaction mixture, such 
as the coupling of tetrazolium reduction to indolyl dimerisation for the 
histochemical demonstration of tissue non-specific esterases (McGadey, 1967).  
The latter usually exploits catalytic properties of the initial marker to facilitate 
localised deposition of secondary marker. An early example is the cobalt-sulfide-
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silver technique (Tyrer and Bell, 1974) which combined the cobalt-sulfide method 
for visualising neurones (Pitman et al., 1972) with the observation, by the German 
chemist Timm, that sulfides were much more powerful catalysts of silver reduction 
than their non-sulfide counterparts (Timm, 1958). This development facilitated the 
observation of the finest neurones that were previously almost impossible to 
distinguish against the background tissue. 
The ‘Timm reaction’, described above, was subsequently applied in a number 
of histochemical contexts and was further refined to selectively demonstrate metals 
in biological tissue (Danscher, 1981a; 1984, Danscher and Stoltenberg, 2006). It 
was the exploitation of this latter technique, for specifically visualising gold in 
biological tissue (Danscher, 1981b), that led to the development of the successful 
immunocolloidal gold-silver method (Holgate et al., 1983). Prior to this, both 
primary antibodies and secondary antibody-colloidal gold conjugates needed to be 
applied in high concentrations for the colloidal gold marker to be directly visible 
(Gu et al., 1981). It is, however, the peroxidase/DAB system that has received the 
greatest interest in terms of both intensification and amplification. The probable 
reason for this is that the reaction, while rapid, is subject to product inhibition, 
unlike alkaline phosphatase. 
 
2.1.1 Intensification of PolyDAB with d-Block Metal Salts 
 
In the late 1970s and early 1980s, the effects of d-block metal compounds on 
the appearance of polyDAB was recognised and exploited in light microscopy to 
produce either an intensification of colour (Hanker et al., 1979), or a profound 
colour change (Adams, 1977; 1981; Hancock, 1982). These observations prompted 
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further studies to evaluate this phenomenon, albeit to a limited extent (Hsu and 
Soban, 1982; Scopsi and Larsson, 1986). 
 
2.1.2 Amplification of PolyDAB with Physical Developers 
The observation that polyDAB could catalyse silver reduction from a physical 
developer (Gallyas et al., 1982) led to the examination of this phenomenon 
following polymerisation of DAB in the presence of d-block metal salts (Przepiorka 
and Myerson, 1986; Gallyas and Merchenthaler, 1988; Green et al., 1989; Mullink 
et al., 1992).  
The high affinity of polyDAB for Au(III)Cl4
-
 (Siegesmund et al., 1979) in 
combination with the Timm reaction led to the development of the powerful gold-
sulfide-silver amplification technique (Newman et al., 1983b). In none of these 
studies, however, was an extensive range of commercially available d-block metal 
salts systematically explored. 
Any investigation of the interaction of d-block metal compounds with 
polyDAB is complicated by the availability of innumerable d-block metal 
complexes. In addition, the absence of either detailed chemistry concerning the 
polymerisation of DAB or its interaction with d-block metal salts renders such 
studies necessarily empirical. Furthermore, some d-block metal salts are either 
insoluble or unstable in aqueous solutions, or are radioactive. Finally, DAB needs 
to be strongly buffered at neutral pH for it to work successfully as a histochemical 
marker and some d-block metal salts are incompatible with these solutions, such as 
the chlorides of copper and palladium with Tris buffered DAB (Hsu and Soban, 
1982).  
84 
 
Some d-block metal salts will be stable, albeit at very low concentrations, with 
DAB in neutral buffered solutions and can therefore be included in the reaction 
(pre-polymerisation). Some of those salts, which are not tolerated by such solutions 
of DAB, will react with the polymerised product after the reaction is complete 
(post-polymerisation), and some will do both.  
 
2.1.3 Amplification in Diagnostic Immunohistochemistry 
Since the demonstration of the potential value of immunohistochemical 
staining in diagnostic pathology (Pearse and Bussolati, 1970), it has become an 
invaluable tool for both the diagnosis and staging of a wide variety of diseases 
(Mason and Gatter, 1987; Idikio, 2010). In particular, it provides predictive 
information regarding the progression of breast cancers and thus informs the 
delivery of appropriate therapy (Walker, 2008). 
Marker amplification has enjoyed a number of successes in diagnostic 
immunohistochemistry, such as the demonstration of the thyroid stimulating 
hormone receptor on normal thyroid follicular cells (Schmid and Jasani, 1987), and 
both the oestrogen receptor in breast tumours (Gee et al., 1991) and Epstein-Barr 
virus DNA in lymph nodes (Mullink et al., 1992) in paraffin wax-embedded tissue, 
but has received progressively less interest over the last two decades due to the 
greater ease with which target retrieval and reporter amplification have been 
incorporated into high through-put, automated laboratories. There remain, 
however, a number of instances where additional amplification still has some 
utility, namely (1) where antigenic concentration is low and, even with the full 
power of target retrieval and reporter amplification, positivity is uncertain, and (2) 
where immunopositive events are rare and could be easily overlooked. Examples of 
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the former include the Epstein-Barr virus antigen, LMP-1 and the T-cell enzyme, 
granzyme B. An example of the latter is -synuclein, a marker of neurodegenerative 
disease. 
 
2.1.3.1 Epstein-Barr Virus and LMP-1 
Epstein-Barr virus (EBV) is a human herpes virus that occurs, 
asymptomatically, in 90% of the human population. Initial inoculation results in 
infected cells, probably B-lymphocytes (antigen-producing cells), entering a lytic 
phase where viruses are produced and released by budding of the cell membrane. 
Following this, infected B-lymphocytes enter a latent phase where proliferation 
occurs, the condition manifesting as mononucleosis, which occurs in 50% of 
individuals that are infected during adolescence and early adulthood (Pai and 
Khanna, 2001; Young, 2001; Rickinson, 2002). It is also associated with a number 
of B-cell cancers, including Burkitt's lymphoma (Levy and Henle, 1966; Henle et 
al., 1968), some cases of Hodgkin's lymphoma (Johansson et al., 1970), and 
lymphoid tumours that can arise in immunosuppressed patients (Nalesnik, 1990) as 
well as epithelial cell cancers such as nasopharyngeal carcinoma (Henle and Henle, 
1970). 
The EBV-derived latent membrane protein, LMP-1, is essential to the induction 
and maintenance of B-lymphocyte transformation and proliferation (Wang et al., 
1985; Kaye et al., 1993) and thus provides a useful target for immunohistochemical 
staining. Comparisons with alternative techniques, such as in situ hybridisation of 
EBV early RNAs and polymerise chain reaction (Lauritzen et al., 1994; Fanaian et 
al., 2009), have suggested that IHC is the least sensitive. 
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2.1.3.2 T-cells and Granzyme B 
Cytotoxic T-lymphocytes (CTLs) and natural killer (NK) cells induce apoptosis 
and lysis in target cells such as those infected with viruses and those of allografts. 
Cytoplasmic granules within CTLs and NK cells contain a variety of cytolytic 
molecules including perforin (Lichtenheld et al., 1988), proteoglycans (Schmidt et 
al., 1985) and serine esterases (Hameed et al., 1988), the latter often being referred 
to as granzymes. The production of antibodies to granzyme B facilitated the 
immunohistochemical demonstration of CTLs in tissue (Hameed et al., 1991) 
which has been of predictive value in acute allograft rejection (Israelbiet et al., 1993; 
Legrosmaida et al., 1994; D'Errico et al., 2003). 
 
2.1.3.3 Neurodegenerative Diseases and -Synuclein  
The principle histological features of the common neurodegenerative diseases 
are the presence of proteinaceous deposits that occur both between cells, as plaques, 
and as cytoplasmic inclusions. In Alzheimer’s disease, the most common 
neurodegenerative disorder, intercellular plaques are composed predominantly of 
amyloid (Margolis, 1959; Terry et al., 1964). Intracellular inclusions, in the form of 
neurofibrillary tangles, consist of tau protein (Brion et al., 1985). In Parkinson’s 
disease, and a number of rarer conditions, the defining histological feature is the 
presence of intracellular Lewy bodies which are composed mainly of -synuclein 
(Spillantini et al., 1997). Synucleins are found in abundance in the brain, but their 
function is poorly understood; - and -synucleins are concentrated in the nerve 
terminal and may be involved in the control of vesicular transport processes 
(Goedert, 2001), whereas -synuclein is found mainly in peripheral and sensory 
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nerves, throughout the nerve cell body and may be involved in microtubule 
function (Zhang et al., 2011). 
 
2.1.4 Amplification of Alkaline Phosphatase Markers 
The literature appears to contain no references to alkaline phosphatase (AP) 
marker amplification. The reason is probably two-fold, namely (1) AP is not 
appreciably inhibited by its insoluble products and (2) the commonly employed 
immunohistochemical AP marker, NBT formazan, (McGadey, 1970), has not been 
reported to form metal complexes, discouraging investigation with subsequent 
application by either physical development alone or in a Timm-style reaction. A 
number of formazans do, however, form d-block metals complexes such as 
diphenylthiocarbazone (dithizone) and its di- -naphthyl analogue (Oesper and 
Klingenberg, 1948; Nineham, 1955). In addition, the observation that the formazan 
of 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyl tetrazolium (MTT) formed more 
insoluble complexes with nickel, cobalt and copper (Hunter and Roberts, 1941), 
prompted its successful application in a histochemical setting (Pearse, 1957). 
 
2.1.5 Model Systems 
2.1.5.1 Dot Blot Model System 
Prior to an investigation of polyDAB amplification in an immunohistochemical 
setting, it is convenient to conduct preliminary studies in a simpler model system, 
since this avoids the necessity of cutting, rehydrating and immunohistochemically 
staining tissue sections. Polyvinyldifluoride (PVDF) membrane is used extensively 
in Western and Northern blotting techniques, for immobilising electrophoretically 
separated proteins and nucleic acids respectively, by virtue of hydrophobic 
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interactions (Pluskal et al., 1986). Its high retention of these polymers makes it an 
ideal substrate for immobilising antibody-enzyme conjugates for subsequent marker 
deposition and amplification experiments. 
 
2.1.5.2 The Tonsil Tissue Model System 
One of the most commonly used tissue models for developing novel 
immunohistochemical marker systems is palatine tonsil, since routine tonsillectomy 
has ensured its regular supply. The paired palatine tonsils are part of a group of 
secondary lymphoid organs that form a ring around the pharynx; the Waldeyer-
Pirogov tonsillar ring (Waldeyer, 1884) or pharyngeal lymphoid ring. The tonsils 
are composed of a surface layer of epithelial cells that invaginates to form the 
lymphoepithelium of the tonsillar crypts, sub-epithelial lymphoid tissue, composed 
of lymphoid follicles and interfollicular regions, and supporting connective tissue 
(figure 2.1). The lymphoepithelium has a honeycomb of epithelial cells filled mainly 
with lymphocytes. Continuous with this is the mantle zone where T-cells are found. 
B-cell maturation occurs in the follicles (figure 2.2). The tonsils provide the first line 
of defence against oral and inhaled bacteria and viruses (Perry and Whyte, 1998).  
Of the many lymphocyte antigens that can be demonstrated in the tonsil, CD45 
represents a particularly good target, since it constitutes up to 10% of the 
lymphocyte cell surface (Thomas and Lefrancois, 1988). CD45 is a receptor-like 
protein tyrosine phosphatase which occurs in a number of isoforms, and controls 
cellular sensitivity to external stimuli by altering the relative threshold of response. 
Perturbation of this function may contribute to autoimmunity, immunodeficiency, 
and malignancy (Hermiston et al., 2003). The 8 isoforms of CD45 result from 
alternative slicing of the 3 exons, labelled A, B, and C (Streuli et al., 1987). 
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Figure 2.1. Low power image of a 4 m thick section of paraffin wax-
embedded human palatine tonsil, stained with H&E, showing 
lymphoepithelium (LE), tonsillar crypt (TC), lymphoid follicles (LF) and 
mantle zone (MZ). 
 
 
 
Figure 2.2. High power image of the same section, showing 
lymphoepithelium (LE), lymphoid follicles (LF) and mantle zone (MZ). 
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2.2 Materials 
2.2.1 Reagents 
All reagents were of analytical grade. Na2S, Ni(II)Cl2.6 
H2O and Mn(II)Cl2.4H2O were purchased from BDH (Lutterworth, Leicestershire, 
U.K.). Cu(II)Cl2.2H2O, sodium acetate, glacial acetic acid, Triton X-100, 
hydroquinone, tris(hydroxymethyl)aminomethane (Tris), citric acid, sodium citrate, 
sodium thiosulfate, pyrogallol, polyethylene glycol (PEG), glycerol, ethanol and 
xylene were purchased from Fisher Scientific (Loughborough, Leicestershire, 
U.K.). 3,3′-diaminobenzidine tetrahydrochloride (DAB) (5-bromo-4-chloro-3-
indolyl phosphate (BCIP), 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyl tetrazolium 
(MTT), Sc(III)Cl3.6H2O, Y(III)Cl3.6H2O, La(III)Cl3.7H2O, V(III)Cl3, Cr(II)Cl2, 
Cr(III)Cl3.6H2O, H3PMo(IV)12O40.hydrate (xH2O), H3PW(IV)12O40.xH2O, 
Na2W(VI)O4.2H2O, Re(III)Cl3, Fe(II)Cl2.4H2O, Fe(III)Cl3.6H2O, Ru(III)Cl3, 
K3Ru(III)Cl6, K2Os(IV)Cl6, Co(II)Cl2.6H2O, Rh(III)Cl3.xH2O, Ir(IV)Cl4.xH2O, 
K3Ir(III)Cl6, K2Ir(IV)Cl6, K2Pd(II)Cl4, K2Pd(IV)Cl6, K2Pt(II)Cl4, K2Pt(VI)Cl6, 
Ag(I)NO3, NaAu(III)Cl4 and Zn(II)Cl2 were purchased from Sigma-Aldrich (Poole, 
Dorset, U.K.). Os(VIII)O4 was purchased from TAAB Laboratories (Aldermaston, 
Berkshire, and U.K.). Chlorides of titanium, zirconium, hafnium, niobium, and 
tantalum were omitted from the study due to insolubility or instability in aqueous 
solution. Chlorides of cadmium and mercury were omitted because of toxicity. 
Technetium was omitted, as it is radioactive. Target retrieval solution, Tris wash 
buffer, Dako antibody diluent, peroxidase block were purchased from Dako (Ely, 
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Cambridgeshire, U.K.), Haematoxylin was purchased from Menarini Diagnostics 
(Wokingham, Berkshire, U.K.). 
 
2.2.2 Antibodies 
Mouse monoclonal anti-CD45Ro (clone UCHL-1), goat anti-mouse 
immunoglobulin (Ig) HRP conjugate (GAM IgPC) and goat anti-mouse Ig alkaline 
phosphatase conjugate (GAM IgAP) were purchased from Autogen Bioclear 
(Calne, Wiltshire, U.K.). Goat anti-mouse Ig – 5nm colloidal gold conjugate 
(GAM IgCG5) was prepared in-house by Dr. Jan Hobot (Slot and Geuze, 1985). 
Mouse anti-LMP-1, anti-granzyme B and Envision detection system (including 
DAB+ chromagen and substrate buffer) were supplied by Dako (Ely, 
Cambridgeshire, U.K.). Mouse monoclonal anti- -synuclin was purchased from 
Novocastra Laboratories Ltd (Newcastle upon Tyne, U. K.). 
 
2.2.3 Physical Developers 
The two physical developers that were chosen for use in the amplification of 
polyDAB were those of Gallyas, and Newman and Jasani (Gallyas, 1979; Newman 
and Jasani, 1998), since their compositions have been published, they are both easy 
to prepare, both are light insensitive and are thus suitable for use under ordinary 
laboratory conditions. All glassware used for preparing and storing solutions was 
cleaned sequentially with chromic acid (20% w/v potassium dichromate in 20% 
sulfuric acid), 0.1M HCl and double distilled water (ddH2O). In both preparations, 
solution of each component was ensured prior to addition of the next. 
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2.2.3.1 Gallyas’ Physical Developer 
Gallyas’ physical developer was prepared for use at a final pH of 5.0. 
Solution A  
11.25 g sodium acetate trihydrate was dissolved in 150 ml ddH2O and 1.875 ml 
glacial acetic acid added with stirring. 0.25 g Ag(I)NO3 was added followed by 7.5 
ml 1% Triton X-100. The resulting solution was made up to 200 ml with ddH2O 
and stored at 4
o
C. 
Solution B 
5% (w/v) sodium(VI)tungstate in ddH2O (stored at RT) 
Solution C (prepared immediately prior to use) 
0.8% hydroquinone in ddH2O. 
The three solutions are combined in order in the ratio of 8:1:1, immediately before 
use (Gallyas, 1979). 
 
2.2.3.2 Newman and Jasani’s Physical Developer 
The two components of Newman and Jasani’s physical developer have a shelf 
lives of at least 10 years when stored at 4
o
C (von Ruhland and Jasani, 2010) and are 
thus conveniently prepared as 1 litre solutions. 
Silver stock solution 
181.5 g Tris base was dissolved in 750 ml ddH2O followed by 3.0 g Ag(I)NO3 and 
glacial acetic acid added to a final pH of 7.4. The solution was made up to 1 l with 
ddH2O and stored at 4
o
C. 
Reducer stock solution 
The reducer stock is prepared initially as two solutions.  
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Solution A 
5.25 g citric acid monohydrate was dissolved in 350 ml ddH2O and 5.00 g 
anhydrous sodium sulfite added, followed by 1.25 g sodium thiosulfate 
pentahydrate, 15.00 g pyrogallol and 100.00 g polyethylene glycol 1500. Sodium 
citrate dihydrate was added to produce a final pH of 5.0 and the solution made up 
to 500 ml with ddH2O. 
Solution B 
100 ml glycerol was mixed with 400 ml ethanol. 
The two solutions were thoroughly mixed and stored at 4
o
C. 
 
Both silver and reducer stock solutions were stored for 1 week at 4
o
C, each 
topped up to 1 l with ddH2O, and filtered through Whatman No 1 filter paper. The 
two solutions were combined in equal volumes immediately prior to use (Newman 
and Jasani, 1998). 
 
2.2.4 Model Systems 
Immobilon P PVDF membrane was purchased from Millipore Ltd (Watford, 
Hertfordshire, U.K.). 
Anonymised human tonsil for preliminary investigations was acquired, with 
consent, from routine tonsillectomy prior to the introduction of the Human Tissue 
Act (2004). Control pathological tissue for diagnostic immunohistochemical 
staining (tonsil from routine tonsillectomy, lymphoid tissue from Stage 4 Hodgkin’s 
lymphoma, brain tissue from Alzheimer’s disease) was supplied by the Department 
of Histopathology, University Hospital of Wales. 
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2.2.5 Preparation of Vectabond-treated Slides 
To ensure adhesion of tissue sections to the glass microscope slides during the 
prolonged immunohistochemical staining and subsequent amplification procedures, 
glass slides required pre-treatment. Slides were immersed in acetone for 5 minutes 
followed by a further 5 minutes in Vectabond reagent (Vector Laboratories, 
Peterborough, U.K.) diluted 
1
/10 in acetone. After a 30 second wash in ddH2O, 
slides were air-dried. 
 
2.2.6 Selection of d-Block Metal Salts and Buffer Systems 
For ease of comparison with published data, only d-block metal chlorides were 
investigated. The exceptions were osmium(VIII)tetroxide (which has been used 
extensively for rendering polyDAB electron dense) phosphotungstic acid, 
phosphomolybdic acid (the former having some affinity for polyDAB (Newman et 
al., 1983a) and both of which have been used in histological staining techniques), 
and silver(I)nitrate (the halides being photolabile). 
The investigation was limited to the two main buffering systems with which 
DAB is commonly employed, namely 100 mM Sorensen’s phosphate pH 7.4 and 
50 mM Tris HCl pH 7.6. 
 
2.3 Methods 
2.3.1 Stability of d-Block Metal Salts in Solutions of DAB 
Metal salts were added, at a final concentration of 1 mM, to 0.05% DAB in 
either 100 mM phosphate buffer pH 7.3 (DAB-PO4) (Adams, 1977) or 50 mM Tris 
HCl buffer pH 7.6 (DAB-Tris) (Hanker et al., 1979) plus 0.005% H2O2. After three 
minutes, solutions were examined, and those metal salts that caused any cloudiness 
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or precipitate to appear (classified as unstable), were excluded from the subsequent 
study. Those metal salts that caused no obvious change in the appearance of the 
solution (classified as stable) were used in subsequent experiments. 
 
2.3.2 Preparation of PVDF Membrane 
PVDF membrane was wetted by immersion in methanol for 5 minutes 
followed by thorough washing in ddH2O. Whatman No. 1 filter paper was soaked 
in ddH2O and surplus water removed by pressing dry filter paper onto it. 3.5 x 1 cm 
wetted membrane was placed on the filter paper and excess water removed by 
applying dry filter paper as described above. Double dilutions of GAM IgPC, such 
that dots were produced that were just visible at the third doubling dilution, from 
1/50,000 to 
1/1,600,000 in ddH2O were applied as 2 µl droplets to the membrane 
(Newman and Jasani, 1998). All incubations and washes were performed in 30 ml 
polystyrene weighing boats (Fisher Scientific, Loughborough, Leicestershire, U. K.) 
containing 10 ml of reagent. 
 
2.3.3 Dot Blot Model System 
2.3.3.1 Pre-polymerisation and Physical Developers 
d-Block metal salts were added, to a final concentration of 1 mM, to either 
DAB-PO4 or DAB-Tris. Dot blots of GAM IgPC were immediately placed in each 
of the solutions and incubated for three minutes. Following thorough washing in 
ddH2O, the preparations were placed directly into either Gallyas’ or Newman and 
Jasani’s physical developer. 
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 Nickel salts have been used at much higher concentrations in DAB-Tris than 
any other metal (Hancock, 1982; 1984; Tago et al., 1986; Lanciego et al., 1997; 
Tajima et al., 2000; Gonzalo et al., 2001). To further investigate this phenomenon, 
dot blots were prepared, as described above, from Tris buffered DAB solutions 
containing 1, 5, 20 or 100 mM Ni(II)Cl2 and incubated for 10 minutes in developer. 
 
2.3.3.2 Post- polymerisation and Physical Developers 
Dot blots were incubated for 3 minutes in DAB-Tris, thoroughly washed in 
ddH2O, and immersed for five minutes in 2.5 mM solutions of the d-block metal 
salts. Dot blots were thoroughly washed in ddH2O and incubated in physical 
developer for ten minutes. 
 
2.3.3.3 Sodium Sulfide Treatment and Physical Developers 
Dot blots were prepared as for 2.3.3.1. and 2.3.3.2., above, immersed in 0.3% 
aqueous, neutralised Na2S (0.3% Na2S) for 2 minutes, thoroughly washed in 
ddH2O and incubated in physical developer for ten minutes. 
 
2.3.3.4 Scoring System 
Intensification and amplification of dot blots was scored on a scale of 0 to 6. A 
score of 0 indicated no amplification and scores of 1 to 6 indicated amplification of 
the first (
1/50,000) to the last (
1/1,600,000) dot. Those metal salts that produced strong 
amplification of polyDAB with low background were chosen for subsequent 
immunohistochemical evaluation. 
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2.3.3.5 Analytical Scanning Electron Microscopy 
In a preliminary examination to determine which metal salts formed complexes 
with polyDAB, dot blots were prepared as above with GAM IgPC diluted 
1/50,000. 
PolyDAB was polymerised in the presence of d-block metal salts, or the salts 
applied post-polymerisation according to sections 2.3.3.1. and 2.3.3.2 respectively. 
Samples were air dried, attached to 32 mm diameter aluminium stubs with double-
sided sticky tape, carbon coated in an Edwards E306A vacuum coater (Edwards, 
Crawley, West Sussex, U.K.) and examined in a JEOL 840A scanning electron 
microscope (JEOL UK Ltd, Welwyn Gardens City, Herts., U.K.) in back-scattered 
electron imaging (BSI) mode and analysed with an INCA X-cite energy dispersive 
X-ray spectrometer (Oxford Instruments, Abingdon, Oxon., U.K.) under the 
following conditions:  
Accelerating voltage: 20 kV Probe current: 10
-8
 amps Magnification x 25 
Working distance: 15 mm Count time: 50 seconds Processing dead time < 10% 
 
2.3.4 Tissue Model System 
2.3.4.1 Tissue Preparation 
For preliminary studies, human tonsil was fixed by immersion for 24 hours in 
4% formaldehyde + 0.2% glutaraldehyde in 100 mM Sorensen’s phosphate buffer 
pH 7.4, dehydrated through graded ethanol, cleared in xylene and embedded in 
paraffin wax. 
Serial 4 µm sections were cut on an RM2155 motorised microtome (Leica 
Microsystems (UK) Ltd, Milton Keynes, Bucks., U.K.) and dried onto Vectabond-
treated slides at 50oC. 
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Pre-cut sections of 10% neutral buffered formalin-fixed, paraffin wax-embedded 
diagnostic control tissue were supplied by the Department of Histopathology, 
University Hospital of Wales. 
 
2.3.4.2 Selection of Appropriate Antibody Dilutions 
Sections were de-waxed in xylene, and rehydrated through graded ethanol. 
Suppression of endogenous peroxidatic activity with methanolic H2O2 (Streefkerk, 
1972) was omitted since this was found to reduce the immunohistochemical 
response by at least 1 doubling dilution of primary antibody, making direct 
comparison with immunocolloidal gold staining unreliable.  
Following 10 minutes equilibration in 20 mM Tris pH 7.4 containing 0.9% 
NaCl and 0.6% bovine serum albumin (TBS/BSA), sections were incubated for 90 
minutes in mouse monoclonal anti-CD45 Ro in doubling dilutions from 
1/1000 to 
1/16,000 with TBS/BSA to determine an appropriate titre such that the subsequent 
level of metal-free immunohistochemical staining was just visible. After 3 x 1 
minute washes in TBS/BSA, sections were incubated for a further hour in 
1/150 
GAM Ig PC in TBS/BSA. Sections were washed for 1 minute in TBS/BSA and 2 x 
1 min in 50 mM Tris-HCl pH 7.6 followed by a 3 minute incubation in DAB-Tris. 
 
2.3.4.3 Immunocolloidal Gold 
To provide a standard against which polyDAB amplification could be 
compared, sections were immunohistochemically stained with 
1/4000 (chosen 
according to 2.3.4.2., above) anti-CD45Ro as above followed by an hour incubation 
in GAM IgCG5. Following thorough washing in ddH2O, sections were fixed for 5 
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minutes with 0.5% glutaraldehyde in 100 mM phosphate buffer pH 7.3. After 
washing in ddH2O, residual aldehyde groups were blocked for 10 minutes in 0.75 
M Tris acetate pH 7.5. Surplus solution was removed, and sections immersed in 
either Gallyas’ or Newman and Jasani’s physical developer and the reaction 
observed microscopically. The reaction was terminated by thorough washing in 
ddH2O. 
 
2.3.4.4 Counterstaining and Mounting 
All sections were lightly counterstained by immersion in 0.02% methyl green 
for 2 minutes, dehydrated through graded ethanol, cleared in xylene and mounted 
in Gurr’s neutral mountant. 
 
2.3.4.5 Immunohistochemical Evaluation of PolyDAB Amplification 
Following thorough washing with either 100 mM phosphate buffer pH 7.3 or 
50 mM Tris buffer pH 7.6, GAM Ig PC labelled sections were incubated with DAB-
PO4 or DAB-Tris plus metal salts respectively, or metals applied post-
polymerisation. After thorough washing in ddH2O, sections were immersed in 
physical developer, with or without 2 minute pre-treatment with 0.3% Na2S, and 
the reaction observed microscopically. 
Silver intensification of specific staining was continued until the time point 
when non-specific staining first became apparent. 
 
  
100 
 
2.3.4.6 Marker Amplification and Diagnostic Immunohistochemistry 
Tissue from Stage 4 Hodgkin’s lymphoma, tonsil, and brain from Alzheimer’s 
disease were immunostained for (a) the Epstein-Barr virus protein, LMP-1 (low 
concentration antigen), (b) the cytotoxic T-cell enzyme, granzyme B (low 
concentration antigen), and (c) -synuclein, a diagnostic indicator of 
neurodegenerative disease (rare event) respectively. 
4 m thick tissue sections on Superfrost Plus slides were rehydrated and 
immunostained according to the standard schedule used by the Department of 
Histopathology, University Hospital of Wales, Cardiff. Briefly, rehydrated sections 
were subjected to high pressure antigen retrieval with target retrieval solution for 1 
minute at 125oC, 20 psi in a Decloaking Chamber (Biocare Medical, Concord, 
California, U.S.A.). Immunohistochemical staining was performed in an 
Autostainer Plus (Dako, Ely, Cambridgeshire, U.K.). Following washing with 
ddH2O and Tris wash buffer (TWB), sections were incubated for 45 minutes in 
primary antibody (all diluted 
1/20 with Dako antibody diluent), washed with TWB 
and treated with peroxidase block for 5 minutes. After a further wash in TWB, 
sections were incubated in Envision detection system for 30 minutes. Sections were 
washed again in TWB and developed with DAB+ chromagen (diluted 
1/50 with 
substrate buffer) with or without amplification. Sections were lightly counterstained 
for 1 minute with haematoxylin, blued in tap water, dehydrated and mounted. For 
amplification, immunohistochemically stained sections were incubated in 2.5 mM 
NaAu(III)Cl4 for 5 minutes, washed thoroughly in ddH2O, incubated for a further 2 
minutes in 0.3% Na2S, washed in ddH2O and treated with Newman and Jasani’s 
physical developer for 10 minutes and counterstained as above. 
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2.3.5 Microscopic Examination and Digital Imaging 
Sections were examined on an Olympus BX51 microscope (Olympus Optical 
Co. (U.K.) Ltd, London, U.K.) in bright field mode and digital photomicrographs 
captured with a Zeiss Axiocam and Axiovision software (Carl Zeiss Vision GmbH, 
Hallbergmoos, Germany). Images were processed with Adobe Photoshop (Adobe 
Systems Incorporated, San Jose, California, U.S.A.). 
 
2.3.6 Alkaline Phosphatase Marker Amplification 
Dot blots were prepared with doubling dilutions of GAM IgAP from 
1/500 to 
1/16,000 as described above. Dot blots were incubated for 30 minutes in 100 mM 
glycine buffer pH 9.0 containing 200 g/ml BCIP and 400 g/ml MTT. For both 
pre- and post- reduction studies, Ni(II)Cl2, Co(II)Cl2 and Cu(II)Cl2 were used at 10 
mM (Pearse, 1957). Dot blots were incubated in the physical developers with and 
without pre-treatment with sodium sulfide as described above. 
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2.4 Results 
2.4.1 Stability of d-Block Metal Salts in Solutions of DAB 
Of the 31 d-block metal salts investigated, 19 were stable (as defined in section 
2.3.1) in both DAB-PO4 and DAB-Tris, and a further 6 were stable in DAB-PO4
 
only. Ni(II)Cl2 was stable in DAB-Tris up to at least 100 mM. In contrast, the other 
DAB-Tris-stable d-block metal salts could only be added up to a final concentration 
of 1 mM. Results are summarised in Table 2.1. 
 
2.4.2 Dot Blot Model System 
Dot blots produced with DAB alone could be clearly seen at GAM IgPC 
dilutions of 
1/50,000 and 
1/100,000, and only just seen at 
1/200,000 (figure 2.3a). 
 
2.4.2.1 Pre-polymerisation and Amplification 
2.4.2.1.1 Physical Developers Alone 
Of the 25 d-block metal salts that were compatible with DAB-PO4, only 3 
produced dot blots that could be intensified with Gallyas’ physical developer, 
namely Co(II)Cl2, Ni(II)Cl2 (figure 2.3b and c) and K2Pt(II)Cl4. The remaining salts 
produced either no discernable increase in signal (dot blot) intensity (16/24) or 
caused an increase in background (PVDF membrane) staining only (5/24). In 
contrast, no intensification occurred in any of the dot blots following treatment with 
Newman and Jasani’s developer. In addition, the blue-black colour of the dots 
produced by solutions containing either Ni(II)Cl2 or Co(II)Cl2 was rapidly lost. 
Only one metal compound, K2Os(IV)Cl6, caused an increase in background 
staining. A similar pattern was observed in dot blots produced from d-block metal 
salts in DAB-Tris. Results are summarised in tables 2.2 and 2.3. 
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Table 2.1. Stability of d-block metal salts in DAB-PO4 and DAB-Tris. 
 
Metal DAB-PO4 DAB-Tris Metal DAB-PO4 DAB-Tris 
Sc(III)Cl3   Os(VIII)O4  
Y(III)Cl3   Co(II)Cl2  
La(III)Cl3   Rh(III)Cl3  
V(III)Cl3   K3Ir(III)Cl6  
Cr(II)Cl2   K2Ir(IV)Cl6  
Cr(III)Cl3   Ir(IV)Cl4  
H3PMo(IV)12O40   Ni(II)Cl2  
Na2W(VI)O4   K2Pd(II)Cl4  
H3PW(IV)12O40   K2Pd(IV)Cl6  
Mn(II)Cl2   K2Pt(II)Cl4  
Re(III)Cl3   K2Pt(IV)Cl6  
Fe(II)Cl2   Cu(II)Cl2  
Fe(III)Cl3   Ag(I)NO3  
Ru(III)Cl3   NaAu(III)Cl4  
K3Ru(III)Cl6   Zn(II)Cl2  
K2Os(IV)Cl6  
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Table 2.2. Amplification of dot blots from DAB-PO4-metal salt combinations with 
Gallyas’ or Newman and Jasani’s developers. 
 
Metal Gallyas Newman & Jasani 
 Foreground Background Foreground Background 
 
Sc(III)Cl3 
 
0 
 
0 
 
0 
 
0 
Y(III)Cl3 0 0 0 0 
La(III)Cl3 0 0 0 0 
V(III)Cl3 0 0 0 0 
Cr(II)Cl2 0 0 0 0 
Cr(III)Cl3 0 0 0 0 
H3PMo(IV)12O40 0 0 0 0 
Na2W(VI)O4 0 0 0 0 
H3PW(IV)12O40 0 0 0 0 
Mn(II)Cl2 0 0 0 0 
Re(III)Cl3 0 0 0 0 
Fe(II)Cl2 0 0 0 0 
Fe(III)Cl3 0 ++ 0 0 
Ru(III)Cl3 0 ++ 0 0 
K3Ru(III)Cl6 - - - - 
K2Os(IV)Cl6 0 + 0 ++ 
Os(VIII)O4 - - - - 
Co(II)Cl2 + 0 0 0 
Rh(III)Cl3 0 0 0 0 
K3Ir(III)Cl6 0 ++++ 0 0 
K2Ir(IV)Cl6 0 0 0 0 
Ir(IV)Cl4 0 0 0 0 
Ni(II)Cl2 ++++++ 0 0 0 
K2Pd(II)Cl4 - - - - 
K2Pd(IV)Cl6 - - - - 
K2Pt(II)Cl4 ++++++ +++ 0 0 
K2Pt(IV)Cl6 0 +++++ 0 0 
Cu(II)Cl2 - - - - 
Ag(I)NO3 0 0 0 0 
NaAu(III)Cl4 - - - - 
Zn(II)Cl2 
0 0 0 0 
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Table 2.3. Amplification of dot blots from DAB-Tris-metal salt combinations with 
Gallyas’ or Newman and Jasani’s developers. 
 
Metal Gallyas Newman & Jasani 
 Foreground Background Foreground Background 
 
Sc(III)Cl3 
 
0 
 
0 
 
0 
 
0 
Y(III)Cl3 0 0 0 0 
La(III)Cl3 0 0 0 0 
V(III)Cl3 0 0 0 0 
Cr(II)Cl2 0 0 0 0 
Cr(III)Cl3 0 0 0 0 
H3PMo(IV)12O40 - - - - 
Na2W(VI)O4 - - - - 
H3PW(IV)12O40 - - - - 
Mn(II)Cl2 0 0 0 0 
Re(III)Cl3 0 0 0 0 
Fe(II)Cl2 - - - - 
Fe(III)Cl3 - - - - 
Ru(III)Cl3 0 ++ 0 0 
K3Ru(III)Cl6 - - - - 
K2Os(IV)Cl6 0 + 0 ++ 
Os(VIII)O4 - - - - 
Co(II)Cl2 - - - - 
Rh(III)Cl3 0 0 0 0 
K3Ir(III)Cl6 0 0 0 0 
K2Ir(IV)Cl6 0 0 0 0 
Ir(IV)Cl4 0 +++ 0 0 
Ni(II)Cl2 ++++++ 0 0 0 
K2Pd(II)Cl4 - - - - 
K2Pd(IV)Cl6 - - - - 
K2Pt(II)Cl4 ++++++ ++ 0 0 
K2Pt(IV)Cl6 0 +++++ 0 0 
Cu(II)Cl2 - - - - 
Ag(I)NO3 0 0 0 0 
NaAu(III)Cl4 - - - - 
Zn(II)Cl2 
0 0 0 0 
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2.4.2.1.2 Effects of Sulfide Treatment on Amplification 
Following treatment with 0.3% Na2S, dot blots from DAB-PO4 solutions 
containing Co(II)Cl2 were further intensified by Gallyas’ developer (figure 2.3d). 
Those from solutions containing Ni(II)Cl2 produced less intensification than before 
Na2S treatment (figure 2.3e), and those from solutions containing K2Pt(II)Cl4 
showed greatly increased background staining. Dot blots from 3 additional metal 
salt solutions were amplified, namely K3Ir(III)Cl6, K2Ir(IV)Cl6 and Ag(I)NO3.  
In the case of DAB-Tris, Ni(II)Cl2 gave a similar result, but a notable 
improvement was seen in the case of Ag(I)NO3, and Rh(III)Cl3 produced some 
intensification over background. In contrast, K3Ir(III)Cl6 and K2Ir(IV)Cl6 produced 
higher background than signal. 
The remaining metal salts produced either no discernable increase in dot blot 
intensity (13/25 (DAB-PO4), 11/19 (DAB-Tris)) or in increased background 
staining only (5/25 (DAB-PO4), 4/19 (DAB-Tris)). 
For DAB-PO4, Newman and Jasani’s developer produced amplification of 
NiCl2 that was comparable to that produced by Gallyas’ developer. Dot blots from 
solutions containing Co(II)Cl2, Ag(I)NO3 (figure 2.3f), Fe(II)Cl2 and K2Pt(II)Cl4 
were also amplified, but background staining was elevated to varying degrees. 
Similar results were observed for Ni(II)Cl2 and Ag(I)NO3 in DAB-Tris, although 
background staining was absent. 
No change was seen in most salts (12/25 (DAB-PO4), 11/19 (DAB-Tris) while 
some (8/25 (DAB-PO4), 8/19 (DAB-Tris)) had higher background than signal. 
Results are summarised in tables 2.4 and 2.5.  
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Table 2.4. Amplification of dot blots from DAB-PO4-metal salt combinations plus 
sulfide with Gallyas’ and Newman or Jasani’s developers. 
 
Metal Gallyas Newman & Jasani 
 Foreground Background Foreground Background 
 
Sc(III)Cl3 
 
0 
 
0 
 
0 
 
0 
Y(III)Cl3 0 0 0 0 
La(III)Cl3 0 0 0 0 
V(III)Cl3 0 0 0 0 
Cr(II)Cl2 0 0 0 0 
Cr(III)Cl3 0 0 0 0 
H3PMo(IV)12O40 0 0 0 0 
Na2W(VI)O4 0 0 0 0 
H3PW(IV)12O40 0 0 0 0 
Mn(II)Cl2 0 0 0 0 
Re(III)Cl3 0 0 0 0 
Fe(II)Cl2 0 ++++ ++++ 0 
Fe(III)Cl3 0 + + + 
Ru(III)Cl3 0 0 0 ++++++ 
K3Ru(III)Cl6 - - - - 
K2Os(IV)Cl6 0 0 0 ++++ 
Os(VIII)O4 - - - - 
Co(II)Cl2 +++++ +++ +++ 0 
Rh(III)Cl3 0 ++ ++ + 
K3Ir(III)Cl6 + 0 0 ++++++ 
K2Ir(IV)Cl6 +++ 0 0 0 
Ir(IV)Cl4 ++++ +++ +++ ++ 
Ni(II)Cl2 ++++ +++ +++ 0 
K2Pd(II)Cl4 - - - - 
K2Pd(IV)Cl6 - - - - 
K2Pt(II)Cl4 ++++ +++ +++ ++++++ 
K2Pt(IV)Cl6 0 0 0 ++++++ 
Cu(II)Cl2 - - - - 
Ag(I)NO3 +++++ +++++ +++++ ++ 
NaAu(III)Cl4 - - - - 
Zn(II)Cl2 
0 0 0 0 
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Table 2.5. Amplification of dot blots from DAB-Tris-metal salt combinations plus 
sulfide with Gallyas’ or Newman and Jasani’s developers. 
 
Metal Gallyas Newman & Jasani 
 Foreground Background Foreground Background 
 
Sc(III)Cl3 
 
0 
 
0 
 
0 
 
0 
Y(III)Cl3 0 0 0 0 
La(III)Cl3 0 0 0 0 
V(III)Cl3 0 0 0 0 
Cr(II)Cl2 0 0 0 0 
Cr(III)Cl3 0 0 0 0 
H3PMo(IV)12O40 - - - - 
Na2W(VI)O4 - - - - 
H3PW(IV)12O40 - - - - 
Mn(II)Cl2 0 0 0 0 
Re(III)Cl3 0 0 0 0 
Fe(II)Cl2 - - - - 
Fe(III)Cl3 - - - - 
Ru(III)Cl3 0 +++++ 0 ++++++ 
K3Ru(III)Cl6 - - - - 
K2Os(IV)Cl6 0 ++++++ 0 ++++++ 
Os(VIII)O4 - - - - 
Co(II)Cl2 - - - - 
Rh(III)Cl3 +++ ++ ++ ++++ 
K3Ir(III)Cl6 0 ++++++ 0 ++++ 
K2Ir(IV)Cl6 +++ ++++ +++ +++++ 
Ir(IV)Cl4 +++ ++++ +++ +++++ 
Ni(II)Cl2 +++ 0 +++ 0 
K2Pd(II)Cl4 - - - - 
K2Pd(IV)Cl6 - - - - 
K2Pt(II)Cl4 ++++ ++++++ +++ +++++ 
K2Pt(IV)Cl6 0 ++++++ 0 ++++++ 
Cu(II)Cl2 - - - - 
Ag(I)NO3 ++++++ 0 ++++++ 0 
NaAu(III)Cl4 - - - - 
Zn(II)Cl2 0 0 0 0 
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2.4.2.1.3 Nickel Concentration and Physical Developers 
Slight increases in the intensity of the dot blots, compared to the metal free 
control, were observed prior to physical developer treatment. These changes were 
most pronounced in dot blots from solutions containing 20 mM and 100 mM 
Ni(II)Cl2. 
Gallyas’ developer produced a dramatic and progressive increase in staining 
intensity with increasing concentrations of Ni(II)Cl2 (figure 2.4a and b). Again, 
Newman and Jasani’s developer caused rapid loss of the blue-black colour from the 
dots and no amplification occurred. 
 
2.4.2.1.4 Nickel Concentration and Physical Developers - Effects of Sulfide 
Treatment 
Following treatment with 0.3% Na2S and amplification with Gallyas’ physical 
developer, only at the highest concentration of Ni(II)Cl2 were all dots visible, and 
these were less intensely stained than the corresponding set without sulfide 
treatment. In addition, background staining was slightly elevated (figure 2.4c and 
d). 
Following amplification with Newman and Jasani’s developer of sulfide treated 
samples, all dots were clearly visible at 5 mM Ni(II)Cl2 (figure 2.4e). At 20 mM and 
100 mM Ni(II)Cl2, dots were more strongly stained at higher concentration of 
peroxidase, and more weakly stained at lower peroxidase concentration, than the 
corresponding dots produced by 5 mM Ni(II)Cl2 (figure 2.4f). Results are 
summarised in table 2.6. 
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Table 2.6. Effects of Ni(II)Cl2 concentration, with and without subsequent sulfide 
treatment, on subsequent amplification with Gallyas’ or Newman and Jasani’s 
developers. 
 
[Ni(II)Cl2] Gallyas Newman & Jasani 
 Foreground Background Foreground Background 
 
1 mM 
 
++++ 
 
0 
 
0 
 
0 
5 mM ++++ 0 0 0 
20 mM +++++ 0 0 0 
100 mM ++++++ 0 0 + 
     
 + 0.3% Na2S + 0.3% Na2S 
 Foreground Background Foreground Background 
 
1 mM 
 
++ 
 
0 
 
++ 
 
+ 
5 mM +++ 0 ++++++ + 
20 mM ++++ 0 +++++ + 
100 mM +++++ + +++++ + 
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2.4.2.2 Post-polymerisation and Amplification 
2.4.2.2.1 Physical Developers Alone 
In sharp contrast to the results of the pre-polymerisation experiments, the 
application of d-block metal salts to polyDAB produced a far greater range (11/31 
cf. 3/19) of dot blots that were amplifiable with Gallyas’ developer. The most 
striking results were with the platinum salts that produced maximal intensification, 
and no background, within 1 minute (figure 2.5a). The remaining 9 salts required 
the full 10 minutes, and 5 had elevated background staining as well. Of the 
remainder, treatment with Gallyas’ developer in 16 had no effect, and in 4, 
background staining only. Interestingly, neither Ni(II)Cl2 nor Co(II)Cl2 produced 
any visible increase in the intensity of the dot blots either before or after physical 
development. 
Newman and Jasani’s physical developer produced similar results, albeit of a 
lesser range than was observed with Gallyas’ developer. 4 metal salt-treated dot 
blots (NaAu(III)Cl4, K2Os(V)Cl6, and Os(VIII)O4) were moderately amplified 
whilst the remainder produced either no discernable increase in signal or 
background intensity (24/31), equal increases in both (2/31) or increased 
background only (1/31). Of particular note was the failure of platinum or iridium 
salts to facilitate amplification, as seen with Gallyas’ developer. Results are 
summarised in table 2.7. 
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Table 2.7. Amplification of dot blots, following post-polymerisation application of 
metal salts, with Gallyas’ or Newman and Jasani’s developers. 
 
Metal Gallyas Newman & Jasani 
 Foreground Background Foreground Background 
 
Sc(III)Cl3 
 
0 
 
0 
 
0 
 
0 
Y(III)Cl3 0 0 0 0 
La(III)Cl3 0 0 0 0 
V(III)Cl3 + 0 0 0 
Cr(II)Cl2 0 0 0 0 
Cr(III)Cl3 0 0 0 0 
H3PMo(IV)12O40 0 0 0 0 
Na2W(VI)O4 0 0 0 0 
H3PW(IV)12O40 0 0 0 0 
Mn(II)Cl2 0 0 0 0 
Re(III)Cl3 0 ++++++ 0 ++++++ 
Fe(II)Cl2 0 0 0 0 
Fe(III)Cl3 0 0 0 0 
Ru(III)Cl3 0 ++++++ 0 0 
K3Ru(III)Cl6 + ++++++ 0 0 
K2Os(IV)Cl6 0 0 ++ + 
Os(VIII)O4 ++++++ ++ ++ + 
Co(II)Cl2 0 0 0 0 
Rh(III)Cl3 + 0 0 0 
K3Ir(III)Cl6 0 0 0 0 
K2Ir(IV)Cl6 ++++++ +++ 0 0 
Ir(IV)Cl4 ++++++ +++ 0 0 
Ni(II)Cl2 0 0 0 0 
K2Pd(II)Cl4 ++ 0 + + 
K2Pd(IV)Cl6 + 0 + + 
K2Pt(II)Cl4 ++++++  0 0 
K2Pt(IV)Cl6 ++++++ 0 0 0 
Cu(II)Cl2 0 0 0 0 
Ag(I)NO3 0 + 0 0 
NaAu(III)Cl4 ++++++ ++ +++ + 
Zn(II)Cl2 
0 0 0 0 
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2.4.2.2.2 Effects of Sulfide Treatment on Amplification 
With Gallyas’ developer, sulfide treatment promoted increased amplification in 
11/31 of the dot blots, 2 having shown no propensity for amplification prior to 
sulfide treatment (Cu(II)Cl2 and K3Ir(III)Cl6). Furthermore, the background 
staining that occurred with NaAu(III)Cl4 in the absence of sulfide treatment was 
abolished without any apparent loss of foreground. Conversely, the intense staining 
seen following K2Pt(II)Cl4 alone was not improved with sulfide treatment; 
background staining was worsened (figure 2.5b).  The remaining metal salts 
produced either no obvious increase in dot blot or background intensity (10/31), 
higher background than foreground (6/31) or increased background only (3/31). 
With Newman and Jasani’s developer, Na2S increased not only the intensity of 
amplification (NaAu(III)Cl4 (figure 2.5c)), but also the range of polyDAB-metal 
‘complexes’ that could be amplified (Fe(II)Cl2, (figure 2.5d) Cu(II)SO4 (figure 2.5e), 
Ag(I)NO3, K2Pt(IV)Cl6). The remaining metal salts produced either no increase in 
dot blot or background staining (18/31), higher background than foreground, e.g. 
K2Pd(IV)Cl4 (figure 2.5f) (5/31) or an equal increase in both (1/31). Results are 
summarised in table 2.8. 
The rapid loss of the blue-black colour associated with dot blots that were 
produced from solutions containing cobalt or nickel, following immersion in 
Newman and Jasani’s developer, together with the failure of this developer to 
produce the striking results seen with the post-polymerisation application of 
platinum in conjunction with Gallyas’ developer prompted an investigation to 
determine which component(s) of Newman and Jasani’s developer were 
responsible for these discrepant observations.  
114 
 
Table 2.8. Amplification of dot blots following post-polymerisation application of 
metal salt and sulfide with Gallyas’ or Newman and Jasani’s developers. 
 
Metal Gallyas Newman & Jasani 
 Foreground Background Foreground Background 
 
Sc(III)Cl3 
 
0 
 
0 
 
0 
 
0 
Y(III)Cl3 0 0 0 0 
La(III)Cl3 0 0 0 0 
V(III)Cl3 +++ 0 0 0 
Cr(II)Cl2 0 0 0 0 
Cr(III)Cl3 0 0 0 0 
H3PMo(IV)12O40 0 0 0 0 
Na2W(VI)O4 0 0 0 0 
H3PW(IV)12O40 0 0 0 0 
Mn(II)Cl2 0 0 0 0 
Re(III)Cl3 0 ++++++ 0 ++++++ 
Fe(II)Cl2 ++++++ ++++++ +++++ + 
Fe(III)Cl3 0 +++ + ++++ 
Ru(III)Cl3 0 ++++++ 0 0 
K3Ru(III)Cl6 + ++++++ 0 0 
K2Os(IV)Cl6 ++ ++++++ 0 ++ 
Os(VIII)O4 ++++++ +++++ ++++ +++ 
Co(II)Cl2 +++ ++++++ 0 0 
Rh(III)Cl3 +++ 0 0 0 
K3Ir(III)Cl6 +++ + 0 0 
K2Ir(IV)Cl6 +++++ ++ 0 0 
Ir(IV)Cl4 +++++ + 0 + 
Ni(II)Cl2 0 0 0 0 
K2Pd(II)Cl4 ++++++ +++ ++ ++++ 
K2Pd(IV)Cl6 +++ ++++++ ++++++ ++++ 
K2Pt(II)Cl4 ++++++ + 0 0 
K2Pt(IV)Cl6 +++++ 0 + 0 
Cu(II)Cl2 ++++++ + ++++++ 0 
Ag(I)NO3 +++ ++++++ ++++++ ++ 
NaAu(III)Cl4 ++++++ 0 ++++++ 0 
Zn(II)Cl2 0 0 0 0 
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a b c 
   
d e f 
   
 
Figure 2.3. Representative dot blots from pre-polymerisation experiments. DAB 
alone (a), Co(II) + Gallyas’ developer (b), Ni(II) + Gallyas’ developer (c), Co(II) + 
Na2S + Gallyas’ developer (d), Ni(II) + Na2S + Gallyas’ developer (e), and Ag(I) + 
Na2S + Newman and Jasani’s developer (f). 
 
a b c 
    
d e f 
   
 
Figure 2.4. Representative dot blots from Ni(II) concentration experiments. 5 mM 
Ni(II) + Gallyas’ developer (a), 100 mM Ni(II) + Gallyas’ developer (b) 5 mM 
Ni(II) + Na2S + Gallyas’ developer (c), 100 mM Ni(II) + Na2S + Gallyas’ 
developer (d), 5 mM Ni(II) + Na2S + Newman and Jasani’s developer (e) and 100 
mM Ni(II) + Na2S + Newman and Jasani’s developer (f). 
 
a b c 
   
d e f 
   
 
Figure 2.5. Representative dot blots from post-polymerisation experiments. Pt(II) + 
Gallyas’ developer (a), Pt(II) + Na2S + Gallyas’ developer (b), Au(III) + Na2S + 
Newman and Jasani’s developer (c) Fe(II) + Na2S + Newman and Jasani’s 
developer (d), Cu(II) + Na2S + Newman and Jasani’s developer (e) and Pd(IV) + 
Na2S + Newman and Jasani’s developer (f). 
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By preparing solutions that omitted each of the various components in turn, 
and observing the loss of colour from dot blots containing either Ni(II)Cl2 or 
Co(II)Cl2, it was found that colour loss was due partly to the citrate buffer of the 
reducer solution, but mainly due to the reducing agent, pyrogallol. A similar effect 
was achieved with 1% neutral EDTA, suggesting that metal salt extraction, rather 
than chemical alteration (e.g. reduction by pyrogallol) of polyDAB was the cause. 
Attempts to subsequently reintroduce either Ni(II)Cl2 or Co(II)Cl2 by immersing 
the dot blots in solutions of up to 100 mM of the salts for 10 minutes failed to 
produce any colour change. 
Since platinum loss could not be visualised directly, dot blots were immersed 
for up to 10 minutes in the various preparations of Newman and Jasani’s developer, 
thoroughly washed, and then immersed in Gallyas’ developer. In contrast to 
Ni(II)Cl2 and Co(II)Cl2, platinum was rapidly extracted by sodium sulphite, a 
component of the reducer solution. Loss of platinum occurred in less than 10 
seconds. 
 
2.4.2.3 Analytical Scanning Electron Microscopy 
The PVDF membrane of the dot blots provided a useful control for 
preliminary examination by BSI, since it appeared brighter than the surrounding 
adhesive tape due to the presence of fluorine and thus its higher average atomic 
number composition. 
The vast majority of dot blots showed no increased brightness, and those that 
did contained d-block metals that were restricted to the second and third row. 
Even with a high probe current and long dwell time, very few dot blots 
produced measurable X-ray signals; only 4 from pre-polymerisation and 5 in the 
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post-polymerisation experiments (figures 2.6 and 2.7 respectively). Quantitation 
was not possible, since the nitrogen peak (0.3924 KeV) due to polyDAB was 
obscured within the broad carbon peak of both the membrane and carbon coating 
(0.2774 KeV). Results are summarised in table 2.9. 
 
2.4.3 Tissue Model System 
From the results above, d-block metal salts that facilitated the strongest 
amplification and lowest background were selected for testing on tissue sections. 
Those to be amplified with Gallyas’ developer were 1) pre-polymerisation; Ni(II)Cl2 
at 1, 5, 20 and 100 mM in DAB-Tris, 2) pre-polymerisation with sulfide; Ag(I)NO3 
in DAB-Tris, Co(II)Cl2, and K3Ir(III)Cl6 in DAB-PO4, 3) post-polymerisation; 
K2Pt(II)Cl4, K2Pt(IV)Cl6 and 4) post-polymerisation with sulfide; V(III)Cl3, 
Fe(II)Cl2, Cu(II)Cl2, Rh(III)Cl3, and NaAu(III)Cl4. Those to be amplified with 
Newman and Jasani’s developer, all following treatment with Na2S, were 1) pre-
polymerisation; Ni(II)Cl2 at 5, 20 and 100 mM and Ag(I)NO3 in DAB-Tris, and 
Co(II)Cl2, in DAB-PO4 and 2) post-polymerisation; Cu(II)Cl2, Fe(II)Cl2, Au(III)Cl3 
and NaAu(III)Cl4.  
 
2.4.3.1 Selection of Appropriate Antibody Dilutions 
The primary antibody dilution that produced immunohistochemical staining 
that was just visible was 
1
/4000 (figure 2.8a). 
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Table 2.9. Summary of results from back-scattered electron imaging and X-ray 
microanalysis. 
 
Metal Pre-
polymerisation 
DAB-PO4 
Pre-
polymerisation 
DAB-Tris 
Post-
polymerisation  
 BSI X-ray BSI X-ray BSI X-ray 
Sc(III)Cl3      
Y(III)Cl3      
La(III)Cl3      
V(III)Cl3      
Cr(II)Cl2      
Cr(III)Cl3      
H3PMo(IV)12O40   - -  
Na2W(VI)O4   - -  
H3PW(IV)12O40      
Mn(II)Cl2      
Re(III)Cl3      
Fe(II)Cl2   - -  
Fe(III)Cl3   - -  
Ru(III)Cl3      
K3Ru(III)Cl6      
K2Os(IV)Cl6      
Os(VIII)O4 - - - -  
Co(II)Cl2      
Rh(III)Cl3      
Ir(IV)Cl4      
K3Ir(III)Cl6      
K2Ir(IV)Cl6      
Ir(VI)Cl4      
Ni(II)Cl2      
Ni(II)Cl2 5 mM - -    
Ni(II)Cl2 20 mM - -    
Ni(II)Cl2 100 mM - -    
K2Pd(II)Cl4 - - - -  
K2Pd(IV)Cl6 - - - -  
K2Pt(II)Cl4      
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K2Pt(IV)Cl6      
Cu(II)Cl2   - -  
Ag(I)NO3   - -  
NaAu(III)Cl4 - - - -  
Zn(II)Cl2      
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Figure 2.6. Back-scattered electron images and corresponding X-ray emission 
spectra of pre-polymerisation dot blots of H3PMo(IV)12O40 (a and b) and 
NaW(VI)O4 (c and d) from DAB-PO4, and Ni(II)Cl2 (e and f) and K2Pt(II)Cl4  
(g and h) from DAB-Tris. 
b a 
d 
e 
c 
f 
h g 
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Figure 2.7. Back-scattered electron images and corresponding X-ray emission 
spectra of post-polymerisation dot blots. Na2W(VI)O4 (a and b), Rh(III)Cl3 (c and 
d), K2Pd(II)Cl4 (e and f) K2Pd(IV)Cl6 (G and h) and NaAu(III)Cl4 (i and j). 
d 
b 
c 
a 
f e 
h g 
j i 
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2.4.3.2 Pre-polymerisation with Gallyas’ Developer 
Ni(II)Cl2 showed a slight concentration dependent increase in maximal 
staining intensity and a more marked concentration dependent decrease in staining 
time. At the highest concentration (100 mM) (figure 2.8b), background staining was 
slightly elevated.  
 
2.4.3.3 Pre-polymerisation plus Sulfide and Physical Developers 
With Gallyas’ developer, Ag(I)NO3 produced increased specific staining with 
little general background, although erythrocyte (red blood cell) staining was 
dramatically increased. Only slight amplification was seen with either Co(II)Cl2, or 
K3Ir(III)Cl6. 
With Newman and Jasani’s developer, Ag(I)NO3 produced the strongest 
response (figure 2.8c). In contrast to Gallyas’ developer, no significant erythrocyte 
staining was observed. Ni(II)Cl2 produced similar, albeit reduced, specific 
amplification compared with Gallyas’ developer. Co(II)Cl2 produced a greater 
amplification than was seen following Gallyas’ developer, but background staining 
was high. 
 
2.4.3.4 Post- polymerisation and Gallyas’ Developer 
Dramatic amplification was seen with both platinum salts which, like the dot 
blots, were both maximally amplified in just 1 minute (figure 2.9a). 
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2.4.3.5 Post- polymerisation plus Sulfide and Physical Developers 
With Gallyas’ developer, amplification was observed with NaAu(III)Cl4, 
V(III)Cl3 (figure 2.9b) and, to a slightly lesser extent, Rh(III)Cl3. K3Ir(III)Cl6 
produced little intensification whereas Cu(II)Cl2 produced increased background 
staining which rapidly overwhelmed the slight increase in specific staining intensity. 
Of the three metal salts tested with Newman and Jasani’s developer, only 
NaAu(III)Cl4 produced any intensification (figure 2.9c). Fe(II)Cl2 produced an 
almost immediate and dramatic increase in background staining which made 
observation of any specific amplification impossible. Cu(II)Cl2 produced similar 
results to those seen with Gallyas’ developer (figure 2.9d). 
Visualisation of immunocolloidal gold required 20 minutes in Gallyas’, and 30 
minutes in Newman and Jasani’s (figure 2.9e) developers, respectively. Background 
staining was restricted to erythrocytes in the case of Gallyas’ developer, but none 
was seen with Newman and Jasani’s. Results are summarised in table 2.10. 
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Table 2.10 Summary of immunohistochemical amplification with Gallyas’ and 
Newman and Jasani’s physical developers arranged in order of strength and 
specificity (signal minus background) 
Metal Application and Developer  Time Signal - 
Background (minutes) 
Colloidal Gold Newman and Jasani 30 6 
NaAu(III)Cl4 + Na2S Post-, Newman and Jasani 8 6 
K2Pt(II)Cl4 Post-, Gallyas 1 5 
K2Pt(IV)Cl6 Post-, Gallyas 1 5 
NaAu(III)Cl4 + Na2S Post-, Gallyas 6 5 
V(III)Cl3 + Na2S Post-, Gallyas 10 5 
Ag(I)NO3 + Na2S Pre-, Newman and Jasani 13.5 5 
Colloidal Gold Gallyas 20 4 
Ni(II)Cl2 100 mM Pre-, Gallyas 4 4 
Ni(II)Cl2 20 mM Pre-, Gallyas 6 4 
Ni(II)Cl2 5 mM Pre-, Gallyas 8.5 4 
Rh(III)Cl3 + Na2S Post-, Gallyas 10 4 
Ni(II)Cl2 1 mM Pre-, Gallyas 10 3 
Ag(I)NO3 + Na2S Pre-, Gallyas 10 3 
Ni(II)Cl2 100 mM + Na2S Pre-, Newman and Jasani 5.5 2 
Co(II)Cl2 + Na2S Pre-, Newman and Jasani 7.5 2 
Ni(II)Cl2 20 mM + Na2S Pre-, Newman and Jasani 8 2 
Ni(II)Cl2 5 mM + Na2S Pre-, Newman and Jasani 11 2 
Co(II)Cl2 + Na2S Pre-, Gallyas 3 1 
K3Ir(III)Cl6 Pre-, Gallyas 10 1 
Na2S Post-, Newman and Jasani 13.5 1 
Cu(II)Cl2 + Na2S Post-, Newman and Jasani 6.5 -2 
Cu(II)Cl2 + Na2S Post-, Gallyas 1.5 -2 
Fe(II)Cl2 + Na2S Post-, Newman and Jasani 1 -6 
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Figure 2.8. 4 m thick paraffin wax-embedded tonsil immunohistochemically 
stained for CD45Ro with metals applied pre-polymerisation; DAB alone (a), 100 
mM Ni(II) + Gallyas’ developer (b). 
a 
b 
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Figure 2.8 (continued). 4 m thick paraffin wax-embedded tonsil 
immunohistochemically stained for CD45Ro with metal applied pre-
polymerisation; Ag(I) + Na2S + Newman and Jasani’s developer (c). 
  
c 
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Figure 2.9. 4 m thick paraffin wax-embedded tonsil immunohistochemically 
stained for CD45Ro with metals applied post-polymerisation; Pt(II) + Gallyas’ 
developer (1 minute) (a) V(III) + Na2S + Gallyas’ developer (b). 
a b 
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Figure 2.9 (continued). 4 m thick paraffin wax-embedded tonsil 
immunohistochemically stained for CD45Ro with metals applied post-
polymerisation; Au(III) + Na2S + Newman and Jasani’s developer (c), Cu(II) + 
Na2S + Newman and Jasani’s developer (d). 
c 
d 
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Figure 2.9 (continued). 4 m thick paraffin wax-embedded tonsil 
immunohistochemically stained for CD45Ro and colloidal gold + Newman and 
Jasani’s developer (e). 
 
  
e 
130 
 
2.4.4 Diagnostic Immunohistochemistry 
In Hodgkin’s lymphoma tissue sections immunostained for LMP-1, marker 
intensity was generally weak, even with both antigen retrieval and reporter 
amplification (figure 2.10a). Marker amplification using NaAu(III)Cl4 + Na2S + 
Newman and Jasani’s developer resulted in dramatic improvements in visible signal 
strength together with the demonstration of additional positively stained sites which 
were previously below the detection limit of the conventional method (figure 
2.10b). 
Marker intensity in control tonsil tissue that had been immunostained for 
granzyme B was barely discernable, even though, as with LMP-1 staining, target 
retrieval and reporter amplification had been employed (figure 2.11a). Following 
marker amplification, immunopositive sites were clearly seen, as were additional 
sites that were previously invisible (figure 2.11b). 
In control Alzheimer's brain sections, -synuclein-positive cells could be clearly 
seen at higher power, although staining in some cases was weak (figure 2.12a). 
Marker amplification resulted in all immunopositive sites becoming clearly visible 
(figure 2.12b). At lower power, positive sites in control sections could just be 
discerned (figure 2.12c). Staining intensity was markedly increased following 
marker amplification, and allowed positively stained cells to be clearly identified 
(figure 2.12d). 
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Figure 2.10. 4 m thick paraffin wax-embedded stage 4 Hodgkin’s lymphoma tissue 
immunohistochemically stained for LMP-1 (a) and after marker amplification (b). 
a 
b 
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Figure 2.11. 4 m thick paraffin wax-embedded tonsil immunohistochemically 
stained for granzyme B (a) and following marker amplification (b). 
a 
b 
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Figure 2.12. Higher power images of 4 m thick paraffin wax-embedded brain 
tissue from Alzheimer’s disease immunohistochemically stained for -synuclein, 
showing clearly visible and faint staining (arrows) (a) and following marker 
amplification (b). 
b 
a 
134 
 
 
 
Figure 2.12 (continued). Lower power images of 4 m thick paraffin wax-
embedded brain tissue from Alzheimer’s disease immunohistochemically stained 
for -synuclein, showing visible staining (arrows) (c) and following marker 
amplification, showing more intense immunopositive sites (arrows) (d). 
c 
d 
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2.4.5 Alkaline Phosphatase Marker Amplification 
In the absence of metal salts, dots were magenta in colour. In the presence of 
cobalt, nickel and copper salts, blue dots were produced under both pre- and post-
reduction conditions. Neither Gallyas’, nor Newman and Jasani’s developer 
succeeded in amplifying any of the dot blot preparations.  
Treatment with sodium sulfide instantly caused both the dots and the 
membrane to turn black. To further investigate this reaction to sulfide treatment, 
MTT was replaced with nitro blue tetrazolium (NBT). Treatment with sodium 
sulfide produced identical results. 
 
  
136 
 
2.5 Discussion 
In preliminary dot blot experiments, amplification of polyDAB combined with 
a number of d-block metal salts in both a pre- and post-polymerisation setting, with 
or without subsequent treatment with Na2S, was achieved by both Gallyas’ and 
Newman & Jasani’s physical developers, and allowed previously invisible amounts 
of marker to be clearly seen. Na2S treatment not only increased the range of 
polyDAB-metal salts that could be amplified but, in general, also increased the 
degree of amplification. 
The best results, which were subsequently evaluated in the 
immunohistochemical model, were those that involved the post-polymerisation 
application of d-block metal salts, usually in combination with Na2S.  
Of groups 3 to 6, only V(III)Cl3 catalysed silver reduction in the post-
polymerisation setting, and only with Gallyas’ developer after Na2S treatment. In 
addition, it performed much better in the tissue model system than the result from 
the dot blot experiment suggested. It was not, however, demonstrable by either BSI 
or EDX. In contrast, H3PMo(IV)12O40, Na2W(VI)O4 and H3PW(IV)12O40 were all 
detectable by these methods in some settings, yet none of them catalysed silver 
reduction. Phosphotungstic acid has previously been reported to increase the 
electron opacity of polyDAB in a post-polymerisation setting (Newman et al., 
1983a) at a similar concentration (1%, 3.4 mM) to that used here (2.5 mM), but was 
not detectable by BSI or X-ray analysis in the post-polymerisation setting. 
Group 7 metals either did not catalyse silver reduction (Mn(II)Cl2), or 
produced widespread background staining of the dot blots (Re(III)Cl3) and were not 
investigated in the tissue model. Neither metal was demonstrable by BSI or EDX. 
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The general effect of Group 8 metals was to elevate non-specific background 
staining of the dot blots. The only exceptions were the combination of Fe(II)Cl2, 
either pre-polymerisation with DAB-PO4 or post-polymerisation, followed by Na2S 
and Newman and Jasani’s developer, or the post-polymerisation application of 
Os(VIII)O4 followed by Gallyas’ developer. In the case of Fe(II)Cl2, the promising 
results of the dot blots were not, however, replicated in the tissue model system 
where widespread background staining occurred within seconds. Only the osmium 
compounds were detectable by BSI, and then only a faint increase in dot blot 
brightness was seen. 
Group 9 metals performed poorly in the pre-polymerisation experiments and, 
like those of Group 8, tended to increase background staining. Co(II)Cl2 produced 
encouraging results when combined with Na2S and Newman & Jasani’s developer, 
but results from the tissue model system were disappointing. Cobalt(II) has received 
considerably less attention in the literature than nickel(II), even though it was the 
first metal to be incorporated into polyDAB for light microscopical applications 
(Adams, 1977).  A probable explanation for this is that the most commonly 
employed buffer for DAB is Tris, and cobalt(II) appears to be unstable in this 
system. In the post-polymerisation setting, no change in the colour of polyDAB was 
observed following incubation in Co(II)Cl2, nor was any reduction of silver noted, 
even after Na2S treatment. In contrast, both Rh(III)Cl3 and the iridium salts 
produced moderate amplification following Na2S treatment, but only with Gallyas’ 
developer. In the immunohistochemical model, Rh(III)Cl3 performed moderately 
well whereas the only iridium salt (K3Ir(III)Cl6) that was tested produced rather 
poor results compared with what had been observed in the dot blot model. 
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Dramatic improvements in staining intensity and specificity were observed with 
Group 10 metals, compared to previous groups. The stability of high concentrations 
of Ni(II)Cl2 in DAB-Tris was both remarkable and unique. In the dot blot model, 
sensitivity increased with nickel(II) concentrations up to 20 mM in combination 
with Gallyas’ developer, but this was not reflected in the immunohistochemical 
model where increasing concentrations of nickel(II) reduced the endpoint time, but 
did not appear to improve sensitivity. A similar pattern was observed with Newman 
and Jasani’s developer, but there was a requirement for Na2S treatment, and 
intensity of staining was less. The blue/black colour of dot blots produced by 
Ni(II)Cl2 in the pre-polymerisation experiments, like Co(II)Cl2, was lost following 
incubation in Newman & Jasani’s developer, and was caused, primarily, by the 
reducing agent, pyrogallol and, to some extent, by the reducer buffer, citrate. This 
extractive effect could be replicated by EDTA, suggesting that it was not necessarily 
due to reduction by pyrogallol. Surprisingly, neither cobalt(II) nor nickel(II) 
appeared to be re-introduced into extracted polyDAB, as indicated by colour 
change. Similarly, neither salt promoted amplification in the post-polymerisation 
setting. Ni(II)Cl2 in DAB-PO4, but not in DAB-Tris was detected by EDX. The 
reason for this is unclear, since results from the amplification experiments suggested 
that greater amounts would be present at the higher concentrations of nickel(II) that 
were included in DAB-Tris combinations. It is, however, possible that nickel(II) 
was also deposited as its phosphate in the DAB-PO4 mixture in addition to catalytic 
quantities in polyDAB, although similar results were not observed for cobalt(II). 
Both compounds might also have altered the nature of the final product during the 
polymerisation process, rendering it more catalytic, which might explain why both 
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nickel(II) and cobalt(II) salts could be successfully employed pre-polymerisation, 
but not post-polymerisation. Nickel(II) salts (either Ni(II)Cl2 or Ni(II)(NH4)2SO4)) 
have been used at concentrations of 1 mM (Hsu and Soban, 1982), 10 mM 
(Lanciego et al., 1997; Gonzalo et al., 2001), 40 mM (Tajima et al., 2000) and 63 
mM (Hancock, 1982; 1984) or over a range of 0.25 – 126 mM (Tago et al., 1986) 
and it surprising that similar nickel(II) concentrations have not been employed in 
combination with physical developers. Where subsequent amplification has been 
applied, nickel(II) salts have not been used in excess of about 4 mM (Przepiorka 
and Myerson, 1986; Gallyas and Merchenthaler, 1988; Merchenthaler et al., 1989; 
Frigo et al., 1991; Mullink et al., 1992). 
The two palladium compounds could only be employed in the post-
polymerisation setting and promoted only slight amplification with physical 
developers alone, even though both could be detected by BSI and EDX. 
Amplification following Na2S treatment resulted in unacceptably high background 
staining and they were not tested in the tissue model system. 
The platinum salts produced the most dramatic results of all in both the dot blot 
and immunohistochemical model systems when used in combination with Gallyas’ 
developer. Amplification was so rapid that it was almost uncontrollable; the 
difference between the end point of signal amplification and the appearance of 
background staining was a matter of seconds. Surprisingly, treatment with Na2S 
had little beneficial effect and tended to worsen background staining. The presence 
of both compounds could, in general, be demonstrated by BSI, but were not so 
easily detectable by EDX. K2Pt(II)Cl4 and K2Pt(IV)Cl6 have been used to increase 
the electron opacity of polyDAB in both a pre- (Hiraoka and Hirai, 1992; 1995) and 
post-polymerisation setting (de Bruijn et al., 1986) respectively. Both studies 
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reported detectable levels of platinum at non-specific sites by EDX, which may 
explain the background staining observed with K2Pt(II)Cl4 in the pre-
polymerisation experiments. The absence of background staining observed in the 
post-polymerisation results may reflect differences in protocols; de Bruijn et al 
(1986) applied K2Pt(IV)Cl6 as a 10% (219 mM) solution in 10% HCl, whereas in 
this study, the salt was applied as a simple 2.5 mM aqueous solution. 
Group 11 metals produced similarly dramatic and intense amplification of 
polyDAB as that seen with the Group 10 metals. The post-polymerisation 
treatment of polyDAB with copper(II)chloride in combination with Na2S gave very 
encouraging results in the dot blot model, but this was not reproduced in the 
immunohistochemical model, where rapid and widespread background staining 
occurred, similar to that seen with Fe(II)Cl2. The suppression of tissue 
autofluorescence with copper(II)sulfate alone (Schnell et al., 1999), and both tissue 
autofluorescence (Kelly, 2010) and argyrophilia (Gallyas and Wolff, 1986) by 
copper(II)sulfate in combination with hydrogen peroxide suggests the widespread 
existence of copper(II) binding sites. 
Silver(I)nitrate performed far better in a pre-polymerisation than in a post-
polymerisation setting, but appeared to have an absolute requirement for Na2S to be 
demonstrable with either developer. This may explain why polyDAB alone was not 
intensified by either developer in this study. Silver(I), from either developer, might 
interact with polyDAB, but not in such a way, or in sufficient quantities to be 
amplifiable. PolyDAB has been intensified with silver either as part of a physical 
developer (Gallyas et al., 1982; Gorcs et al., 1986) or in related silver staining 
techniques such as silver methanamine (Rodriguez et al., 1984) or ammoniacal 
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silver (Quinn and Graybiel, 1996). Metallic silver has been deposited directly by 
HRP in the enzyme metallography technique and has shown dramatically 
improved staining intensity when compared with clearly visible polyDAB (Hainfeld 
et al., 2002). No obvious metallic silver deposit was observed in the pre-
polymerisation experiments involving silver(I)nitrate. Since the composition of the 
reagents that are used in the enzyme metallographic process have not been 
published it is not possible to account for these discrepancies. 
NaAu(III)Cl4, following treatment with Na2S produced excellent results with 
both developers, and was much more controllable than the platinum salts discussed 
above. It was the only metal in the group to be demonstrable by both BSI and EDX. 
The affinity of polyDAB for gold(III) salts was first noted in 1979 (Siegesmund et 
al., 1979) and was subsequently advocated as a replacement for osmium(VIII) as a 
means of rendering polyDAB electron opaque (Newman et al., 1983a). 
NaAu(III)Cl4 has been investigated previously with both Gallyas’ (Newman et al., 
1983b; Scopsi and Larsson, 1986; Green et al., 1989) and Newman and Jasani’s 
developer (Newman and Jasani, 1998). 
Zn(II)Cl2, the only representative of the group 12 metals, failed to catalyse 
silver reduction either alone, or following treatment with Na2S. Zinc(II) in tissue 
can be demonstrated by the sulfide-silver technique (Danscher and Stoltenberg, 
2006), but it presumably does not complex with DAB in appreciable quantities. 
The most surprising feature of the pre-polymerisation experiments was how few 
d-block metal salts promoted silver amplification. With Gallyas’ developer, only 
three salts produced any response at all, and Newman and Jasani’s, developer gave 
negative results across the whole range. The failure of the latter developer to 
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perform as well as the former was due to the metal-extracting properties of some of 
its components, namely pyrogallol, citrate and sulfite. 
The majority of metal salts were stable in both DAB-PO4 and DAB-Tris at a 
final concentration of 1 mM. The instability of some d-block metal salts, namely 
copper(II) and palladium(II) has been noted previously (Hsu and Soban, 1982). 
Interestingly, these authors found cobalt(II) and iron(III), but not silver(I), to be 
stable in DAB-Tris, results that conflict with the findings here. In a detailed study of 
the d-block metal catalysed polymerisation of DAB in Tris buffer, Litwin found 
both copper(II) and cobalt(II) and, to a lesser extent, iron(III) and manganese(II) to 
be powerful catalysts (Litwin, 1982) and thus unsuitable for use in the pre-
polymerisation setting. Similar effects were observed here, with the exception of 
manganese(II), which probably reflected both sub-optimal pH and concentration for 
this reaction. 
Treatment with Na2S probably has two effects, namely increasing the catalytic 
activity of bound metal (Timm, 1958) and differentiation. The former effect has 
been used to advantage previously both at the light (Newman et al., 1983b) and 
electron microscopic levels (Smiley and Goldman-Rakic, 1993). The differentiating 
effect of Na2S has been observed previously with gold(III) salts (Newman and 
Jasani, 1998) and explains the difference in catalytic activity of polyDAB from 
nickel(II) containing solutions with Gallyas’ developer, with or without Na2S 
treatment; proportionately more nickel(II) was dissolved by Na2S at lower 
concentrations of nickel(II) than at higher concentrations. Differences in the 
catalytic activity of polyDAB-metal complexes presumably reflect a balance 
between the two. Whether metal are completely converted to their respective 
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sulfides and are simply immobilised as insoluble products in polyDAB, or remain 
partly co-ordinated to polyDAB is unclear. 
Analytical SEM examination of dot blots revealed a number of metals that had 
formed complexes with polyDAB. In addition, there was general agreement 
between BSI and EDX. BSI is a qualitative technique that relies on average atomic 
number for contrast. Consequently, it is less sensitive to low concentrations of low 
atomic number elements than to higher ones, which might explain the lack of 
contrast imparted to dot blots by the first row elements. EDX is both qualitative 
and quantitative and does not suffer from the same restrictions, but suffers, 
particularly in the SEM, from a high background Bremstrahlung radiation at the 
lower energy ranges. Quantitation was not possible since the nitrogen peak of 
polyDAB was obscured by the broad carbon peak of both the membrane and the 
conductive carbon coating. Some separation of these peaks might have been 
achieved by increasing processing time, but this would have been at the expense of 
sensitivity, and acquisition time would have been considerably extended. 
Accurate diagnosis in a busy histopathological setting ideally requires positive 
staining to be unequivocal. In the majority of cases where immunohistochemical 
staining is required, this is achieved by both target retrieval and reporter 
amplification techniques. There exist, however, a small number of cases where 
these are still inadequate to demonstrate clear positivity, and additional 
amplification is required. The application of the most powerful marker 
amplification technique to diagnostically relevant samples resulted in both the 
clarification of immunopositivity and the revelation of additional positivity that was 
below the visible detection limit of the conventional system. In a busy diagnostic 
setting, these former sites could be easily overlooked, leading to false diagnosis. In 
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addition, the detection of additional immunopositive sites might have implications 
for both diagnosis and subsequent treatment. Where immunopositive cells were 
visible before marker amplification, but present in low numbers and sparsely 
distributed i.e. in the control Alzheimer’s brain sample, marker amplification made 
these positive sites much more easily visible and had the potential to facilitate rapid 
evaluation of large areas of tissue at low magnification. 
Interest in marker amplification has diminished as a consequence of 
developments in target retrieval and reporter amplification, since these have leant 
themselves more readily to automation and thus widespread application, 
particularly in diagnostic laboratories and industry. Such techniques are not 
without their own problems, however. Target retrieval must be tailored to each 
antigen, making the establishment of standardised procedures difficult. In addition, 
it has been noted to increase false positive results due to biotin or biotin-like 
molecules (Kim et al., 2002). As the number of layers used in reporter amplification 
is increased, to detect ever smaller quantities of antigen, background staining may 
become an inevitable problem since each successive layer is applied in excess to 
ensure maximal detection of the previous layer. While polymeric conjugates 
overcome this to a certain extent, steric hindrance associated with such 
macromolecular structures might compromise sensitivity. The tyramide 
amplification technique represents another powerful method for detecting low 
concentrations of antigen but its widespread introduction has been confounded by 
problems such as non-specific background staining (Freedman and Maddox, 2001), 
uneven staining or paradoxical overstaining (Mengel et al., 1999). 
Unlike other detection systems, marker amplification has the flexibility to be 
employed once the marker has been deposited, if required e.g. where positivity is 
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uncertain. Furthermore, fresh sections do not have to be cut and stained since the 
technique can be applied to the stained section, thus saving time and labour. An 
additional advantage of this is that archival tissue sections can be revisited.  
The complexity of the techniques precludes their widespread use in routine 
laboratories, and considerable simplification is required. An understanding of both 
the co-ordination chemistry of polyDAB and the mechanistic chemistry underlying 
the amplification reaction would aid the rational design of novel amplifiable 
markers. Co-ordination complexes of aromatic amines and diamines have been 
described, such as those of 1,2-diaminobenzene and Ni(II) (Pank and Jun, 2005) 
(figure 2.13a) or Cr(III) (Redshaw et al, 1992) (figure 2.13b) or benzidine and 
Co(II) (Topacli and Topacli, 2003) (figure 2.13c). There was no obvious evidence of 
complex formation in solutions that remained stable in the presence of DAB, such 
as colour change, even though this was particularly evident post-polymerisation in a 
number of cases, notably Ni(II) and Co(II). What little co-ordination chemistry of 
polyDAB that exists is largely speculative; it has been suggested that the bonding of 
Pt(IV)Cl6
2-
 to polyDAB at low pH (<0.3) is via electrostatic bonds to protonated 
amines (de Bruijn et al, 1986) (figure 2.13e). A more plausible structure might be 
that based on the Pt(II)-phenazine compounds of Siedle et al (1985), where the 
metal centre is directly co-ordinated to the nitrogen ligand (figure 2.13e). Both 
indamine and phenazine structures that are suggested to occur in polyDAB 
(Seligman et al, 1968) could thus act as ligands for d-block metals. 
The failure of the alkaline phosphatase (AP) marker, MTT-metal, to catalyse silver 
reduction from either developer was unexpected in view of the success of the DAB 
experiments. Presumably, the co-ordination chemistry of the formazan-metal 
complex renders it non-catalytic. 
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Figure 2.13. Co-ordination complexes of aromatic amines, diamines, polyDAB and 
phenazine. Bis(1,2-diaminobenzene)Ni(II) (a), 1,2-diaminobenzene Cr(III)Cl4 (b),  
bis(3,3’-diaminobiphenyl)Co(II)Cl2 (c), polyDAB-Pt(IV)Cl6
2-
 complex (d) and 
(phenazine)2-Pt(II)Cl2 complex (e).  
a b 
c 
d e 
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The coordination chemistry of a number of metal-formazan complexes have 
been described, such as those of with Fe(II), Ni(II), Cu(II) or Pd(II) centres, which 
adopt the form  ML2 with bidentate ligands (Siedle and Pignolet, 1980; Gilroy et 
al., 2008; Pervova et al., 2010,) and those with Fe(III) or Co(III) centres, which 
form ML3 complexes with tetradentate ligands (Gilroy et al., 2008). Whether MTT 
adopts similar complexes remains to be determined, since this might provide useful 
insights into the mechanism of metal-catalysed silver reduction. The non-specific 
reaction to Na2S was also surprising, particularly the blackening of the PVDF 
membrane which was presumably relatively free of formazan. Bound tetrazolium, 
which would probably be barely visible, may react with Na2S to yield the black 
product and, given the identical response of NBT, this may be a common reaction 
of tetrazoliums. 
 
2.6 Summary and Conclusions 
The main advantages of the peroxidise/DAB system are the rapidity of product 
formation and the permanence of the marker, polyDAB. It is probably for these two 
reasons alone that it has become and remained the marker of choice for 
immunohistochemistry at the light microscopic level. The main weakness of the 
system is product inhibition, and it is this that has necessitated the development of 
the various intensification and amplification procedures.  
Amplification of polyDAB combined with a number of d-block metal salts in 
both a pre- and post-polymerisation setting, with or without subsequent treatment 
with sodium sulfide, was achieved by both Gallyas’ and Newman and Jasani’s 
physical developers, and allowed previously invisible amounts of marker to be 
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clearly seen. Na2S treatment not only increased the range of polyDAB-metal salts 
that could be amplified but, in general, also increased the degree of amplification. 
With the notable exception of V(III)Cl3, those metal compounds that formed 
catalytic complexes with polyDAB were restricted to groups 8 – 11. Of these, 
metals in groups 10 and 11 were particularly powerful and, generally, resulted in 
the greatest specificity of reactivity. 
Current marker amplification technology is too complex to be introduced into 
high-throughput automated procedures and suffers from a number of additional 
weaknesses namely:  
(1) The silver reagent of Gallyas’ developer has a relatively short shelf life (about 3 
months) and the reducer (hydroquinone) must be freshly prepared each time. 
(2) Newman and Jasani’s developer, while considerably more stable that Gallyas’, 
contains components, such as citrate and pyrogallol, which appear to extract 
almost all metals from polyDAB. 
(3) Na2S, which is an essential pre-treatment for Newman and Jasani’s developer 
to work optimally, is unstable and has a pungent smell. 
(4) The choice and application of metal and silver developer requires experience 
and expertise. 
This chapter has focussed on the histological application of marker 
amplification yet the technology described above could equally well be applied in 
other contexts, particularly those that seek to visualise molecules on membranes 
e.g. Western blotting. Under these conditions, many of the problems associated 
with tissue, mentioned above, no longer pertain and the use of, for example, 
platinum salts with Gallyas’ developer or copper(II) + Na2S with Newman and 
Jasani’s developer might well produce more superior results than hitherto obtained.  
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Chapter 3 
Marker Amplification at the Limits of 
Sensitivity  
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3.1 Introduction 
The ultimate test of any amplification system is its ability to perform as well, or 
better, than the most sensitive system currently available. When applied to tissue 
model systems, the practical limit of sensitivity of a particular amplification 
procedure is indicated by the highest primary antibody dilution at which positivity 
can be unequivocally identified. This is analogous to circumstances where 
exceptionally small amounts of target molecule are present and considerable 
amplification is required, thus prolonged times in the physical developer become 
essential. In these circumstances, a number of factors become particularly 
important, namely (1) endogenous enzymatic and non-enzymatic catalytic activity, 
(2) unwanted reactions of other amplifying reagents with tissue components (3), 
tissue argyrophilia, (4) self-nucleation of the physical developer, and (5) the 
affinities/avidities of antibody conjugates. 
Given the widespread application of the peroxidase-DAB system, it is not 
surprising that considerable attention has been given to the suppression of both 
enzymatic (peroxidase, catalase etc.) and non-enzymatic (haem proteins, metals) 
peroxidase-like activity in tissue. Such activities are commonly overcome by 
application of aqueous or methanolic solutions of H2O2 (van Duijn, 1957; 
Streefkerk, 1972), aqueous solutions of azide or phenylhydrazine (Straus, 1972), or 
combination thereof (Li et al, 1987). Such reagents can be deleterious to the 
immunohistochemical reactivity of the tissue and are used at low concentrations. 
Complexing of d-block metal compounds to tissue components has been noted 
(Newman et al, 1983; de Bruijn et al. 1986), but has received little attention in the 
context of marker amplification (Newman and Jasani, 1998). At low concentrations 
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of polyDAB, selectivity can be improved by reducing the concentrations of both 
NaAu(III)Cl4 and Na2S (Dr. Geoff Newman, personal communications). 
Argyrophilia have been extensively studied by the Hungarian neurobiologist, 
Ferenc Gallyas, who sub-divided the process into three categories based on 
physicochemical considerations, namely Type I; the reduction of silver(I) by 
catalytic and reducing groups of the tissue, Type II; the reduction of silver(I) by a 
soluble reducing agent that is catalysed by compounds that have been deposited in 
the tissue by staining techniques, or as a result of a physiological or pathological 
process, and Type III; the reduction of silver(I) in the presence of a soluble reducing 
agent under the influence of catalytic tissue groups (Gallyas, 1979a; 1979b; 1982a; 
1982b; 2008). It has recently been shown that suppression of tissue argyrophilia 
using copper(II)/H2O2 (Gallyas and Merchenthaler, 1988) is incompatible with the 
sulfide/silver amplification technique, but La(III)/H2O2, in contrast, has some 
utility in this regard (Kelly, 2010). 
Self-nucleation within physical developer solutions is, initially, a light-catalysed 
reaction that results in the reduction of silver(I). The resulting sub-microscopic 
particles of metallic silver catalyse further reduction of silver(I) until the particles 
become visible (i.e. greater than approximately 200 nm), and this defines the bench-
life of the developer. The light-catalysed reaction can be suppressed by including 
colloidal protectants such as gum arabic (Danscher, 1981b) or sodium tungstate 
(Gallyas, 1979c) in the developer, or by complexing the silver(I) with Tris 
(Newman and Jasani, 1998) or citrate (Hacker et al, 1990). 
A number of techniques for preparing antibody-enzyme conjugates have been 
devised, but the most popular are the two-step glutaraldehyde (Avrameas and Uriel, 
1966) and periodate (Nakane and Kawaoi, 1974) techniques. The former is 
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considered the less deleterious of the two, with respect to antibody affinity and 
enzymatic activity (Boorsma et al, 1976). Colloidal gold conjugates are prepared by 
adsorption of the antibody onto the metal particle surface (Hayat, 1989). 
 
3.2 Materials 
3.2.1 Reagents 
Mouse monoclonal anti-CD45 Ro (clone UCHL-1) was purchased from 
Autogen Bioclear (Calne, Wiltshire, U.K.). Goat anti-mouse Ig HRP conjugates 
(GAM IgPC) were supplied by Autogen Bioclear (Calne, Wiltshire, U.K.), Sigma-
Aldrich (Poole, Dorst, U.K.) and Dako (Ely, Cambridgeshire, U.K.). Envision ™ 
was supplied by Dako (Ely, Cambridgeshire, U.K.). Silver(I)acetate, silver(I)lactate 
and 90% lactic acid were supplied by Fisher Scientific (Loughborough, 
Leicestershire, U.K.). Gum arabic was purchased from BDH (Lutterworth, 
Leicestershire, U.K.). All other reagents were purchased from suppliers listed in 
section 2.2.1. 
 
3.2.2  Physical Developers 
Gallyas’ and Newman and Jasani’s physical developers were prepared 
according to section 2.2.3 of the previous chapter. Two further developers were 
employed, since both have been specifically designed to visualise metal sulfides in 
tissue, namely Danscher’s silver lactate developer (Danscher, 1981a) and Hacker’s 
silver acetate developer (Hacker et al, 1990). 
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3.2.2.1 Danscher’s Developer 
Solution A 
100 g of gum arabic was dissolved over 5 days in 200 ml ddH2O and filtered 
through a 0.2 m pore syringe filter. 
 
Solution B 
3.15 ml of 50% sodium lactate and 6 ml of 90% lactic acid were dissolved, 
mixed, and made up to 100 ml in ddH2O. 
 
Solution C 
0.85 g hydroquinone was dissolved in 15 ml ddH2O just before use. 
 
Solution D 
0.12 g silver(I)lactate was dissolved in 15 ml ddH2O and protected from light 
by wrapping the vial in tin foil. 
 
The developer was prepared by mixing 60 ml of solution A, 10 ml of solution B 
and 15 ml of solution C, followed by 15 ml solution D. The solution was poured 
into a Coplin jar in a light-tight water bath at 26
o
C (Danscher, 1981a). 
 
3.2.2.2 Hacker’s Developer 
Solution A 
Solution A was prepared freshly each time. 100 mg silver(I)acetate was 
dissolved in ddH2O to a final volume of 50 ml and filtered through a 0.2 m pore 
syringe filter. 
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Solution B 
25.5 g citric acid and 23.5 g trisodium citrate 2H2O were dissolved in ddH2O to 
a final volume of 100 ml and adjusted to pH 3.8 with citric acid. Immediately 
before use, 500 mg hydroquinone was dissolved in the buffer. 
 
The developer was prepared by mixing solutions A and B in the ratio of 1:2 
immediately before use (Hacker et al, 1990). 
 
3.3 Methods 
3.3.1 Determination of the Limits of Sensitivity of the Colloidal Gold/Silver 
Method 
Tonsil sections were immunohistochemically stained and developed with silver 
as in section 2.3.4.3., above, with approximately logarithmic dilutions of the 
primary antibody (
1/5,000, 
1/10,000, 
1/20,000, etc. down to 
1/1,000,000). The highest 
dilution of the primary antibody where positivity could be unequivocally identified 
was chosen as the standard against which polyDAB amplification was compared. 
 
3.3.2 Inhibition of Endogenous Enzymatic Activity 
In preliminary experiments, tissue sections were pre-treated with either 50 mM 
phenylhydrazine in 50 mM phosphate buffer pH 7.3 at 37
o
C for 1 hour (Straus, 
1972), 50 mM phenylhydrazine in 50 mM phosphate buffer pH 7.3 at 37
o
C for 10 
minutes + 0.0003% H2O2 for 20 minutes (Jasani et al, 1986; Wynford-Thomas et al, 
1986), 0.1% sodium azide + 0.3% H2O2 for 10 minutes (Li et al, 1987), methanol 
for 20 minutes + 0.025% H2O2 in PBS 20 minutes (Streefkerk, 1972), or 0.02 M 
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HCl for 20 minutes (Liu et al, 2006), followed by immunohistochemical staining 
using the colloidal gold/silver method as in section 2.3.4.3, above, with UCHL-1 at 
1/50,000, 
1/100,000 and 
1/200,000 to determine the effects of inhibitors on 
immunohistochemical reactivity.  
In a further experiment, endogenous enzymatic inhibition was repeated 
followed by incubation in DAB-PO4 for 3 minutes and subsequent treatment with 
2.5 mM NaAu(III)Cl4, 0.3% Na2S and Newman and Jasani’s developer for 10 
minutes, as in section 2.3.4.5., above.  
The treatment that least effected immunohistochemical sensitivity and 
maximally suppressed endogenous enzymatic activity was selected for subsequent 
evaluation using the peroxidase/DAB system. 
 
3.3.3 Determination of Sensitivity Limit for Peroxidase/DAB Au/Na2S/Silver 
Following inhibition of endogenous enzymatic activity with 0.02 M HCl for 20 
minutes, as determined in the previous section, tissue sections were 
immunohistochemically stained with UCHL-1 from 
1/1000, to 
1/20,000 followed by 
GAM Ig PC and DAB-PO4, with or without subsequent amplification with 2.5 mM 
NaAu(III)Cl4 + 0.3% Na2S + Newman and Jasani’s developer, as above.  
 
3.3.4 Reduction of Non-specific Complexing of Amplifying Reagents with 
Tissue 
Following inhibition of endogenous enzymatic activity and 
immunohistochemical staining with UCHL-1 at 
1/10,000, sections were incubated in 
NaAu(III)Cl4 at 2.5 mM, 1 mM, 0.3 mM and 0.1 mM and in Na2S at 0.3%, 0.1%, 
169 
 
0.03% and 0.01% followed by treatment with Newman and Jasani’s developer. The 
concentrations of NaAu(III)Cl4 and Na2S that produced the strongest signal and 
minimal background staining were chosen for subsequent experiments. 
 
3.3.5 Suppression of Tissue Argyrophilia 
Following immunohistochemical staining with UCHL-1 at 
1/20,000 and 
1/50,000 
as above, sections were treated with 10 mM La(III)Cl3 for 1 hour followed by 3% 
H2O2 for 10 minutes post-DAB polymerisation (Kelly, 2010) prior to amplification 
using 0.3 mM gold/0.1% sulfide and physical development.  
 
3.3.6 Comparison of Physical Developers 
Following immunohistochemical staining as above, with UCHL-1 at 
1/20,000 and 
1/
50,000, and Santa Cruz GAM IgPC, sections were developed with either Newman 
and Jasani’s, Gallyas’, Danscher’s or Hacker’s developers. In the case of 
Danscher’s developer, the progress of amplification could not be followed under 
daylight conditions so sections were removed from the developer at 5 minute 
intervals, washed thoroughly in distilled water, and examined under the light 
microscope before being returned to the developer if further amplification was 
indicated. Where overstaining occurred, silver deposits were differentiated with 
0.5% potassium ferricyanide, and the process observed microscopically. 
 
3.3.7 Comparison of Secondary Antibody Conjugates 
The antibody used to prepare the colloidal gold conjugate was not available as 
a peroxidase conjugate (Sigma-Aldrich personal communications), so direct 
comparison was not possible. A Sigma-Aldrich peroxidase conjugate, linked by the 
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periodate method, was chosen for comparison with the Santa Cruz antibody to 
determine whether any differences existed between commercial sources. In 
addition, a peroxidase conjugate from Dako, prepared by the glutaraldehyde 
method was also examined. All conjugates were applied at 
1/150 in PBS/BSA and 
immunohistochemical staining performed as above. 
In a further experiment, a proprietary polymeric conjugate, Envision™, was 
employed to determine whether any differences in sensitivity might be due to the 
final amounts of polyDAB deposited. Such conjugates are composed of several 
peroxidase enzymes covalently attached to a polyethylene glycol backbone which, 
in turn, is covalently attached to several antibodies (Dako, personal 
communication). Envision™ was applied as a 
1/10 of the stock solution in 10mM 
phosphate buffer pH 7.4 containing 0.9% (w/v) NaCl and 0.6% (w/v) bovine serum 
albumin (PBS/BSA) 
PBS/BSA since this was found to produce lower background staining than the 
undiluted proprietary formulation. Immunohistochemical staining was performed 
as above, except that UCHL-1 was used at 
1/50,000, 
1/100,000, 
1/200,000 and 
1/500,000. 
In a final experiment, the peroxidase conjugates were diluted to a final IgG 
concentration of 1µg/ml and further diluted 
1/2, 
1/5, 
1/10, 
1/
20, 
1/50 etc. to 
1/1000 
and 2 µl drops applied to PVDF membrane and incubated for 3 minutes in DAB-
PO4 as in section 2.3.2., to determine whether any differences existed in enzymatic 
activity. 
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3.4. Results 
3.4.1 Determination of the Limit of Sensitivity for the Colloidal Gold/Silver 
Method 
Clear and unequivocal immunopositive staining could be seen at primary 
antibody dilutions as low as 
1/100,000 at low magnification (x 10 objective) (figure 
3.1a, c, e, g and i), and down to 
1/500,000 at higher magnification (x 40 objective) 
(figure 3.1b, d, f, h, j, l and n), although the number of immunopositive cells was 
considerable reduced. At 
1/1,000,000 UCHL-1, it was not possible to identify positive 
cells with any certainty (figure 3.1o and p). Development time increased with 
primary antibody dilution and only the slightest argyrophilic reaction, involving 
erythrocytes, was noted with Newman and Jasani’s developer. UCHL-1 at 
1/500,000 
was chosen as the standard against which polyDAB amplification was to be 
compared. 
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Figure 3.1. 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained with UCHL-1 and GAM Ig CG5 followed by 
Newman and Jasani’s developer. UCHL-1 at 
1/5000.  
Low magnification (a) and high magnification (b). 
a 
b 
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Figure 3.1 (continued). 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained with UCHL-1 and GAM Ig CG5 followed by 
Newman and Jasani’s developer. UCHL-1 at 
1/10,000.  
Low magnification (c) and high magnification (d). 
c 
d 
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Figure 3.1 (continued). 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained with UCHL-1 and GAM Ig CG5 followed by 
Newman and Jasani’s developer. UCHL-1 at 
1/20,000. 
Low magnification (e) and high magnification (f). 
e 
f 
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Figure 3.1 (continued). 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained with UCHL-1 and GAM Ig CG5 followed by 
Newman and Jasani’s developer. UCHL-1 at 
1/50,000. 
Low magnification (g) and high magnification (h). 
g 
h 
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Figure 3.1 (continued). 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained with UCHL-1 and GAM Ig CG5 followed by 
Newman and Jasani’s developer. UCHL-1 at 
1
/100,000. 
Low magnification (i) and high magnification (j). 
i 
j 
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Figure 3.1 (continued). 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained with UCHL-1 and GAM Ig CG5 followed by 
Newman and Jasani’s developer. UCHL-1 at 
1/200,000. 
Low magnification (k) and high magnification (l). 
k 
l 
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Figure 3.1 (continued). 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained with UCHL-1 and GAM Ig CG5 followed by 
Newman and Jasani’s developer. UCHL-1 at 
1/500,000. 
Low magnification (m) and high magnification (n). 
n 
m 
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Figure 3.1 (continued). 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained with UCHL-1 and GAM Ig CG5 followed by 
Newman and Jasani’s developer. UCHL-1 at 
1/1,000,000. 
Low magnification (o) and high magnification (p).  
o 
p 
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3.4.2 Inhibition of Endogenous Enzymatic Activity 
No effect of any of the inhibitors on the immunohistochemical responsiveness 
of the tissue was seen. 
In the absence of inhibitors, staining following DAB/Au/Na2S/silver occurred 
predominantly in erythrocytes and, to a lesser extent, collagen (figure 3.2a). 
Following inhibition with phenylhydrazine, either alone (figure 3.2b) or in 
combination with H2O2 (figure 3.2c), or with azide + H2O2 (figure 3.2d), 
erythrocyte staining was abolished, but intense staining of vascular endothelium 
occurred. In the case of phenylhydrazine alone, collagen staining was also elevated. 
Both methanol + H2O2 (figure 3.2e) and HCl treatment (figures 3.2f) reduced the 
staining of erythrocytes and collagen, methanol + H2O2 being slightly better, 
although a slight endothelial staining was evident. 0.02 M HCl was chosen for 
simplicity of application. 
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Figure 3.2. 4 m thick sections of paraffin wax-embedded human tonsil.  
Effects of endogenous peroxidase inhibitors on subsequent treatment with 2.5 mM 
NaAu(III)Cl4 + 0.3% Na2S + Newman and Jasani’s developer. No inhibitors (a) 
and 50 mM phenylhydrazine (b). 
a 
b 
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Figure 3.2 (continued). 4 m thick sections of paraffin wax-embedded human 
tonsil. Effects of endogenous peroxidase inhibitors on subsequent treatment with 
2.5 mM NaAu(III)Cl4 + 0.3% Na2S + Newman and Jasani’s developer. 50 mM 
phenylhydrazine + 0.0003% H2O2 (c) and 0.1% NaN3 + 0.3% H2O2 (d). 
c 
d 
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Figure 3.2 (continued). 4 m thick sections of paraffin wax-embedded human 
tonsil. Effects of endogenous peroxidase inhibitors on subsequent treatment with 
2.5 mM NaAu(III)Cl4 + 0.3% Na2S + Newman and Jasani’s developer. Methanol 
+ 0.025% H2O2 in PBS (e) and 0.02 M HCl (f). 
e 
f 
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3.4.3 Determination of the Limit of Sensitivity for Peroxidase/DAB 
Au/Na2S/Silver 
In the absence of amplification, immunopositivity could be clearly seen at both 
low (x 10 objective) and high (x 40 objective) magnification at 
1/1000 and 
1/2000 
(figure 3.3a – d) but only seen at high magnification at 
1/5,000 UCHL-1 (figure 3.3f). 
No staining could be seen at 
1/10,000 (figure 3.3g and h). Following amplification 
with 2.5 mM NaAu(III)Cl4, 0.3% Na2S and Newman and Jasani’s developer, 
immunopositivity was clear at 
1/5000 (figure 3.4a and b) and 
1/10,000 (figure 3.4c and 
d), but at 
1/20,000 background staining prevented unequivocal identification of 
immunopositive sites (figure 3.4e and f). 
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Figure 3.3. 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained with UCHL-1 and GAM Ig PC and DAB-PO4. 
UCHL-1 at 
1/1,000. Low magnification (a) and high magnification (b). 
a 
b 
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Figure 3.3 (continued). 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained with UCHL-1 and GAM Ig PC and DAB-PO4. 
UCHL-1 at 
1/2,000. Low magnification (c) and high magnification (d). 
c 
d 
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Figure 3.3 (continued). 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained with UCHL-1 and GAM Ig PC and DAB-PO4. 
UCHL-1 at 
1/5,000. Low magnification (e) and high magnification (f). 
e 
f 
188 
 
 
 
Figure 3.3 (continued). 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained with UCHL-1 and GAM Ig PC and DAB-PO4. 
UCHL-1 at 
1/10,000. Low magnification (g) and high magnification (h). 
g 
h 
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Figure 3.4. 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained with UCHL-1 and GAM Ig PC and DAB-PO4 
followed by 2.5 mM NaAu(III)Cl4 and 0.3% Na2S. UCHL-1 at 
1/5,000.  
Low magnification (a) and high magnification (b). 
a 
b 
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Figure 3.4 (continued). 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained with UCHL-1 and GAM Ig PC and DAB-PO4 
followed by 2.5 mM NaAu(III)Cl4 and 0.3% Na2S. UCHL-1 at 
1/10,000. 
Low magnification (c) and high magnification (d). 
c 
d 
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Figure 3.4 (continued). 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained with UCHL-1 and GAM Ig PC and DAB-PO4 
followed by 2.5 mM NaAu(III)Cl4 and 0.3% Na2S. UCHL-1 at 
1/20,000. 
Low magnification (e) and high magnification (f).
e 
f 
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3.4.4 Reduction of Non-specific Complexing of Amplifying Reagents with Tissue 
At 2.5 mM NaAu(III)Cl4, the best result was seen with 0.3% Na2S (figure 
3.5a), signal strength declining and background staining increasing as the 
concentration of Na2S was reduced (figure 3.5b – d). At 1 mM  NaAu(III)Cl4, a 
similar pattern was seen, although both signal strength and background were 
reduced (figure 3.5e – h) When NaAu(III)Cl4 was applied at 0.3 mM, faint staining 
with high background was seen following 0.3% Na2S (figure 3.5i), but lowering the 
concentration of Na2S to 0.1% dramatically improved signal strength without 
elevating background (figure 3.5j). At lower concentrations of Na2S, signal strength 
progressively fell (figure 3.5k) and background staining increased (figure 3.5l). At 
the lowest concentration of NaAu(III)Cl4, positivity could be seen at all 
concentrations of Na2S, but in all cases, a fine granular background was present. In 
addition, positive sites were also granular in appearance (figure 3.5m – p). 
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Figure 3.5. 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained with 1/10,000 UCHL-1 and GAM Ig PC/DAB-PO4 
followed by 2.5 mM NaAu(III)Cl4 and Na2S at 0.3% (a) and 0.1% (b). 
a 
b 
194 
 
 
 
Figure 3.5 (continued). 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained with 1/10,000 UCHL-1 and GAM Ig PC/DAB-PO4 
followed by 2.5 mM NaAu(III)Cl4 and Na2S at 0.03% (c) and 0.01% (d). 
c 
d 
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Figure 3.5 (continued). 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained with 1/10,000 UCHL-1 and GAM Ig PC/DAB-PO4 
followed by 1 mM NaAu(III)Cl4 and Na2S at 0.3% (e), 0.1% (f). 
e 
f 
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Figure 3.5 (continued). 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained with 1/10,000 UCHL-1 and GAM Ig PC/DAB-PO4 
followed by 1 mM NaAu(III)Cl4 and Na2S at 0.03% (g) and 0.01% (h). 
g 
h 
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Figure 3.5 (continued). 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained with 
1/10,000 UCHL-1 and GAM Ig PC/DAB-PO4 
followed by 0.3 mM NaAu(III)Cl4 and Na2S at 0.3% (i) and  0.1% (j). 
i 
j 
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Figure 3.5 (continued). 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained with 
1/10,000 UCHL-1 and GAM Ig PC/DAB-PO4 
followed by 0.3 mM NaAu(III)Cl4 and Na2S at 0.03% (k) and 0.01% (l). 
k 
l 
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Figure 3.5 (continued). 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained with 
1/10,000 UCHL-1 and GAM Ig PC/DAB-PO4 
followed by 0.1 mM NaAu(III)Cl4 and Na2S at 0.3% (m), 0.1% (n). 
m 
n 
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Figure 3.5 (continued). 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained with 
1/10,000 UCHL-1 and GAM Ig PC/DAB-PO4 
followed by 0.1 mM NaAu(III)Cl4 and Na2S at 0.03% (o) and 0.01% (p). 
o 
p 
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3.4.5 Suppression of Tissue Argyrophilia 
Post-DAB polymerisation treatment with 10 mM La(III)Cl3 followed by 3% 
H2O2 extended the development time and resulted in an improvement in 
immunohistochemical signal intensity such that staining, which could only be seen 
at 
1/20,000 in its absence (figure 3.6a and b), could now be clearly seen at 
1/50,000 
(figure 3.6c and d). 
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Figure 3.5. 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained for CD45Ro. Effects of suppression of tissue 
argyrophilia with 10 mM LaCl3 followed by 3% H2O2 on amplification with 0.3 
mM NaAu(III)Cl4 + 0.1% Na2S + Newman and Jasani’s developer. UCHL-1 at 
1/20,000 (a) and 
1/50,000 (b) without suppression. 
a 
b 
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Figure 3.5 (continued). 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained for CD45Ro. Effects of suppression of tissue 
argyrophilia with 10 mM LaCl3 followed by 3% H2O2 on amplification with 0.3 
mM NaAu(III)Cl4 + 0.1% Na2S + Newman and Jasani’s developer. UCHL-1 at 
1/20,000 (c) and 
1/50,000 (d) with suppression.  
c 
d 
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3.4.6 Comparison of Physical Developers 
As previously shown, Newman and Jasani’s developer was able to reveal 
immunopositivity at UCHL-1 dilutions of both 
1/20,000 and 
1/50,000 (figure 3.7a and 
b). Gallyas’ developer did not achieve the same level of amplification as Newman 
and Jasani’s, mainly due to problems of self-nucleation, which resulted in the 
appearance of numerous particles in the developer solution (figure 3.7c and d). 
Danscher’s developer was extremely powerful, and background staining was clearly 
evident at both UCHL-1 concentrations after just 5 minutes (compared with 27 and 
32 minutes for Newman and Jasani’s developer for UCHL-1 at 
1/20,000 and 
1/50,000, 
respectively). Inspection of the sections revealed clear positivity at 
1/20,000 UCHL-1, 
and differentiation with 0.5% potassium ferricyanide to remove the background 
staining was able to demonstrate positivity at 
1/50,000 as well (figure 3.7e and f). 
Hacker’s developer did not suffer the problems of self-nucleation that occurred with 
Gallyas’ developer, but was only able to reveal positivity at 
1/20,000 UCHL-1 (figure 
3.7g and h). 
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Figure 3.7. 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained for CD45Ro. Comparison of physical developers 
on amplification. Newman and Jasani’s developer, with UCHL-1 at 
1/20,000 (a) and 
1/50,000 (b). 
a 
b 
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Figure 3.7 (continued). 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained for CD45Ro. Comparison of physical developers 
on amplification. Gallyas’ developer, with UCHL-1 at 
1/20,000 (c) and 
1/50,000 (d). 
c 
d 
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Figure 3.7 (continued). 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained for CD45Ro. Comparison of physical developers 
on amplification. Danscher’s developer, with UCHL-1 at 
1/20,000 (e) and 
1/50,000 (f). 
e 
f 
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Figure 3.7 (continued). 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained for CD45Ro. Comparison of physical developers 
on amplification. Hacker’s developer, with UCHL-1 at 
1/20,000 (g) and 
1/50,000 (h). 
  
g 
h 
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3.4.7 Comparison of Secondary Antibody Conjugates 
Compared to the Santa Cruz peroxidase conjugate, the Sigma-Aldrich 
conjugate performed poorly. While staining with the Santa Cruz conjugate could be 
clearly seen at both 
1/20,000 and 
1/50,000 UCHL-1 (figure 3.8a and b), staining with 
the Sigma-Aldrich conjugate could only just be seen at 
1/10,000 and at 
1/20,000, not at 
all (figure 3.8c and d). The Dako conjugate, performed the worst of all, with 
positivity being visible at 
1/2,000 and barely visible at 
1/5,000 (figure 3.8e and f). 
Using the Envision™ system, UCHL-1 at dilutions of 
1/50,000 and 
1/100,000 could be 
clearly seen, although staining was finely granular in the latter case. (figure 3.8g and 
h). 
In dot blot preparations, dot blots produced by the Santa Cruz conjugate could 
be detected at all concentrations down to 5 ng/ml (figure 3.9a and b), and those 
produced by the Dako peroxidase conjugate, down to 10 ng/ml IgG (figure 3.9c 
and d). Those produced by the Sigma conjugate could be seen only down to 50 
ng/ml (figure 3.9e). 
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Figure 3.8. 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained for CD45Ro. Comparison of secondary antibody 
conjugates. Santa Cruz peroxidase conjugate with UCHL-1 at 
1/20,000 (a) and 
1/50,000 (b). 
a 
b 
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Figure 3.8 (continued). 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained for CD45Ro. Comparison of secondary antibody 
conjugates. Sigma Aldrich peroxidase conjugate with UCHL-1 at 
1/5,000 (c) and 
1/10,000 (d). 
c 
d 
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Figure 3.8 (continued). 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained for CD45Ro. Comparison of secondary antibody 
conjugates. Dako peroxidase conjugate with UCHL-1 at 
1/2,000 (e) and 
1/5,000 (f). 
e 
f 
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Figure 3.8 (continued). 4 m thick sections of paraffin wax-embedded human tonsil 
immunohistochemically stained for CD45Ro. Comparison of secondary antibody 
conjugates. Dako Envision™ peroxidase conjugate with UCHL-1 at 
1/50,000 (g) and 
1/100,000 (h).  
g 
h 
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Figure 3.9. Dot blots of peroxidase conjugates logarithmically diluted from 1 g/ml 
to 1 ng/ml. Santa Cruz (a and b), Dako (c and d) and Sigma (e). 
 
a 
b 
c 
d 
e 
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3.5 Discussion 
At the limits of immunohistochemical sensitivity, as defined in these studies by 
the colloidal gold/silver method, a number of factors became particularly important 
where the amplification of polyDAB was concerned, namely (1) the choice of 
endogenous peroxidase inhibitor, (2) the concentrations of amplifying reagents, (3) 
tissue argyrophilia, (4) the choice of physical developer, and (5) the choice of 
peroxidase conjugate. 
None of the endogenous peroxidase inhibitors caused any obvious reduction in 
immunohistochemical sensitivity, but treatment of tissue sections with either 
phenylhydrazine or azide followed by gold/sulfide/silver resulted in an unexpected 
staining of vascular endothelium and the reason for the specificity of this reaction is 
unclear. 
Reductions of the concentrations of both tetrachloraurate and sulfide lowered 
background staining such that immunohistochemical sensitivity was improved by 
one doubling dilution. A further improvement was observed when tissue 
argyrophilia was suppressed by metal-catalysed oxidation with La(III)/H2O2. The 
increase in development time, as noted by Gallyas (Gallyas and Wolff, 1986), 
permitted much smaller quantities of polyDAB to be seen, such that sensitivity was 
extended to 
1/50,000 of the primary antibody, representing a five-fold improvement 
over the original technique. 
Gallyas’ developer might have been able to achieve the same level of 
amplification as Newman and Jasani’s, had self-nucleation not been such a 
problem. Different preparations, made over the course of several years, have 
revealed Gallyas’ developer to be somewhat capricious in this regard. The power of 
Danscher’s developer, which has been specifically formulated for revealing the 
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presence of trace metals in tissue sections following their conversion to sulfides 
(Danscher, 1981a), was apparent when gross overstaining occurred after just 5 
minutes. Examination of the sections revealed immunopositivity, and the 
subsequent removal of background staining by differentiation in potassium 
ferricyanide allowed it to be clearly seen. Greater control over development might 
be achieved by lowering the concentration of reducing agent. Hacker’s developer in 
contrast, took over 40 minutes before background staining became problematic, and 
amplification was much weaker than either Danscher’s or Newman and Jasani’s. In 
all cases, no improvement in sensitivity was observed, suggesting that the limit of 
sensitivity of the particular secondary antibody conjugate had been reached. 
The choice of technique for covalently coupling enzymes to antibodies can 
influence both enzyme activity and immunohistochemical sensitivity (Boorsma et 
al, 1976). In addition, the results indicated that the choice of commercial source can 
also dramatically affect the final immunohistochemical sensitivity, making 
comparisons between coupling methods difficult, if not impossible. Peroxidase 
conjugates from Santa Cruz and Sigma-Aldrich are both coupled by the periodate 
method, yet that of the former was five-fold more sensitive than the latter. 
Furthermore, Dako’s conjugate is coupled by the glutaraldehyde method and might 
have been expected to perform better (Boorsma et al, 1976), but was the worst of 
all. It has been noted, however, that the periodate conjugation method, by linking 
larger numbers of enzyme molecules to the antibody, gives greater sensitivity at low 
antigen concentrations (Tsang et al, 1984). In contrast, Dako’s Envision™ 
polymeric conjugate performed almost as well as colloidal gold. This improvement 
in sensitivity may, in part, reflect the greater quantity of polyDAB that the system 
deposits. The proprietary coupling method may also have contributed, but it seems 
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unlikely that this alone could account for an improvement of nearly two orders of 
magnitude. It is conceivable that the proximity of enzymes to the antibody that 
have been coupled by either the glutaraldehyde or periodate method, or proprietary 
variations, cause stearic interference with the antibody-antigen interaction and this 
might not pertain in the case of the Envision™ system, where enzymes might be at 
some distance from the antibody. In principle, it is possible to evaluate the 
contribution of secondary antibody affinity to the final result by indirect methods, 
such as (1) detection of the secondary antibody conjugate by a tertiary anti-goat or 
anti-peroxidase colloidal gold conjugate or (2) adsorption of colloidal gold onto the 
peroxidase conjugates. Either system could then be visualised by silver 
development. Preparation of reagents for both techniques are expensive and time 
consuming, particularly the latter, and were not attempted.  
Colloidal gold/silver remained the most sensitive system and may, in part, 
have reflected the nature of conjugation, namely adsorption onto the metal particles 
without any covalent modification. Under these conditions, the antibody is 
probably in its most native state and thus exhibited the greatest sensitivity. In 
addition, the initial marker is solid metal rather than a deposit composed mostly of 
organic polymer with complexed metal, and this may confer greater catalytic 
potency with regard to silver reduction.  
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3.6 Summary and Conclusions 
At the limits of immunohistochemical sensitivity, the colloidal gold/silver 
system is the simplest method and outperforms all peroxidase/DAB amplification 
techniques. The high cost of colloidal gold conjugates and the need for silver 
development, however, have restricted its use to research laboratories. 
Current marker amplification technology, while achieving up to a 10-fold 
improvement in sensitivity, is far too complicated to be routinely employed, and a 
more rationalised approach is required if the various problems are to be 
surmounted.  
The rational design of novel marker systems that exploit current technologies 
can adopt two approaches, namely (1) novel enzyme substrates that do not result in 
the deposition of enzyme-inhibiting markers and/or (2) the development of directly 
amplifiable markers. The design of both would be aided by knowledge of the 
structure and co-ordination chemistry of polyDAB together with an understanding 
of the mechanistic chemistry underlying the marker amplification process, 
particularly the effects of sulfide on both the amount of metal sulfide 
formed/remaining and the final amount of silver reduced. 
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Electron Microscopic Immunohistochemistry 
and Analytical Electron Microscopical 
Tomography 
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4.1 Introduction 
An Ultrastructural Sonnet 
 
In sombre beauty in her room she broods;  
Tis night-and all her pumps are deathly still,  
And thus she slumbers peacefully, until  
The morn, when unkind amperes end this interlude. 
 
With steady beat her motors wheeze and keen,  
Industrious vapours drain the inner core,  
That Bohr's electrons shortly will explore,  
In headlong torrent downward to her screen. 
 
What truths does she uncover with her beam?  
How much is artefact produced by man, 
And how much really fits into the plan  
Of nature? That believed is easily seen! 
 
But even if she may promote confusion,  
It is at least an elegant illusion. 
(Yeomans, 1975) 
 
The demonstration of antigens at the electron microscopic level has mainly 
relied on the capacity of the marker to scatter electrons. Early studies, focussing on 
techniques for use in the TEM, stained the primary antibody with electron opaque 
elements such as mercury (Pepe, 1961), uranium (Sternberger et al., 1963) and 
iodine (Mekler et al., 1964), or attached inherently electron opaque particles such as 
ferritin (Singer, 1959) or colloidal gold (Faulk and Taylor, 1971) to the antibody. 
The great advantage of the colloidal gold marker system is the ease with which 
particle size can be manipulated (Slot and Geuze, 1985), which has two distinct 
benefits, namely (1) particle size can be chosen to suit the magnification at which 
the specimen is to be examined and (2) multiple antigens can be demonstrated 
simultaneously by labelling each with a different sized particle. 
The precision with which antigens can be localised is dependent upon the 
distance from the marker to the target. For the most commonly used reporter 
system, namely a primary antibody plus a secondary antibody conjugate, this can 
be as much as 30 nm (Huber et al., 1976; Murphy et al., 1988). Attempts to reduce 
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this value have employed antibody fragments in conjunction with very small gold 
particles to minimise steric hindrance (Hainfeld, 1987). 
The analytical capabilities of the electron microscope have been exploited for 
detecting antibodies labelled with boron (Bendayan et al., 1989; Malecki et al., 
2003) or recombinant antibody fragments hybridised with metal-binding domains 
(Malecki et al., 2002). In both cases, in-column and post-column electron energy 
filtering techniques were used, which require expensive instrumentation. Since a 
variety of techniques already exist for immunohistochemical staining of thin 
sections, which give comparable results and are far easier to perform, such esoteric 
procedures are rarely used.  
The disadvantage of the most commonly employed IHC marker for TEM, 
colloidal gold, is that labelling efficiency is inversely proportional to particle size 
(Slot and Geuze, 1981). A further disadvantage is the inability of colloidal gold-
labelled antibodies to penetrate tissue sections (Stierhof et al., 1986; Newman and 
Hobot, 1987; Stierhof and Schwarz, 1989,) which places constraints on sensitivity, 
since only antigens at the surface of the section can be detected, and also has 
important implications for the exploitation of electron tomography. 
More recently, attention has been focussed on correlating dynamic events that 
are observed at the light microscopic level with the greater resolution afforded by 
the electron microscope in a technique that has come to be known as correlative 
light and electron microscopy (CLEM). Since many of these dynamic processes are 
observed by confocal microscopy, the use of tomographic systems at the electron 
microscopic level becomes a logical extension of this approach. 
With the commercial availability of tomographic systems for TEMs, penetrable 
reporter-marker systems for electron microscopic IHC are clearly required to 
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advance this technology beyond simple morphological investigations and pre-
embedding (immuno)histochemical techniques, since this will allow a greater range 
of histochemical techniques to be deployed for answering important biological 
questions.  
There is evidence to suggest that enzyme conjugates might penetrate resin-
embedded tissue sections to a limited extent (Newman and Hobot, 1987), although 
this remains controversial; perhaps not surprising given the size of antibody 
molecules (150 kD). Little, if anything, is known regarding the molecular weight 
cut-off of resins and tissues embedded therein. 
 
4.1.1 Electron Tomography 
3-dimensional reconstruction from 2-dimensional images of an object can be 
achieved in two ways; by stacking images of serial sections and by back projection 
from images taken from a number of different angles.  
In light microscopy, the simplest method is to cut serial sections from a sample 
and reconstruct from images of each, but uncertainty exists regarding the exact 
thickness of the section after staining and mounting, particularly for paraffin wax-
embedded tissue. Confocal microscopy avoids this problem by optically sectioning 
the sample.  
In the electron microscope, reconstruction from serial sections is the simplest, 
albeit technically demanding, technique (Bruns and Palade, 1968) but mass loss 
from sections in the instrument is problematic (Aronova et al., 2010), again leading 
to uncertainties regarding exact specimen thickness. This problem has recently been 
addressed by using the SEM to image the surface of tissue blocks as serial layers are 
progressively removed by either ion beam ablation (De Winter et al., 2009) or by 
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inserting a modified ultramicrotome into the instrument (Denk and Horstmann, 
2004). In both cases, however, the process is necessarily destructive. 
Transmission electron microscopes often have stages that allow axial rotation, 
permitting a series of images from different angles to be acquired, and 
reconstruction by back projection performed.  Early studies focussed on highly 
ordered structures such as viruses (De Rosier and Klug, 1968). The mathematical 
principles underlying the application of tomography in the electron microscope 
were subsequently described (Crowther et al., 1970), but it was not until the early 
1980s that structures with irregular morphology were successfully reconstructed 
(Olins et al., 1983). Practical limitations of specimen holder design restrict the angle 
through which a sample can be rotated. 
 
4.1.2 Immunohistochemical Markers and Electron Opacity 
Since it is preferable to be able to observe immunohistochemical labelling prior 
to any analysis, marker electron opacity is desirable. 
PolyDAB is slightly electron opaque (Newman et al., 1983) but benefits from 
treatment with d-block metal compounds. Osmium tetroxide has remained the 
preferred reagent since its early application (Graham and Karnovsky, 1966), 
probably due to its additional use as a secondary fixative in epoxy resin-embedding. 
Sodium gold chloride has a number of advantages over Os(VIII)O4, in that it binds 
to polyDAB in greater amounts (Siegesmund et al., 1979), improves 
immunohistochemical staining intensity in the electron microscope (Newman et al., 
1983) and is more compatible with acrylic resin embedding (Wynford-Thomas et 
al., 1986). Alkaline phosphatase markers have exploited the production of insoluble 
metal phosphates following hydrolysis of phosphorylated enzyme substrates 
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(Hanker et al., 1964; Robinson and Karnovsky, 1983; Halbhuber et al., 1988). In 
electron microscopic immunohistochemistry, cerium appears to be the only metal 
that has been examined (Rowden and Dean, 1991).  
 
4.1.3 Analytical Instrumentation 
Two principle methods exist for determining elemental composition in the 
electron microscope; X-ray spectroscopy and electron energy loss spectroscopy. In 
X-ray spectroscopy, high energy beam electrons ionise atoms within the sample, 
sometimes by ejecting core shell electrons. Where this occurs, outer shell electrons 
fill the gap, emitting X-rays in the process. The energy of these transitions, and thus 
the energy of the resulting X-rays, is characteristic of the particular element. Such 
transitions can only occur in elements with atomic numbers higher than 2, but 
limitations imposed by instrument design usually restrict detectability to boron and 
above.  
X-rays can be analysed in two ways; energy dispersion and wavelength 
dispersion. In energy dispersive spectrometers (EDS or EDX), the charge resulting 
from ionisation of the detector material (Si(Li), Ge(Li) or Si) is proportional to the 
energy of the incident X-ray photon. Detection and analysis are thus a single event 
and multiple elements can be detected simultaneously, but this is at the expense of 
both energy resolution (and thus analytical precision) and sensitivity. Wavelength 
dispersive spectrometers (WDS or WDX) separate element-specific X-rays by 
diffracting them through a specifically selected crystal. Energy resolution and 
sensitivity (particularly for light elements) are improved by an order of magnitude, 
but the range of elements that can be simultaneously detected is restricted to 5 per 
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spectrometer. EDX systems cost approximately £25k, whereas WDX systems are 
usually twice this price. 
Electron energy loss analyses the energies of electrons that have been 
inelastically scattered by the sample. This can be achieved in two ways; energy loss 
spectroscopy and energy filtering. Electron energy loss spectroscopy (EELS) utilises 
a post-column magnetic prism to separate electrons of different energies. It is 
particularly sensitive for the analysis of light elements (carbon through to the 3d 
transition elements) and can easily distinguish between allotropes of carbon and 
oxidation states of 3d elements (Keast et al., 2001). Energy filtering (EF) utilises an 
in-column Ottensmeyer lens to select/exclude electrons of particular energies for 
subsequent image acquisition (Ottensmeyer, 1986). In both cases, analytical 
resolution is limited by the energy spread of the primary electron beam and the 
requirement to keep interactions to single events, thus restricting sample thickness. 
In addition, instrumentation is very expensive (e.g. £350k for an entry level EELS 
system, £1M for an energy-filtered TEM). 
Not surprisingly, EDX systems are the most commonly encountered analytical 
instruments on both SEMs and TEMs and it is with these in mind that the 
development of novel markers for analytical tomography should be directed. 
 
4.1.4 Analytical Electron Microscopical Tomography 
A limited number of studies have demonstrated the practicality of analytical 
electron microscopical tomography (AEMT) including the three-dimensional 
distribution of magnetite in bacteria (Midgley and Weyland, 2003), phosphorus in 
nematode cells (Leapman et al., 2004) and Drosophila larvae (Aronova et al., 2007), 
and of phosphorus and nitrogen in the nuclei of fibroblasts (Bazett-Jones et al., 
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1999) and thymocytes (Aronova et al., 2010). All these, however, have used energy 
filtering techniques to achieve the highest spatial resolution. Such technologies are 
expensive and restrict the applicability of this form of AEMT to a few laboratories. 
In the case of immunohistochemistry, spatial resolution is less of an issue for the 
reasons given above. Furthermore, subcellular localisation, rather than molecular 
resolution is all that is often required. Consequently, AEMT may be possible with 
relatively low cost TEM technology, namely a TEM with beam control and an 
EDX detector, thus broadening its availability. Development of markers for AEMT 
entails some important considerations. 
 
4.1.5 Elemental Mapping 
Elemental mapping involves the movement of a focussed electron beam across 
the specimen in a raster and the collection and analysis of characteristic X-rays. The 
resulting elemental maps correspond to, and can be overlaid upon, the original 
image. 
The spatial resolution of the analytical image is dictated, primarily, by the 
minimum size to which the electron beam can be focussed i.e., the spot size. This, 
in turn, is dictated by the choice of electron source. Tungsten filaments, by far the 
cheapest and most commonly encountered electron source in the TEM can achieve 
a spot size of 40 nm whereas LaB6 produce probes of approximately 5 nm. Field 
emission guns can produce probes below 0.2 nm (Williams and Carter, 1996). 
A further consideration is the image resolution of the elemental map and its 
consequences upon acquisition time. By way of illustration, figure 4.1 shows the 
influence of image resolution on image quality. Compared to the original 300 x 300 
pixel image (figure 4.1a), figure 4.1b, with an image resolution of 256 x 256 pixels 
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is, as might be expected, of comparable quality. In the setting of AEMT, with an 
arbitrary beam dwell time of 1 second per pixel and a single axis tilt series at 1o 
intervals over +/- 70o, an analytical image of such quality would take 214 days to 
acquire. The analytical image resolution can be reduced to 128 x 128, which 
maintains acceptable image quality (figure 4.1c), and the number of images in the 
tilt series can be lowered (since all that is required is marker identification) but 
whilst retaining the 1 second dwell time, acquisition time is still unacceptably long 
(5.5 days).  
The only parameter that can now be altered is the dwell time per pixel, since 
image quality is unacceptably low when reduced to 64 x 64 pixels (figure 4.1d). 
This can be achieved by either increasing the brightness of the beam, i.e. switching 
to a LaB6 or field emission gun (Williams and Carter, 1996, Goldstein et al., 2003), 
and/or increasing the concentration of specific element in the final marker. 
Since PolyDAB could be rendered electron opaque by various d-block metals 
these might be present in sufficient concentrations to permit AEMT in an 
acceptable time frame.  
 
4.1.6 Choice of Section Substrate 
In section 2.4.2.3, X-ray spectra of PVDF membrane contained, as expected, a 
prominent fluorine peak at 0.6768 KeV (Goldstein et al., 2003). While this would 
not have interfered with the d-block elements under study, the choice of a suitable 
section support substrate for preliminary scanning electron microscopy should not, 
ideally, be composed of elements whose X-ray emission spectra contain peaks that  
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Figure 4.1. Electron micrograph of an 80 nm thick transverse section of an epoxy 
resin-embedded cultured cell showing the effects of image resolution on image 
quality. Standard 300 pixel image (a), 256 x 256 pixels (b). 
b 
a 
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Figure 4.1 (continued). Electron micrograph of an 80 nm thick transverse section of 
an epoxy resin-embedded cultured cell showing the effects of image resolution on 
image quality. 128 x 128 pixels (c) and 64 x 64 pixels (d). 
d 
c 
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might mask, or be confused with peaks of the element under examination. The 
choice is further constrained by the requirement for adherence of tissue sections and 
compatibility with rehydration and staining reagents. 
 
4.1.7 Tissue Model Systems 
The development of any novel immunohistochemical staining technique should 
initially seek to demonstrate an antigen that is present in abundance. At the light 
microscopic and scanning electron microscopic levels, smooth muscle actin (SMA) 
provides a suitable target. As the name suggests, SMA is present in (involuntary) 
smooth muscle, such as the wall of the gut. In addition, it is present in the 
contractile cells of blood vessels, and thus almost ubiquitous in mammalian tissue. 
At the transmission electron microscopic level, exocrine and endocrine 
granules provide clearly identifiable and discrete structures that contain abundant 
levels of demonstrable antigen, such as -amylase and trypsin in the exocrine 
granules of the pancreas (Bendayan and Ito, 1979), and various hormones in the 
endocrine granules of the pituitary (Mirecka and Pearse, 1971; Naik, 1973; 
Martincomin and Robyn, 1976). 
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4.2 Materials 
4.2.1 Reagents 
All reagents and suppliers are listed in section 2.2.1. 
 
4.2.2 Model Systems 
Vectabond-treated glass microscope slides were prepared according to section 
2.2.5 of Chapter 2. Thermanox™ coverslips were supplied by Nalge Nunc 
International (Rochester, New York). Nescofilm™ was purchased from Bando 
Chemical Industries Ltd (Kobe, Japan). Archival normal human peritoneum, fixed 
for 24 hours in 4% formaldehyde + 0.2% glutaraldehyde in 100 mM Sorensen’s 
phosphate buffer pH 7.4 + 2% sucrose (SPB) and stored at 4oC in SPB was supplied 
by the Peritoneal Biopsy Study Group. Archival rat pancreas and pituitary, 
perfusion-fixed with 1% glutaraldehyde and stored at 4oC in 100 mM sodium 
phosphate buffer pH 7.4, were supplied by Dr. Jan Hobot, Medical Microscopy 
Sciences, Cardiff University. 
 
4.2.3 Antibodies 
Mouse monoclonal anti- -amylase, anti-adrenocorticotropic hormone 
(ACTH), and goat ant-mouse IgG peroxidase conjugate were supplied by Autogen 
Bioclear (Calne, Wiltshire, U.K.). Mouse monoclonal anti-smooth muscle actin 
was supplied by Dako (Ely, Cambridgeshire, U.K.). 
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4.3 Methods 
4.3.1 Choice of Section Substrate 
Vectabond-treated glass microscope slides and Thermanox™ coverslips were 
carbon-coated and examined in a JEOL 840A analytical SEM as in section 2.3.3.5. 
Thermanox coverslips were subsequently selected for use as support substrates for 
tissue sections. 
 
4.3.2 Tissue Model Systems 
4.3.2.1 Preparation of Paraffin Wax-embedded Sections for Preliminary 
Immunoelectron Microscopy 
Peritoneum was embedded in paraffin wax and sectioned according to section 
2.3.4.1 of Chapter 2. 
 
4.3.2.2 Preparation of Acrylic Resin-embedded Sections for Immunoelectron 
Microscopy 
4.3.2.2.1 Resin Embedding 
Dehydration and resin infiltration were performed at RT on a rotary mixer. 5 x 
1 x 1 mm samples were post-fixed for 2 hours in 2% aqueous uranyl acetate, 
washed for 3 x 10 minutes in ddH2O and partially dehydrated through graded 
ethanol (50% for 10 minutes and 2 x 70% for 10 minutes), infiltrated with LR 
White acrylic resin (2:1 LR White:70% ethanol for 30 minutes and neat resin for 4 
x 20 minutes). Samples were placed into size O gelatine capsules containing 0.64 
ml LR White resin + 1.5 l/ml LR White accelerator in a pre-cooled (0oC) 
aluminium heat sink and transferred to a 4oC refrigerator to polymerise overnight. 
Samples were further polymerised at 50oC for 2 hours. 
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4.3.2.2.2 Microtomy and Ultramicrotomy 
Following removal of the gelatine capsule, surplus resin was removed from 
around the samples (blocks) with a fine coping saw and the faces of the blocks 
trimmed to trapeziums with a glass knife (prepared with an LKB knife maker (LKB 
Produkter AB. Bromma, Sweden)). Preliminary 0.35 m thick sections were cut on 
an Ultracut E ultramicrotome (Reichert-Jung, Wien, Austria) with a glass knife 
fitted with a plastic boat and filled with 0.2 m filtered ddH2O. Sections were 
picked up over the tip of dumoxel number 5 forceps (Dumont, Montignez, 
Switzerland), placed onto a droplet of water on a glass slide, dried at 60oC on a hot 
plate and stained for 10 seconds with 0.5% toluidine blue in tetraborate buffer. 
Following thorough washing with ddH2O, the slide was dried on the hot plate and 
the sections mounted with Gurr’s neutral mountant and coverslipped for light 
microscopical identification of suitable areas for subsequent immunohistochemical 
staining. For scanning electron microscopy, areas containing blood vessels in 
sections of normal human peritoneum were identified, the block trimmed down, 
and 0.35 m thick sections placed onto droplets of water on 5 mm diameter 
Thermanox™ coverslip discs and dried at 50oC for 60 minutes. For transmission 
electron microscopy, exocrine granule-rich areas of pancreas were identified and 
80nm thick sections cut and picked up on pre-washed (5 seconds each in acetone, 
ethanol and 0.2 m filtered ddH2O) 300 mesh nickel grids and allowed to air dry.  
To examine the feasibility of immunoelectron tomography, endocrine granule-
rich areas of pituitary were identified and 1 m thick sections collected as above. 
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4.3.2.3 Immunohistochemical Staining 
All immunohistochemical stainings were performed in humidified chambers. 
For scanning electron microscopy, solutions were applied/removed as droplets 
directly onto/from the sections with a pipette.  
For transmission electron microscopy, grids were transferred through 50 l 
droplets of solutions on Nescofilm™. 
Sections were equilibrated with PBS/BSA for 10 minutes followed by 60 
minutes incubation in either mouse monoclonal anti-smooth muscle actin diluted 
1/1000 in PBS/BSA (for staining of blood vessels in peritoneal sections) or mouse 
monoclonal anti-amylase diluted 
1/10,000 in PBS/BSA (for staining of exocrine 
granules in pancreas sections). Following 3 x 1 minute washes in PBS/BSA, 
sections were incubated for a further 60 minutes in goat anti-mouse Ig HRP. 
Sections were washed for 1 minute in PBS/BSA and 2 x 1 minute in either PO4 
buffer or Tris buffer, as appropriate to the subsequent DAB polymerisation 
conditions. For SEM, DAB was polymerised in an identical manner for the 
preparation of dot blots in section 2.3.3 of Chapter 2. Those DAB-metal 
combinations that resulted in specific immunohistochemical labelling, as seen by 
BSI were subsequently tested on thin resin sections for TEM. 
For electron tomography, staining was performed on rat pituitary sections as 
above, except that incubation times were extended to 3 hours in 
1/800 anti-ACTH 
followed by 3 x 5 minute washes and a further 3 hours in the peroxidase conjugate. 
Following 3 x 5 minutes washes in ddH2O, sections were incubated in DAB-PO4 as 
above, and polyDAB rendered electron opaque with 2.5 mM NaAu(III)Cl4. 
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4.3.3 Scanning Electron Microscopy 
All preparations were examined in a JEOL 840A analytical scanning electron 
microscope as in section 2.3.3.5 of Chapter 2 under the following conditions 
Accelerating voltage: 20kV Probe current: 10
-8
 amps Magnification x 200 
Working distance: 15 mm. Acquisition time 3 hours 
 
4.3.4 Analytical Transmission Electron Microscopy 
Thin resin sections were examined in a Philips CM12 transmission electron 
microscope at 80kV. X-ray spectra were acquired from a 600 nm spot, focused on 
an exocrine granule, using an EDAX Sapphire X-ray spectrometer and Genesis 
software (Mahwah, New Jersy, U.S.A.). 
 
4.3.5 Electron Tomography 
Sections were examined in a JEOL 2100 tomographic electron microscope at 
the Rothamsted Research Laboratories, Hertfordshire, U.K. A 
+/- 50
o tilt series was 
collected at 200 kV. Image alignment was performed by Dr. Andy Yarwood of 
JEOL UK Ltd (Welwyn Gardens City, Herts., U.K.). Red-green anaglyphs of serial 
tilt images were produced with Adobe Photoshop (Adobe Systems Incorporated, 
San Jose, California, U.S.A.).  
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4.4 Results 
4.4.1 Choice of Section Substrate 
Vectabond-treated glass microscope slide contained, in addition to the expected 
major components of silicon and oxygen, detectable quantities of sodium, 
magnesium, potassium, calcium and aluminium (figure 4.2a). In contrast, 
Thermanox™ coverslips contained only carbon and oxygen (figure 4.2b). 
 
4.4.2 Scanning Electron Microscopy 
4.4.2.1 Preliminary Studies in Paraffin Wax-embedded Sections 
Immunohistochemical staining of smooth muscle actin in the wall of peritoneal 
blood vessels could be clearly seen by back-scattered electron imaging, as could the 
surrounding collagen (figure 4.3a). Elemental mapping revealed the presence of 
gold both in the smooth muscle cells of the blood vessel wall and in the surrounding 
collagen fibres (figure 4.3b).  
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Figure 4.2. X-ray spectra of glass slide (a) and Thermanox coverslips (b) 
 
a 
b 
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Figure 4.3. Back-scattered electron image (a) and corresponding gold elemental 
map (b) of a 4 m thick section of paraffin wax-embedded peritoneal blood vessel 
immunohistochemically stained for smooth muscle actin and visualised with 
DAB/NaAu(III)Cl4. 
  
a 
b 
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4.4.2.2 Resin Sections 
Back-scattered electron imaging provided a simple and rapid method for 
identifying immunopositive staining that contained elements of higher atomic 
number than the background tissue and resin. In addition, it allowed non-specific 
staining of tissue to be identified. 
Of the 31 d-block metal compounds tested in pre- and post-polymerisation 
settings, only 8 resulted in specific complexing with polyDAB such that high back-
scattered imaging contrast occurred between immunopositive sites and the 
surrounding tissue, namely; pre-polymerisation with DAB-Tris plus Re(III)Cl3 
(figure 4.4.a), K3Ir(III)Cl6 or K2Pt(IV)Cl6 and DAB-PO4 plus K2Pt(IV)Cl6 (figure 
4.4.b), and post-polymerisation with NaW(VI)O4, K2Os(IV)Cl6 (figure 4.3.c), 
Os(VIII)O4 (figure 4.3.d), K3Ir(III)Cl6 (slight) (figure 4.4.e), K2Pt(II)Cl4, 
K2Pt(IV)Cl6 and NaAu(III)Cl4 (figure 4.4.f). Post-polymerisation treatment with 
La(III)Cl3 resulted in light staining of the tissue and strong staining of elastic fibres 
within the blood vessel walls and between the collagen fibres of the peritoneal 
membrane (figure 4.4.g). H3PW(IV)12O40 stained all the tissue with no obviously 
increased staining of polyDAB (figure 4.4.h). 
Elemental mapping was not performed, as resin sections suffered from 
considerable beam damage during prolonged exposure, which was noted during 
attempts to acquire high quality images with the instrument in slow scanning mode. 
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Figure 4.4. Back-scattered electron micrographs of 0.35 m thick LR White-
embedded human peritoneum sections immunohistochemically stained for smooth 
muscle actin. Pre-polymerisation with Re(III)Cl3 (a) and K2Pt(IV)Cl6 (b). 
a 
b 
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Figure 4.4 (continued). Back-scattered electron micrographs of 0.35 m thick LR 
White-embedded human peritoneum sections immunohistochemically stained for 
smooth muscle actin. Post-polymerisation with K2Os(IV)Cl6 (c) and Os(VIII)O4 (d). 
c 
d 
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Figure 4.4 (continued). Back-scattered electron micrographs of 0.35 m thick LR 
White-embedded human peritoneum sections immunohistochemically stained for 
smooth muscle actin. Post-polymerisation with K3Ir(III)Cl6 (e) and 
 NaAu(III)Cl4 (f). 
e 
f 
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Figure 4.4 (continued). Back-scattered electron micrographs of 0.35 m thick LR 
White-embedded human peritoneum sections immunohistochemically stained for 
smooth muscle actin. Post-polymerisation with, La(III)Cl3 (g), and  
H3PW(IV)12O40 (h). 
h 
g 
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4.4.3 Transmission Electron Microscopy 
Unstained pancreatic exocrine granules had slight inherent electron opacity 
(figure 4.5a). Immunohistochemical staining for -amylase with DAB alone 
resulted in specific electron opacity in the exocrine granules (figure 4.5b). In sharp 
contrast to the results from scanning electron microscopy, d-block metal 
compounds that were applied pre-polymerisation did not appreciable increase the 
electron opacity of polyDAB (figure 4.5c-f). 
Post-polymerisation application of d-block metal compounds to polyDAB 
resulted in an increase in electron opacity in some, but not all cases. NaW(VI)O4 
(figure 4.5g), Os(VIII)O4 (figure 4.5i) and NaAu(III)Cl4 (figure 4.5n) all increased 
the electron opacity of polyDAB, and the electron opacity of the surrounding tissue 
was also elevated to varying degrees, NaW(VI)O4 causing the most, and 
Os(VIII)O4 causing the least. The remaining compounds did not affect the electron 
opacity of either polyDAB or the tissue to any appreciable extent (figure 4.5i, k, l, 
and m). 
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Figure 4.5. Transmission electron micrographs of 80 nm thick LR White-embedded 
rat pancreas sections immunohistochemically stained for -amylase. Unstained (a) 
and DAB alone (b). 
b 
a 
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Figure 4.5 (continued). Transmission electron micrographs of 80 nm thick LR 
White-embedded rat pancreas sections immunohistochemically stained for -
amylase. Pre-polymerisation in Tris with Re(III)Cl3 (c) and K3Ir(IV)Cl6 (d). 
c 
d 
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Figure 4.5 (continued). Transmission electron micrographs of 80 nm thick LR 
White-embedded rat pancreas sections immunohistochemically stained for  
-amylase. Pre-polymerisation in Tris with K2Pt(IV)Cl6 (e) and in PO4 with  
K2Pt(IV)Cl6 (f). 
e 
f 
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Figure 4.5 (continued). Transmission electron micrographs of 80 nm thick LR 
White-embedded rat pancreas sections immunohistochemically stained for  
-amylase. DAB alone (g), and post-polymerisation with NaW(VI)O4 (h). 
g 
h 
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Figure 4.5 (continued). Transmission electron micrographs of 80 nm thick LR 
White-embedded rat pancreas sections immunohistochemically stained for  
-amylase. Post-polymerisation with K2Os(IV)Cl6 (i), Os(VIII)O4 (j). 
i 
b 
 
j 
b 
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Figure 4.5 (continued). Transmission electron micrographs of 80 nm thick LR 
White-embedded rat pancreas sections immunohistochemically stained for  
-amylase. Post-polymerisation with K3Ir(III)Cl6 (k), K2Pt(II)Cl4 (l). 
 
k 
b 
 
l 
b 
 
256 
 
 
 
Figure 4.5 (continued). Transmission electron micrographs of 80 nm thick LR 
White-embedded rat pancreas sections immunohistochemically stained for  
-amylase. Post-polymerisation with K2Pt(IV)Cl6 (m), and NaAu(III)Cl4 (n). 
 
  
m
 
b 
 
n 
b 
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4.4.4 Analytical Transmission Electron Microscopy 
X-ray microanalysis demonstrated the presence of metal in some, but not all 
cases. No signal could be detected in samples that had been treated with Re(III)Cl3 
or K3Ir(III)Cl6, pre-polymerisation. Both platinum compounds could be detected 
when applied pre-polymerisation but acquisition required a minimum of 10 seconds 
for unequivocal identification of signal (figure 4.6a). 
All metal compounds, when applied post-polymerisation could be detected 
with a 50 second acquisition time, with the exception of K3Ir(III)Cl6, which could 
not be detected at all. Both NaW(VI)O4 (figure 4.6b) and Os(VIII)O4 (figure 4.6c) 
could be identified after just 5 seconds whereas K2Os(IV)Cl6 required twice as long. 
Both platinum compounds and sodium tetrachloraurate (figure 4.6d) could be 
identified in as little as 2 seconds. In most cases, elements were present at 
approximately 0.1% by weight, but Os(VIII)O4 was measured at 0.3%, K2Pt(II)Cl4 
at 0.6%, K2Pt(IV)Cl6 at 0.9% and NaAu(III)Cl4 at 3.2%. Measurements of 
background levels of metals indicated that most were present at 0.1%, with the 
exception of K2Pt(II)Cl4 (0.2%) and NaAu(III)Cl4 (0.5%). 
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Figure 4.6. X-ray spectra from pancreatic exocrine granules 
immunohistochemically stained for -amylase and developed, pre-polymerisation, 
with DAB and K2Pt(II)Cl4 (a) or post-polymerisation with NaW(VI)O4 (b). 
a 
b 
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Figure 4.6 (continued). X-ray spectra from pancreatic exocrine granules 
immunohistochemically stained for -amylase.  Post-polymerisation with 
Os(VIII)O4 (c) or NaAu(III)Cl4 (d). 
  
c 
d 
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4.4.5 Electron Tomography 
1 m thick resin sections were stable throughout the tomographic tilt series 
acquisition and no serious beam damage was evident. Immunopositivity in 
endocrine granules of pituitary corticotrophs could be clearly seen, and granules 
appeared uniformly stained (figure 4.7a).  3-D reconstruction of the tilt series was 
not performed, but image alignment allowed a stereo anaglyph to be produced from 
consecutive images (figure 4.7b). 
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Figure 4.7. Electron tomography images of 1 m thick section of LR White-
embedded pituitary. Corticotroph granules immunohistochemically stained for 
ACTH and visualised with DAB/NaAu(III)Cl4. Bright field image (a) and stereo 
anaglyph (b). (requires red/green glasses). 
a 
b 
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4.5 Discussion 
In preliminary studies, glass microscope slides were rejected as suitable support 
substrates for tissue sections due to the presence of elements whose X-ray emission 
peaks were too close to those of the d-block metals under investigation, such as 
silicon (K  1.7389 KeV) and tungsten (M  1.773 KeV). Thermanox™ coverslips 
provided suitable support surfaces for the immunohistochemically staining of both 
paraffin wax and acrylic resin sections, since sections adhered to them well without 
the pre-treatment that is normally required for glass slides. An additional advantage 
of Thermanox™ coverslips is their lower atomic number composition compared to 
that of glass, which facilitated back-scattered electron imaging (BSI) of resin 
sections. BSI exploits average atomic number to achieve contrast, and small 
amounts of higher atomic number material can easily be overlooked by an 
overwhelming signal from a much larger amount of lower atomic number substrate.  
In preliminary studies, using 4 m thick sections of paraffin wax-embedded 
peritoneum immunohistochemically stained for smooth muscle actin, BSI revealed 
a strong signal from blood vessel walls, and subsequent elemental mapping 
demonstrated sufficiently large amounts of gold for an analytical image to be 
produced, although acquisition time was considerable. In both cases, adherence of 
gold to background tissue, particularly collagen, was evident. 
Thermanox™ coverslips, like glass slides, are poor conductors of heat and 
electricity, and resin sections experienced considerable damage when electron beam 
dwell time was extended, such as occurred during slow beam scanning for high 
quality image acquisition. In the SEM, electrons are of lower energy than in the 
TEM, and consequently interact much more strongly with specimens. A major 
consequence of this is an increased interaction volume and a subsequent reduction 
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in the spatial resolution that is achievable. In addition, beam damage can be much 
more severe, and this was noted in resin sections, even though the resin had been 
specifically formulated to be electron beam-stable in the TEM. Conditions in the 
TEM are, however, somewhat different; resin sections are usually supported on a 
thin metal mesh which dissipates heat and electrons, and high energy electrons 
result in reduced beam-specimen interaction. 
Back-scattered electron imaging revealed a small number of d-block metal 
compounds that formed complexes with polyDAB, some with considerable 
specificity, notably those of platinum and gold. General tissue staining was seen 
with La(III)Cl3 and H3PW(IV)12O40  and this is, perhaps, not surprising since the 
former has been advocated as a pre-embedding stain for electron microscopy 
(Leeson and Higgs, 1982) and the latter has been used as a biological TEM stain for 
a considerable time (Silverman and Glick, 1969). Phosphotungstic acid has been 
reported to increase the electron opacity of polyDAB (Newman et al., 1983) and 
this should have been observable by BSI, but no increased signal was seen. 
In the TEM, selected d-block metals increased the electron opacity of 
polyDAB, but not to the same extent as previously reported (Newman et al., 1983). 
The reason for this is unclear, since development of photographic plates and prints 
was reported to be identical in the 1983 study, and raw digital images, taken under 
identical levels of illumination without automatic gamma correction were collected 
here. 
X-ray microanalysis of polyDAB-metal deposits on exocrine granules was able 
to demonstrate the presence of most metals, and signal was strongest when the d-
block compounds were applied post-polymerisation. Few studies have attempted to 
compare the incorporation of metal into polyDAB, but the results presented here 
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are in broad agreement with them. In the earliest study, gold(III) was demonstrated 
to complex with polyDAB in approximately 3-fold greater amounts than 
osmium(VIII)tetroxide (Siegesmund et al., 1979) but here, proportionately more 
gold was detected (10-fold). Complexing of hexachloroplatinate with polyDAB has 
also been compared with Os(VIII)O4 in histochemically stained preparations, and 
was shown to impart greater specificity, but absolute values were not reported (de 
Bruijn et al., 1986). Here, both platinum compounds were present in higher 
concentrations then Os(VIII)O4 while background values were comparable. 
The minimum acquisition time required to unequivocally demonstrate the 
presence of metal was 2 seconds in the case of both platinum compounds and 
tetrachloraurate. Unfortunately, this would be too long for analytical electron 
tomography to be a practical proposition using this staining technology, since pixel 
dwell times of less than 50 ms would be necessary to acquire an analytical 
tomogram in less than 6 hours. 
The controversy surrounding antibody penetration into resin-embedded tissue 
sections was briefly investigated, since this has profound implications for the 
successful implementation of immunohistochemical staining in a tomographic 
setting. The polyDAB-gold complex was stable throughout the acquisition period 
and the resin remained intact. 3-D reconstruction from the tilt series was not 
performed, but a stereo anaglyph from two consecutive images gave the impression 
that staining had occurred to some depth. The pre-penultimate line of Yeoman’s 
sonnet, ‘that believed is easily seen’ is particularly apposite; careful inspection of the 
individual bright field images of the tilt series suggested staining of the granules to 
be more consistent with discs, rather than spheres; if staining had penetrated 
through the entire depth of the section, spherical granules would appear darker in 
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the central region than at the periphery. There are a number of possible 
explanations for this, namely (1) antibody penetration does not occur in resin-
embedded tissue, (2) antibody penetration occurs, but antibody conjugates do not 
(3) both primary and secondary antibodies penetrate resin sections, but polyDAB 
rapidly forms an impenetrable barrier to further diffusion of monomer and (4) 
endocrine granules are too dense to allow antibodies to penetrate. 
 
4.6 Summary and Conclusions 
A number of d-block metal compounds formed complexes with polyDAB that 
increased its electron opacity and were demonstrable by analytical TEM. In some 
cases, notably platinum and gold compounds, they could be identified with short 
acquisition times. Unfortunately, none could be unequivocally detected in less than 
2 seconds, which was still too long for the purposes of AEMT. 
The brief investigation of immunohistochemical staining for electron 
tomography may not have been successful, and suggested that further studies would 
be required to dissect the reason for the apparent failure of one or more components 
of the staining system to penetrate resin-embedded tissue sections. 
For multiple labelling of tissue constituents to become a realistic proposition in 
electron tomography, much higher concentration of specific element will be 
required. These elements cannot be carbon, nitrogen or oxygen, since they are, of 
course, abundant in biological tissue. Any element with an atomic number higher 
than 4, and preferably higher than 11 to allow identification by the older detectors, 
would be adequate for the purpose. The issue of reporter/marker penetration will 
also have to be addressed. 
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Chapter 5 
Halogenated Aromatic Diamine Polymers as 
Potential Markers for Analytical Electron 
Microscopical Tomography  
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5.1 Introduction 
From the results of the previous chapter, it was evident that the concentration 
of metal in polyDAB-metal complexes, while permitting immunohistochemical 
deposits to be identified by analytical electron microscopy in some cases, was 
inadequate for practical purposes. The presence of the prominent fluorine peak of 
the PVDF membrane, in spectra of dot blot preparations that were examined in 
Chapter 2, suggested that elements other than transition metals might be more 
fruitfully explored.  
Any element, other than those commonly encountered in biological specimens 
or preparations thereof, in sufficient quantity might serve as an analytical marker. 
The choice of specific element, to be incorporated into a suitable marker, is dictated 
by chemistry. 
With the exception of the enzyme metallography technique, mentioned in 
Chapter 2, peroxidase markers are all derived from aromatic amines, including 
benzidine (Adler and Adler, 1904), 3-amino-9-ethylcarbazole (Graham et al., 1965), 
3,3'-diaminobenzidine (Graham and Karnovsky, 1966), p-phenylenediamine 
(Hanker and Rabin, 1975; Hanker et al., 1977), tetramethylbenzidine (Hardy and 
Heimer, 1977), o-dianisidine (Carthew, 1978), and o-toluidine (Somogyi et al., 
1979). All are rendered electron-opaque by treatment with osmium(VIII)tetroxide. 
The simplest method of labelling aromatic compounds with specific elements is 
halogenation, and a number of methods exist for generating electrophilic halogen 
species such as fluoroborate (Balz and Schiemann, 1927), acetyl hypofluorite 
(Lerman et al., 1981), reaction of ferric chloride or bromide with chlorine and 
bromine, respectively, and iodine with sulfuric acid/iodic acid (Kraszkiewicz et al., 
2004) or oleum (Symons, 1957a; 1957b). 
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5.1.1 Commercially Available Halogenated Phenylene Diamines 
A brief catalogue survey revealed a number of compounds that might be 
suitable for investigation (figure 5.1). 
 
5.1.2 Synthesis of Halogenated Phenylene 1,2-Diamines 
In addition to the compounds above, a number of synthetic routes exist for 
preparing halogenated marker precursors. The simplest is reduction of 
commercially available halogenated nitroanilines with SnCl2/ethanol (Xing and 
Ogata, 1982) or Sn/HCl. Slightly more complex is the orthonitration of 
haloanilines and halogenated bis-4-aminophenyls via N-acetylation-protected 
intermediates. Where suitable precursors are commercially unavailable or 
prohibitively expensive, synthesis can be achieved by halogenation of nitrobenzenes 
and subsequent reduction (Stephens and Bower, 1950; Cheeseman, 1962; 
Youngblood, 2006). 
 
5.1.3 Synthesis of Halogenated DAB  
Given the properties of polyDAB, and the suggestion that a labelled analogue 
might prove a useful marker for analytical electron microscopy (Chandler, 1973), 
an attempt at halogenated DAB synthesis seems reasonable. Synthesis of the 2,2΄-
dibromo analogue might be achieved via bromination of commercially available 
4,4΄-dinitrobiphenyl (Bunnett and Rauhut, 1958), nitration of commercially 
available 2,2΄-dibromobiphenyl or bromination of DAB (Shaffer et al., 1985).  
A number of synthetic routes for preparing the iodo analogue were attempted 
by Shaffer et al, with a view to providing a starting material for the synthesis of 
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Figure 5.1. Commercially available halogenated phenylene diamines.  
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lightweight high temperature-resistant composites, including direct iodination of the 
protected biphenyl tetramine and biaryl coupling of dihalo derivatives of o-
phenylenediamine, but none of these procedures proved successful (Shaffer et al., 
1985). A number of alternative synthetic routes might exist based on (1) direct 
iodination of aromatic amines (Monnereau et al., 2005), (2) monoiodination of 4-
nitrotoluene (Kraszkiewicz et al., 2004; Chaikovskii et al., 2007) (3) iodination of 
dinitrobenzene (Youngblood) or (4) nitration of commercially available 2,2΄-
diiodobiphenyl. The starting material in this last approach is prohibitively 
expensive, but halogen exchange of the dibromo analogue (Klapars and Buchwald, 
2002) might provide a cheaper solution. 
 
5.1.4 Selection of Suitable Substrates for Preliminary Dot Blot and 
Immunohistochemical Staining 
PVDF membrane is clearly unsuitable for use in X-ray analysis of fluorinated 
aromatic compounds and an alternative is required. Ideally, the substrate should 
not contain nitrogen in case sufficient marker is deposited that quantitation 
becomes a possibility i.e. comparison of marker nitrogen with halogen. Two 
commercially available membranes fulfil these requirements, namely cellulose 
acetate (CA) and reconstituted cellulose (RC). 
In section 4.4.1 of the previous chapter, it was noted that glass microscope 
slides contained elements whose X-ray peaks interfered with those of some of the d-
block elements under study. Similarly, the aluminium K  peak (1.4866 KeV) is 
very close to the L  peak of bromine (1.4805 KeV). For this reason, Thermanox 
coverslips were again chosen as section support substrates for 
immunohistochemical staining. 
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5.2 Materials 
5.2.1 Reagents 
All reagents were of analytical grade. Tin powder, concentrated hydrochloric 
acid, concentrated (90%) sulfuric acid, 20% oleum, iodine, potassium nitrate, 
sodium sulfite, sodium hydroxide, magnesium sulfate, chloroform, ethyl acetate 
and hexane were supplied by Fisher Scientific (Loughborough, Leicestershire, 
U.K.). 1-amino-2-nitro-4-bromobenzene, 1-amino-2-nitro-4-iodobenzene, 1-amino-
3,4-dibromobenzene, 1-methyl-4-nitrobenzene, 1-methyl-3,4-dinitrobenzene, 4,4′-
dinitrobiphenyl, 4,4'-(1,1,1,3,3,3-hexafluoropropane-2,2-diyl)dianiline, 4,4′-
methanediyldianiline,  triethylamine, dimethylaminopyridine, and acetic anhydride 
were purchased from Sigma-Aldrich (Poole, Dorset, U.K.). 2,2′-dibromobiphenyl 
was purchased from Tokyo Chemical Industry UK Ltd (Oxford, Oxfordshire, 
U.K.). Monoclonal mouse anti-human smooth muscle actin (MAH SMA) was 
supplied by Dako (Ely, Cambridgeshire, U.K.). Monoclonal mouse anti-human 
amylase and polyclonal goat anti-mouse Ig HRP conjugate (GAM IgPC) were 
purchased from Autogen Bioclear (Calne, Wiltshire, U.K.). All antibodies were 
diluted in TBS/BSA. 
 
5.2.2 Tissue 
Archival, post-mortem human adrenal and pancreas tissue were acquired, with 
consent, prior to the introduction of the Human Tissue Act (2004) and prepared 
according to section 2.3.4.1. Archival normal human peritoneum and rat pancreas 
were prepared according to section 4.3.2.2. 
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5.3 Methods 
5.3.1 Organic Synthesis 
The general scheme for synthesis of halogenated aromatic diamines is 
summarised in figure 5.2. 
 
5.3.1.1 Characterisation of Intermediates and Final Products of Syntheses 
Given the structural simplicity of the compounds under investigation, 
characterisation was performed by 
1
H NMR on a Bruker AMX-400 spectrometer 
(Bruker UK Ltd., Coventry, U.K.). Where uncertainty existed regarding structure, 
infra red spectroscopy and/or mass spectrometry (performed by Dr. Rob Jenkins, 
School of Chemistry, Cardiff University) was performed. Formal names were 
generated with Chemsketch and NMR spectra were analysed with NMR Processor 
freeware (both ACD/Labs Toronto, Ontario, Canada). 
Trivial names of compounds are indicated in parentheses. For brevity, 
derivatives of phenylene-1,2-diamines will be referred to as halo-OPDs and those of 
1,4-diamine isomers as halo-PPDs. 
 
5.3.1.2 Synthesis of Halogenated Phenylene 1,2-Diamines 
5.3.1.2.1 1,2-Diamino-4-bromobenzene (4-Br-OPD) 
1,2-Diamino-4-bromobenzene was prepared by a single step Sn/HCl reduction 
of 1-amino-2-nitro-4-bromobenzene. 
1 g (4.60 mmol) 1-amino-2-nitro-4-bromobenzene was dissolved in 10 ml 
ethanol and 8 ml conc. HCl added. The mixture was heated under reflux to 110
o
C 
and 0.82 g (6.9 mmol, 1.5eq), dispersed in 2 ml of ethanol, added. Reflux was 
continued until all visible tin had been consumed and the reaction mixture had
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Figure 5.2. Generalised scheme for synthesis of halogenated aromatic diamines. X1 and 
X2 are H, Br or I.  
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changed from deep red to clear. The mixture was cooled to RT, basified with 2 M 
NaOH to alkaline pH and extracted with ethyl acetate. The organic phase was 
dried sequentially with brine and MgSO4, and solvent removed by rotary 
evaporation. 1,2-Diamino-4-bromobenzene was purified by recrystallisation from 
ethanol/water, yielding 149 mg of white crystals (0.79 mmol) (17.28%). 
1
H NMR 
(400 MHz, CDCl3)  3.14 (br, s, 4H; NH2), 6.49 (d, 
3
JHH = 8.13, 1H; C6), 7.36 (dd, 
3
JHH = 8.13, 
4
JHH = 2.22, 1H; C5) and 8.21 (d, 
4
JHH = 2.22, 1H; C3) ppm. 
 
5.3.1.2.2 1,2-Diamino-4-iodobenzene (4-I-OPD) 
1,2-Diamino-4-iodobenzene was prepared by Sn/HCl reduction of 1 g (4.61 
mmol) 1-amino-2-nitro-4-iodobenzene according to section 5.3.1.2.1, above. The 
organic solvent extract of the basified reaction mixture darkened rapidly and 
yielded, initially, only a small amount of tarry product. Drying under vacuum 
resulted in the appearance of crystals that yielded 305 mg (1.30 mmol) (28.2%) pale 
brown needles of 1,2-diamino-4-iodobenzene upon recrystallisation from ethyl 
acetate/hexane. 
1
H NMR (400 MHz, CDCl3)  3.40 (br, s, 4H; NH2), 6.47 (dd, 
3
JHH = 7.02, 
4
JHH = 1.46, 1H; C5), 7.01 (2H, overlapping peaks from C3 and C6 
could not be individually resolved, but 
3
JHH = 7.02 and 
3
JHH = 1.46 couplings could 
be identified) ppm. 
 
5.3.1.2.3 1,2-Diamino-4,5-dibromobenzene (4,5-diBr-OPD) 
1,2-Diamino-4,5-dibromobenzene was prepared from 1-amino-3,4-
dibromobenzene by a four-step procedure; (1) acetylation of the amine, (2) 
orthonitration, (3) hydrolysis and (4) reduction. 
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Acetylation was performed according to Yang et al (2009). 3.77 g (12.86 mmol) 
1-amino-3,4-dibromobenzene was dissolved in 50 ml acetone on ice, 5 ml (52.90 
mmol) acetic anhydride added dropwise and a catalytic quantity (approximately 20 
mg) of 4-dimethylaminopyridine (DMAP) (Höfle et al., 1978) added and stirred for 
3 hours. The reaction was terminated by the addition of 5 ml triethylamine and the 
product precipitated by addition of H2O (Yang et al., 2009). 
The mixture was extracted twice with ethyl acetate and the organic phase dried 
as above. The product was purified by recrystallisation from both hot ethanol and 
ethyl acetate/hexane to yield 4.18 g (14.27 mmol) 1-acetamido-3,4-
dibromobenzene (95.12%). 
1
H NMR (400MHz, CDCl3)  2.20 (s, 3H; acetyl), 7.34 
(dd, 
3
JHH = 8.77, 
4
JHH = 2.34, 1H; C6), 7.53 (d, 
3
JHH = 8.77, 1H; C5), 7.63 (br, s, 
1H; NH) and 7.89 (d, 
4
JHH = 2.34, 1H C2) ppm. 
1.8 g (6.14 mmol) 1-acetamido-3,4-dibromobenzene was dissolved in 10 ml 
conc. H2SO4, cooled on ice, and 0.27 g (2.73 mmol) KNO3 added with stirring 
(Stephens and Bower, 1950). After 3 hours, the mixture was poured onto ice, 
neutralised with 2 M NaOH and extracted twice with ethyl acetate. 
Recrystallisation from both hot ethanol and chloroform/hexane yielded 1.61 g 
(47.64%) of pale yellow 1-acetamido-2-nitro-4,5-dibromobenzene. 
1
H NMR (400 
MHz, CDCl3)  2.24 (s, 3H; acetyl), 8.39 (s, 1H; C6), 9.16 (s, 1H; C3) and 10.22 
(br, s, 1H; NH) ppm. 
1 g (2.96 mmol) 1-acetamido-2-nitro-4,5-dibromobenzene was hydrolysed by 
dissolving in 10 ml ethanol plus 2 ml conc. HCl and refluxing overnight at 100
o
C. 
The mixture was cooled, basified by addition of 2 M NaOH and extracted twice 
with ethyl acetate. Recrystallisation from chloroform/hexane yielded 0.55 g (1.86 
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mmol) of red/orange needles; 1-amino-2-nitro-4,5-dibromobenzene (62.81%) 
1
H 
NMR (400 MHz, CDCl3)  6.08 (br, s, 2H; NH2), 7.20 (s, 1H; C6) and 8.38 (s, 1H; 
C3) ppm. 
600 mg (2.03 mmol) 1-amino-2-nitro-4,5-dibromobenzene was reduced with 
Sn/HCl as above 0.326 g (1.22 mmol) of white crystals of 1,2-diamino-4,5-
dibromobenzene (60.38%). 1H NMR (400 MHz, CDCl3)  3.42 (br, s, 4H; NH2) 
and 6.95 (s, 2H; C3 & C6) ppm. Overall yield of the preparation was 17.18%. 
 
5.3.1.2.4 1,2-Diamino-4,5-diiodobenzene (4,5-diI-OPD) 
Preparation of 1,2-diamino-4,5-diiodobenzene was achieved by a two step 
reaction; (1) diiodination of 1,2-dinitrobenzene (Youngblood, 2006) and (2) 
reduction of the resulting dinitro compound to the diamine. 
38 ml 20% oleum was heated in an oil bath, with stirring, to 120
o
C in a three-
necked round-bottomed flask fitted with a condenser and nitrogen bubbler. 6.86 g 
(27.0mmol) I2 was added and, after 20 minutes, 4.54 g (27 mmol) 1,2-
dinitrobenzene. After 75 minutes, the reaction mixture was poured into a 1 l conical 
flask filled with ice. The mixture was quenched by addition of NaOH until slightly 
alkaline to pH paper, ice being added as required to keep the mixture cold. The 
mixture was filtered through Whatman No. 1 filter paper and the filtrate extracted 
with chloroform. The organic phase was washed with aqueous Na2S2O5, water, and 
dried as above. The light brown cake was resuspended in 200 ml ddH2O and 
Na2S2O5 added until no smell of SO2 was detectable. The cake was recovered by 
filtration and extracted with both chloroform and hot ethanol. The organic solvent 
extracts were combined, the solvent evaporated and the product recrystallised from 
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chloroform/hexane to yield 2.95 g (7.02 mmol) of pale yellow crystals of 1,2-
dinitro-4,5-diiodobenzene (26.02%). 
1
H NMR (400 MHz, CDCl3)  8.34 (s; C3 and 
C6) ppm. 
Sn/HCl reduction of 2 g (4.76 mmol) 1,2-dinitro-4,5-diiodobenzene was 
performed as above to yield 1.369 g (3.80 mmol) of 1,2-diamino-4,5-diiobenzene 
(79.91%). 
1
H NMR (400 MHz, CDCl3)  3.31 (s, 4H; NH2) and 7.09 (s, 2H; C3 and 
C6) ppm. The overall yield was 20.79%. 
 
5.3.1.3 Synthesis of Halogenated bis-Phenylene 1,2-Diamines 
The general scheme for the synthesis of 4,4'-(1,1,1,3,3,3-hexafluoropropane-2,2-
diyl)dibenzene-1,2-diamine and 4,4′-methanediyldibenzene-1,2-diamine is shown in 
figure 5.3. 
 
5.3.1.3.1 4,4'-(1,1,1,3,3,3-Hexafluoropropane-2,2-diyl)dibenzene-1,2-diamine 
(F6) 
F6 was prepared in an analogous fashion to the synthesis of 4,5-dibromo-OPD 
in section 5.3.1.2.3, above. 
Acetylation of 3 g (8.97 mmol) 4,4'-(1,1,1,3,3,3-hexafluoropropane-2,2-
diyl)dianiline yielded 3.50 g (8.37 mmol) of N,N'-[(1,1,1,3,3,3-hexafluoropropane-
2,2-diyl)bis(2-nitrobenzene-4,1-diyl)]diacetamide (93.08%). 1H NMR (400 MHz, 
MeOD)  2.15 (s, 6H; acetyl), 7.32 (d, 
3
JHH = 8.77, 4H; C2, C2', C6 and C6') and 
7.62 (m, 
3
JHH = 8.77, 4H; C3, C3, C5 and C5' and 
5
JHF = 1.75Hz) ppm. 
Nitration of 3.50 g (8.37 mmol) N,N'-[(1,1,1,3,3,3-hexafluoropropane-2,2-
diyl)bis(2-nitrobenzene-4,1-diyl)]diacetamide with 2 equivalents of KNO3 yielded
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Figure 5.3. Generalised scheme for synthesis of 4,4'-(1,1,1,3,3,3-
hexafluoropropane-2,2-diyl)dibenzene-1,2-diamine and 4,4′-methanediyldibenzene-
1,2-diamine. X is trifluoromethyl or H respectively.
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 2.223 g (4.27 mmol) N,N'-[(1,1,1,3,3,3-hexafluoropropane-2,2-diyl)bis(2-
nitrobenzene-4,1-diyl)]diacetamide (52.25%). 
1
H NMR (400 MHz, CDCl3)  2.35 
(s, 6H; acetyl), 7.62 (d, 
3
JHH = 9.06, 2H; C6 and C6'), 8.31 (br, s, 2H; NH), 8.93 (d, 
3
JHH = 9.06, 2H; C5 and C5') and 10.44 (s, 1H; C3 and C3') ppm. 
Hydrolysis of 2.00 g (3.93 mmol) of the above dinitro product gave 4,4'-
(1,1,1,3,3,3-hexafluoropropane-2,2-diyl)bis(2-nitroaniline) in good yield; 1.47 g 
(3.46 mmol) (88.11%). 
1
H NMR (400 MHz, CDCl3)  6.68 (br, s, 4H; NH2), 6.92 
(d, 
3
JHH = 9.02, 2H; C6 and C6'), 7.22 (d, 
3
JHH = 9.02, 2H; C5 and C5') and 8.06 (s, 
2H; C3 and C3') ppm. 
Sn/HCl reduction of 0.6 g of 4,4'-(1,1,1,3,3,3-hexafluoropropane-2,2-diyl)bis(2-
nitroaniline) yielded 0.164 g (0.45 mmol) 4,4'-(1,1,1,3,3,3-hexafluoropropane-2,2-
diyl)dibenzene-1,2-diamine (31.93%). 1H NMR (400 MHz, CD3CN)  3.83 (br; 
NH2) ppm. Aromatic protons resolved poorly in CD3CN and could not be assigned. 
Overall yield of the synthesis was 15.53%. 
 
5.3.1.3.2 4,4′-Methanediyldibenzene-1,2-diamine 
The fluorescence of the F6 reaction product following immunohistochemical 
deposition (section 5.4.2.1, below) prompted an investigation to determine whether 
this was due to the presence of the methylene bridge in the starting material (since 
polyDAB does not fluoresce to any appreciable extent) or to the presence of the two 
trifluoromethyl residues. Synthesis of 4,4'-methanediyldibenzene-1,2-diamine from 
4,4′-methanediyldianiline was performed according to section 5.3.1.3.1, above. 
Acetylation of 2.00 g (10.09 mmol) 4,4′-methanediyldianiline yielded 0.57 g 
(2.02 mmol) N,N'-(methanediyldibenzene-4,1-diyl)diacetamide (20.01%). 
1
H NMR 
286 
 
(400 MHz, MeOD)  2.11 (s, 6H; acetyl), 3.90 (s, 2H; methylene), 7.14 (d, 
3
JHH = 
8.48, 4H; C3, C3′, C5 and C5′) and 7.45 (d, 
3
JHH = 8.48, 4H; C2, C2′, C6 and C6′) 
ppm. Nitration of 400 mg (1.42 mmol) of the acetamide yielded 0.213 g (0.57 
mmol), not of N,N'-[methanediylbis(2-nitrobenzene-4,1-diyl)]diacetamide as 
required, but of N,N'-[(dinitromethanediyl)dibenzene-4,1-diyl]diacetamide 
(40.28%). 
1
H NMR (400 MHz, CDCl3)  2.27 (s, 6H; acetyl), 7.52 (br, s, 2H; NH), 
7.72 (m, 
3
JHH = 9.06, 
4
JHH = 2.92, 
5
JHH = 2.03, 4H; C2, C2′, C6 and C6′) and 8.23 
(m, 
3
JHH = 9.06, 
4
JHH = 2.92, 
5
JHH = 2.05, 4H; C3, C3′, C5 and C5′) ppm. No 
further attempt was made to synthesise this compound. 
 
5.3.1.3.3 6,6′-Dibromobiphenyl-3,3′,4,4′-tetramine 
5.3.1.3.3.1 Bromination of 4,4′-Dinitrobiphenyl 
Bromination of was performed according to Bunnet and Rauhut (1958). 1 g 
(4.09 mmol) 4,4′-dinitrobiphenyl was added to 25 ml glacial acetic acid containing 
2 g (8 mmol) Br2 and 100 mg Fe powder at 70
o
C and refluxed for 2 hours under a 
nitrogen blanket. The reaction mixture was poured onto ice, neutralised with 2 M 
NaOH and extracted with chloroform. Only starting material was recovered. 
 
5.3.1.3.3.2 Nitration of 2,2′-Dibromobiphenyl 
Nitration of 0.5g (1.60mmol) 2,2′-dibromobiphenyl was performed according to 
section 5.3.1.2.3, above, and yielded 0.34 g (0.84 mmol) 2,2′-dibromo-4,4′-
dinitrobiphenyl (52.78%). 1H NMR (400 MHz, CDCl3)  7.95 (d, 
3
JHH = 8.77, 2H; 
C6 and 6′),  8.17 (d, 
4
JHH = 2.63, 2H; C3 and 3′) and  8.22 (dd, 
3
JHH = 8.77, 
4
JHH 
= 2.63, 2H; C5 and 5′) ppm. This synthesis was not concluded due to lack of time.  
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5.3.1.3.4 6,6′-Diiodobiphenyl-3,3′,4,4′-tetramine 
Preliminary syntheses were performed on mono- and dinitrotoluene as cheaper 
surrogates for mono- and dinitrobiphenyl respectively. 
 
5.3.1.3.4.1 1-Methyl-2-iodo-4-nitrobenzene 
1-Methyl-4-nitrobenzene was used a surrogate for 4,4′-dinitrobiphenyl. 
Monoiodination was performed according to Kraszkiewicz et al (2004). 1.22 g (4.40 
mmol) powdered I2 and 0.39 g (2.20 mmol) HIO3 were added to 30 ml conc. 
H2SO4 and stirred for 30 minutes at RT. The mixture was added drop-wise to 1.37 
g (10 mmol) 1-methyl-4-nitrobenzene in 20 ml conc. H2SO4 and stirred for a further 
15 minutes at RT. The mixture was poured onto ice, extracted with diethyl ether, 
washed with Na2SO3 solution and recrystallised with chloroform/hexane. The 
reaction yielded 0.34 g (1.30 mmol) 1-methyl-2-iodo-4-nitrobenzene (13%). 
1
H 
NMR (400 MHz, CDCl3)  2.57 (d, JHH = 4.70, 3H; methyl), 7.41 (dd, 
3
JHH = 8.18, 
JHH = 4.70, 1H; C6), 8.13 (dd, 
3
JHH = 8.18, 
4
JHH = 2.34, 1H; C5) and 8.67 (d, 
4
JHH 
= 2.34, 1H; C3) ppm. 
 
5.3.1.3.4.2 1,3-Diiodo-2-methyl-4-nitrobenzene 
Diiodination was performed according to Arotsky et al (1970). 8 g (31.54 
mmol) I2 was added to 20 ml 20% oleum and stirred for 30 minutes at RT. 2.16 g 
(15.77 mmol) 1-methyl-4-nitrobenzene was added and the mixture stirred for 18 
hours at RT. The mixture was poured onto ice, extracted with chloroform, washed 
with Na2SO3 solution and recrystallised from chloroform/hexane. The reaction 
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yielded 4.98 g (12.80 mmol) 1,3-diiodo-2-methyl-4-nitrobenzene (81.17%). 
1
H 
NMR (400 MHz, CDCl3)  2.87 (s, 3H; methyl) and 8.68 (s, 2H; C3 and C5) ppm. 
 
5.3.1.3.4.3 1-Methy-2-iodo-4,5-dinitrobenzene 
Monoiodination of 1.46 g (8.0 mmol) 1-methyl-3,4-dinitrobenzene was 
performed according to section 5.3.1.3.4.1, above, but only starting material was 
recovered. 
Diiodination of was performed as in section 5.3.1.3.4.2, using 2 g (11.0 mmol) 
1-methyl-3,4-dinitrobenzene. Refluxing for 75 minutes resulted in a small amount 
of tarry product. Extending the reaction to 4 hours yielded only 100 mg (0.23 
mmol) of 1-iodo-2-(iodomethyl)-4,5-dinitrobenzene (2.09%). 
1
H NMR (400 MHz 
CDCl3)  4.75 (d, JHH = 4.68, 2H; iodomethyl), 8.12 (s, 1H; C6) and 8.36 (s, 1H; 
C3) ppm. 
 
5.3.1.3.5 2,2′-Diiodo-4,4′-dinitrobiphenyl 
Iodination of 0.5 g (4.09 mmol) of 4,4′-dinitrobiphenyl was performed 
according to section 5.3.1.3.4.2, above. Only 50 mg of gray/brown product was 
recovered. 
1
H NMR indicated the presence of starting material and minor, 
unidentified, products. 
 
5.3.2 Dot-blot model system 
Dot blots were prepared according to section 2.3.3. For preliminary evaluation, 
dot blots of 
1/50,000 GAM IgPC were prepared. Where deposit of marker was 
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evident, further dot blots were prepared from doubling dilutions of GAM IgPC 
from 
1/50,000 to 
1/1,600,000 for visual comparison with polyDAB.  
Preliminary attempts to dissolve the compounds in Tris buffer were 
unsuccessful. This was overcome by initially dissolving 5 mg in 1 ml DMSO 
followed by addition of 9 ml citrate buffer pH 6.5 and 15 l H2O2. Dot blots were 
incubated in each solution for 3 minutes, thoroughly washed with ddH2O and air 
dried. Digital images were acquired as previously described. 
For analysis by analytical SEM, all dot blots were prepared with GAM IgPC 
on RC membrane. The peroxidase solution tended to spread over a larger area on 
RC membrane prior to adsorption, compared to PVDF, thus a higher concentration 
of GAM IgPC were used, namely 
1/5,000. Preparations were attached to 32 mm 
diameter aluminium stubs with double-sided sticky tape and carbon coated. Those 
dot blots that contained measureable amounts of halogen were subsequently tested 
in the tissue model. 
 
5.3.3 Tissue model system 
5.3.3.1 Light Microscopy 
Rehydrated sections of either human pancreas or adrenal tissue were 
equilibrated for 10 minutes with TBS/BSA and incubated for 1 hour in 1/500 MAH 
SMA. Following 3 x 1 minute washes in TBS/BSA, sections were further incubated 
for 1 hour in 
1/150 GAM IgPC. Following a 1 minute was in TBS/BSA, sections 
were washed twice in either Tris or Citrate buffer, as appropriate to the subsequent 
marker generating solution. Sections were thoroughly washed in ddH2O, 
dehydrated, cleared in xylene and mounted, initially, in Gurr’s neutral mountant. 
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In cases where the marker dissolved in one of the dehydrating solutions, mounting 
was performed with the aqueous mountant, Fluorsave™ (Vector Laboratories, 
Peterborough, U.K.). 
 
5.3.3.2 Electron Microscopy 
For SEM, tissue sections were stained in an identical manner as above, and 
allowed to air dry. Regions containing well stained blood vessels, together with the 
underlying coverslip, were cut out and mounted on 32 mm diameter aluminium 
stubs with conductive carbon adhesive discs (TAAB Laboratories Equipment Ltd, 
Aldermaston, Berks., U.K.) and carbon coated. 
For TEM, 80 nm thick sections of either LR White-embedded human 
peritoneum or rat pancreas were immunohistochemically stained as in section 
4.3.2.4 of the previous chapter. Markers were rendered electron dense by a 2 minute 
wash with either 2.5 mM NaAu(III)Cl4 or Os(VIII)O4, or examined unstained to 
assess any inherent electron opacity. 
 
5.3.3.3 Analytical Electron Microscopy 
For SEM, analytical conditions for examining dot blots were as follows: 
Accelerating voltage: 10 kV Probe current: 10
-7
 amps Magnification x 20 
Working distance: 15 mm Count time: 100 seconds Processing time 6 
For immunohistochemically stained preparations, elemental mapping 
conditions were as above, except that magnification was set at x 100. Initial 
mapping was performed at an image resolution of 256 x 192 pixels with 1200 s 
beam dwell-time per pixel and accumulation of 5 image frames. Where strong 
signal specific signal was detected, further mapping was performed at 1 frame, 
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which reduced total acquisition time from 595 seconds to 121 seconds, or pixel 
dwell time reduced to 100 s and accumulation of 5 or 1 frames, which reduced 
total acquisition time to 57 or 12 seconds respectively. In some cases, where 
moderate specific signal was initially detected, accumulation was performed over 
10 frames. 
TEM acquisition conditions were as described in section 4.3.4. 
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5.4 Results 
5.4.1 Dot Blot Model System 
5.4.1.1 Choice of Dot Blot Substrate for Analytical SEM 
Application of GAM IgPC solution to CA membranes resulted in considerable 
spreading of the solution such that subsequent dot blots covered a much larger area 
and were more diffuse than those seen in previous experiments using PVDF. In 
contrast, solutions applied to RC membranes remained focussed, resulting in 
intense dot blots. One minor problem of the RC membrane was the tendency to 
curl upon drying. This was overcome by briefly blotting the membranes with filter 
paper, to remove surplus water, and applying them to double-sided adhesive tape 
before they fully dried. 
 
5.4.1.2 Polymerisation of Halogenated Compounds on Dot Blots 
All halogenated compounds produced visible deposits, although dot blot 
intensity varied to a greater or lesser extent. Of the fluorinated compounds, 1,2-
diamino-4-trifluoromethylbenzene (TriFMe-OPD) produced the faintest dots 
(figure 5.3a), followed by 1,2-diamino-3,4-difluorobenzene (3,4-diF-OPD) (figure 
5.3b). Both 1,2-diamino-4-fluorobenzene (4-F-OPD) (figure 5.3c) and 1,2-diamino-
4,5-difluorobenzene (4,5-diF-OPD) (figure 5.3d) produced dots of equal intensity. 
In all cases, dot colour was yellow-brown. 
The chlorinated compounds produced blots of varying colour and intensity; 
1,2-diamino-4-chlorobenzene (4-Cl-OPD) was faint and pale yellow brown (figure 
5.3e) whereas those of 1,2-diamino-4-fluoro-5-chlorobenzene (4-F-5-Cl-OPD) were 
intense and dark brown (figure 5.3f). The two chlorinated 1,4-diamines, 1,4-
diamino-2,5-dichlorobenzene (2,5-diCl-PPD) (figure 5.3g)  and 1,4-diamino-2,6-
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dichlorobenzene (2,6-diCl-PPD) (figure 5.3h) were purple-brown and orange-brown 
respectively, and each produced intense dots. 1,4-diamino-4,5-dichlorobenzene 
(4,5-diCl-OPD) produced intense orange-brown dots (figure 5.3i). 
The brominated compounds were similarly varied, with both 4-Br-OPD (figure 
5.3j) and 1,2-diamino-3,5-dibromobenzene (3,5-diBr-OPD) (figure 5.3k) producing  
yellow-brown dots that were of moderate and low intensity respectively, whilst the 
dots of 4,5-diBr-OPD  were pale and purple-brown (figure 5.3l). 
Both iodinated compounds produced intense dots, those of 4-I-OPD  being 
deep purple-brown (figure 5.3m) whereas those of 4,5-diI-OPD  were a rather 
attractive dusky-pink (figure 5.3n). 
F6 produced intense yellow dots (figure 5.3o). DAB was included for 
comparison and produced brown dots (figure 5.3p). 
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Figure 5.3. Dot blots of polymerised halogenated compounds prepared by 
incubating PVDF with 2 l drops of doubling dilution of GAM IgPC, from 
1/50,000 
to 1/1,600,000, in 0.5 mg/ml solutions of TriFMe-OPD (a) 4-F-OPD (b), 3,5-diF-
OPD (c), 4,5-diF-OPD (d), 4-Cl-OPD (e), 4-F-5-Cl-OPD (f) 2,5-diCl-PPD (g), 3,5-
diCl-PPD (h), 4,5-diCl-OPD (i), 4-Br-OPD (j), 3,5-diBr-OPD (k) 4,5-diBr-OPD (l), 
4-I-OPD (m), 4,5-diI-OPD (n), F6 (o) and DAB (p). 
f e 
d c 
b a 
l k 
j i 
h g 
p o 
n m 
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5.4.1.3 Analytical Scanning Electron Microscopy 
Even with a high probe current, a long acquisition and long processing time, it 
was not possible to resolve any polymer nitrogen peak, since it formed part of a 
broad shoulder of the oxygen signal from the RC membrane. All spectra contained 
detectable amounts of sulfur, typically 0.1 weight %, 0.35 atomic %, presumably 
due to residual DMSO solvent.  
Of the 5 fluorinated compounds examined, only one, F6, produced a dot blot 
that contained detectable amounts of fluorine. With the exception of 4-F-5-Cl-OPD, 
all polymerised chlorinated compounds had measurable levels of chlorine, mostly 
below 0.25 atomic%. The dot blot of polymerised 4,5-diCl-OPD  could just be seen 
by BSI and had the highest detected concentration of chlorine (figure 5.4a and b). 
Polymerised 4-Br-OPD could not be discerned by BSI and only had low amounts of 
detectable bromine (figure 5.4c and d). In contrast, 4,5-Br-OPD produced a dot blot 
that was both bright by BSI and contained the second highest concentration of 
halogen of all the compounds tested (figure 5.4e and f). Bromine could not be 
detected in dot blots produced from either 3,5-diBr-OPD nor 2,5-diBr-PPD.  
Both polymerised iodinated compounds produced BSI-bright dot blots and both 
were detectable by EDX, although, unlike either their chlorinated or brominated 
analogues, they both contained comparable amounts of iodine (figure 5.4g to j). 
The results of X-ray microanalysis are summarised in table 5.1. 
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Figure 5.4. Representative back-scattered images and corresponding X-ray spectra 
of dot blots for halogenated aromatic compounds. 4,5-diCl-OPD (a and b), 4-Br-
OPD (c & d), 4,5-diBr-OPD (e & f), 4-I-OPD (g & h) and 4,5-diI-OPD (i & j). 
a b 
c d 
e f 
g h 
i j 
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Table 5.1 Results of X-ray analysis on halogenated aromatic diamine dot blots. 
Substrate Trivial Name
Weight % Atomic %
4-F-OPD N/D N/D
4,5-diF-OPD N/D N/D
3,5-diF-OPD N/D N/D
4-TriFMe-OPD N/D N/D
F6 6.44 5.5
4-F-5-Cl-OPD N/D N/D
4-Cl-OPD 0.29 0.13
4,5-diCl-OPD 2.29 1.05
2,5-diCl-OPD 0.41 0.19
2,6-diCl-OPD 0.55 0.25
4-Br-OPD 2.94 0.61
4,5-diBr-OPD 12.12 2.7
3,5-diBr-OPD N/D N/D
2,5-diBr-PPD N/D N/D
4-I-OPD 6.18 0.83
4,5-diI-OPD 7.24 0.98
X-ray Analysis
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5.4.2 Tissue Model System 
5.4.2.1 Light Microscopy 
All immunohistochemically deposited halogenated polymers were soluble in 
the dehydrating solvents used for conventional mounting of slides, and it was 
necessary to use an aqueous mountant instead. 
Intensity and colour of staining was broadly similar to what was seen in dot 
blots, but additional background staining of tissue sections was also noted in many 
cases. 
TriFMe-OPD produced localised yellow staining (figure 5.5a) whereas 4-F-
OPD produced deposits that were restricted to background tissue (figure 5.5b). The 
faint deposits seen in dot blots were mirrored in tissue section in the case of 3,5-diF-
OPD (figure 5.5c) as was the intense staining of 4,5-diF-OPD. In this latter case, a 
yellow background staining, similar to that seen with 4-F-OPD was also evident, 
and the colour of immunopositive deposits was of a red-brown colour (figure 5.5d). 
The chlorinated compounds produced deposits that were consistent in terms of 
colour and intensity to those seen in dot blots (figures 5.5e to i). In all cases, 
background staining was evident but generally light, with the exception of 4-Cl-
OPD where a yellow background, similar to that seen in some of the fluorinated 
compounds, was clearly present (figure 5.5e). 
The deposits produced from brominated compounds were somewhat different 
from those of their respective dot blots; those of 4-Br-OPD were orange-brown 
(figure 5.5j) and those of 4,5-diBr-OPD were intense and orange-red (figure 5.5k). 
Background staining in both cases was light to moderate respectively. 
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The iodinated compounds produced deposits that were qualitatively similar to 
those seen in dot blots, with those of 4-I-OPD being purple-brown (figure 5.5l), and 
those of 4,5-diI-OPD being dusky pink, although intensity was lower (figure 5.5m). 
F6 produced a localised pale yellow deposit similar to that seen in dot blots 
(figure 5.5n). Again, DAB was included for comparison (figure 5.5o). 
To conserve polymerised halogenated compounds for subsequent 
characterisation, it became common practice to add surplus peroxidase conjugate to 
the monomer solutions and extract the polymers with ethyl acetate or chloroform. 
When this was performed on F6, the extracted polymer appeared fluorescent under 
daylight conditions. Subsequent immunohistochemical staining of a spare section 
of rat colon with MAH SMA revealed a yellow/orange fluorescence of the marker 
against the background green autofluorescence of the tissue when irradiated with 
blue light (figure 5.5p). 
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Figure 5.5. 4 m thick sections of paraffin wax-embedded pancreas. Blood vessel 
immunohistochemically stained for smooth muscle actin.  
TriFMe-OPD (a) and 4-F-OPD (b). 
a 
b 
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Figure 5.5 (continued). 4 m thick sections of paraffin wax-embedded pancreas. 
Blood vessel immunohistochemically stained for smooth muscle actin.  
3,5-diF-OPD (c) and 4,5-diF-OPD (d). 
c 
d 
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Figure 5.5 (continued). 4 m thick sections of paraffin wax-embedded pancreas. 
Blood vessel immunohistochemically stained for smooth muscle actin.  
4-Cl-OPD (e) and 4-F-5Cl-OPD (f). 
e 
f 
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Figure 5.5 (continued). 4 m thick sections of paraffin wax-embedded pancreas. 
Blood vessel immunohistochemically stained for smooth muscle actin.  
2,5-diCl-PPD (g) and 2,6-diCl-PPD (h). 
g 
h 
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Figure 5.5 (continued). 4 m thick sections of paraffin wax-embedded pancreas. 
Blood vessel immunohistochemically stained for smooth muscle actin.  
4,5-diCl-OPD (i) and 4-Br-OPD (j). 
i 
j 
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Figure 5.5 (continued). 4 m thick sections of paraffin wax-embedded pancreas. 
Blood vessel immunohistochemically stained for SMA.  
4,5-diBr-OPD (k) and 4-I-OPD (l). 
k 
l 
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Figure 5.5 (continued). 4 m thick sections of paraffin wax-embedded pancreas. 
Blood vessel immunohistochemically stained for SMA.  
4,5-diI-OPD (m) and F6 (n). 
 
m 
n 
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Figure 5.5 (continued). 4 m thick section of paraffin wax-embedded pancreas. 
Blood vessel immunohistochemically stained for SMA. DAB (o) and F6 
fluorescence in 4 m thick section of paraffin wax-embedded colon. Blood vessel 
immunohistochemically stained for SMA (p). 
o 
p 
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5.4.2.2 Analytical Scanning Electron Microscopy 
 Preliminary elemental mapping of pancreatic blood vessels on Thermanox 
cover slips took 595 seconds. Total beam dwell-time on the samples was 295 
seconds, but acquisition time was considerably extended due to the long signal 
processing time. 
In agreement with the result from the dot blot model system, F6 did not 
generate any observable back-scattered signal but, in contrast to the high 
concentration of fluorine that was detected in the dot blot, F6 in 
immunohistochemically stained blood vessel (figure 5.6a) produced only a poor 
signal in the tissue model, which could only just be discerned against the relatively 
high background noise (figure 5.6b). 
Of the four chlorinated compounds that produced detectable levels of chlorine 
in the dot blot model, three (4-Cl-OPD, 2,5-diCl-PPD and 2,6-diCl-PPD) could not 
be detected by BSI and were either undetectable (4-Cl-OPD (figures 5.6c and d)), or 
only just demonstrable by elemental mapping (figures 5.6e to h respectively). In 
contrast, the blood vessel that was developed with 4,5-diCl-OPD (figure 5.6i) could 
just be seen by BSI (figure 5.6j) and was clearly detectable by elemental mapping 
(5.6k). Furthermore, the polymer was still detectable when the number of 
accumulated frames was reduced to 1 (figure 5.6l), when the pixel dwell-time was 
reduced to 100 ms with 5 accumulated frames (figure 5.6m) and just detectable with 
1 frame (figure 5.6n). 
Both 4-Br-OPD and 4,5-diBr-OPD produced polymers that could be clearly 
seen by BSI and elemental mapping. In the case of 4-Br-OPD, 
immunohistochemical staining could be seen as bright areas in the secondary 
electron (SE) image (figure 5.7a). The back-scattered electron (BSI) signal (figure 
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5.7b) was much more easily seen than was the case for the dot blot but the X-ray 
signal, like that of the dot blot, was not particularly strong (figure 5.7c), but 
improved when the signal was accumulated over 10 frames (figure 5.7d), although 
this extended total acquisition time to 1187 seconds. The SE image of 4,5-diBr-
OPD did not display the same bright specific staining that was seen with its 
monohalogenated analogue (figure 5.7e) even though the BSE signal, like that seen 
with the dot blots, was dramatically brighter (figure 5.7f). Similarly, the X-ray 
signal was strong and the corresponding map showed clear localisation of stain 
with little background noise (figure 5.6g) and could still be detected when the frame 
number was reduced to 1, or pixel dwell-time reduced to 100 s with accumulation 
over 5 frames (figure 5.6h), but not 1 frame. 
In contrast to the brominated compounds, the iodinated analogues, while 
producing bright BSIs, gave rather poor X-ray signals. 4-iodo-OPD could not be 
seen in the SE image (figure 5.6i) but produced very good contrast in the BSI (figure 
5.6j). The X-ray signal strength, like that of its brominated analogue, was not very 
strong (figure 5.6k) but was, again, improved by extending the number of 
accumulated frames to 10 (5.6l). Similar results were seen with 4,5-diI-OPD, where 
no staining could be seen in the SE image (figure 5.6m), but the BSI had higher 
contrast (figure 5.6n) and a stronger X-ray signal was produced (figure 5.6o) that 
improved slightly when frame accumulation was increased to 10 (figure 5.6p). In 
both cases, background noise was problematic. 
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Figure 5.6. Secondary electron (a) and corresponding elemental map (b) of 4 m 
thick section of paraffin wax-embedded pancreatic blood vessels 
immunohistochemically stained for SMA and developed with F6. 
a 
b 
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Figure 5.6 (continued). Secondary electron image (c) and corresponding elemental 
map (d) of 4 m thick section of paraffin wax-embedded pancreatic blood vessels 
immunohistochemically stained for SMA and developed with 4-Cl-OPD. 
c 
d 
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Figure 5.6 (continued). Secondary electron image (e) and corresponding elemental 
map (f) of 4 m thick section of paraffin wax-embedded pancreatic blood vessels 
immunohistochemically stained for SMA and developed with 2,5-diCl-OPD. 
e 
f 
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Figure 5.6 (continued). Secondary electron image (g) and corresponding elemental 
map (h) of 4 m thick section of paraffin wax-embedded pancreatic blood vessels 
immunohistochemically stained for SMA and developed with 2,6-diCl-OPD. 
g 
h 
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Figure 5.6 (continued). Secondary electron (i) and back-scattered electron (j) images 
of 4 m thick section of paraffin wax-embedded pancreatic blood vessels 
immunohistochemically stained for SMA and developed with 4,5-dichloro-OPD. 
i 
j 
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Figure 5.6 (continued). Elemental maps of 4 m thick section of paraffin wax-
embedded pancreatic blood vessels immunohistochemically stained for SMA and 
developed with 4,5-dichloro-OPD. Pixel dwell-times of 1200 s and either 5 frames 
(k) or 1 frame (l). 
k 
l 
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Figure 5.6 (continued). Elemental maps of 4 m thick section of paraffin wax-
embedded pancreatic blood vessels immunohistochemically stained for SMA and 
developed with 4,5-dichloro-OPD. Pixel dwell-time of 100 s and either 5 frames 
(m) or 1 frame (n). 
m 
n 
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Figure 5.7. Secondary electron (a) and back-scattered electron (b) images of 4 m 
thick section of paraffin wax-embedded pancreatic blood vessels 
immunohistochemically stained for SMA and developed with 4-Br-OPD. 
a 
b 
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Figure 5.7 (continued). 4 m thick section of paraffin wax-embedded pancreatic 
blood vessels immunohistochemically stained for SMA and developed with 4-Br-
OPD. Elemental maps with accumulation over either 5 (c) or 10 frames (d). 
c 
d 
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Figure 5.7 (continued). Secondary electron (e) and back-scattered electron (f) 
images of 4 m thick section of paraffin wax-embedded pancreatic blood vessels 
immunohistochemically stained for SMA and developed with 4,5-diBr-OPD.  
e 
f 
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Figure 5.7 (continued). 4 m thick section of paraffin wax-embedded pancreatic 
blood vessels immunohistochemically stained for SMA and developed with 4,5-
diBr-OPD. Elemental maps accumulated over 5 frames with pixel dwell-times of 
either 1200 s (g) or 100 s (h). 
g 
h 
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Figure 5.7 (continued). Secondary electron (i) and back-scattered electron (j) images 
of 4 m thick section of paraffin wax-embedded pancreatic blood vessels 
immunohistochemically stained for SMA and developed with 4-I-OPD. 
i 
j 
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Figure 5.7 (continued). 4 m thick section of paraffin wax-embedded pancreatic 
blood vessels immunohistochemically stained for SMA and developed with 4-I-
OPD. Elemental maps accumulated over 5 (k) or 10 (l) frames. 
k 
l 
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Figure 5.7 (continued). Secondary electron (m) and back-scattered electron (n) 
images of 4 m thick section of paraffin wax-embedded pancreatic blood vessels 
immunohistochemically stained for SMA and developed with 4,5-diI-OPD. 
 
m 
n 
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Figure 5.7 (continued). 4 m thick section of paraffin wax-embedded pancreatic 
blood vessels immunohistochemically stained for SMA and developed with 4,5-diI-
OPD. Elemental maps accumulated over 5 (o) or 10 (p) frames. 
  
o 
p 
325 
 
5.4.2.3 Transmission Electron Microscopy 
Preliminary examination of 4,5-diCl-OPD in the TEM on similarly stained LR 
White-embedded normal human peritoneal blood vessels revealed the resulting 
marker to be fibrillary in appearance. Where individual fibres could be clearly seen, 
e.g. in sparsely staining areas such as red blood cells, they were at least 2 m in 
length (figure 5.7a and b). When staining was repeated on pancreatic exocrine 
granules, using 4,5-diCl-OPD from a different supplier (Sigma), the morphology of 
the deposit was dramatically different, being more granular in appearance. In 
addition, numerous, randomly distributed pleomorphic deposits were also seen 
(figures 5.7c and d). No electron diffraction pattern was seen, suggesting that these 
deposits were not crystalline in nature. 
4-Br-OPD produced a well localised finely granular deposit (figure 5.7e), but 
inherent electron opacity was revealed to be low in the absence of automatic 
gamma correction (figure 5.7f). In contrast, 4,5-diBr-OPD produced only a 
moderately well localised deposit (figure 5.7g), the appearance of which can 
reasonably be described as bizarre (figure 5.7h). 
Staining with 4-I-OPD was localised, in that it occurred largely over the 
exocrine granule-rich areas of the cells (figure 5.7i), but deposits were large (400 – 
600 nm diameter) and tended to coalesce. In addition, the high inherent electron 
opacity of these large granules obscured underlying structure (figure 5.7j). The 
appearance of 4,5-diI-OPD was close to that of an ideal marker in that it was finely 
granular, remained localised to the sites of immunopositivity, and was inherently 
electron opaque (figures 5.7k and l). Occasionally, pleomorphic deposits, similar to 
those seen with 4,5-diCl-OPD, were observed (figures 5.7m and n). Again, no 
electron diffraction pattern was noted, indicating a non-crystalline nature. 
326 
 
 
 
Figure 5.8. 80 nm thick section of LR White-embedded peritoneum. Blood vessel 
immunohistochemically stained for SMA. Polymerised 4,5-diCl-OPD, supplied by 
Acros, in preliminary studies (a and b). 
a 
b 
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Figure 5.8 (continued). 80 nm thick sections of LR White-embedded rat pancreas. 
Exocrine granules immunohistochemically stained for -amylase. Polymerised 4,5-
diCl-OPD, supplied by Sigma (c and d). 
c 
d 
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Figure 5.8 (continued). 80 nm thick sections of LR White-embedded rat pancreas. 
Exocrine granules immunohistochemically stained for -amylase. Polymerised 4-
Br-OPD with automatic gamma-correction (e) and without (f). 
e 
f 
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Figure 5.8 (continued). 80 nm thick sections of LR White-embedded rat pancreas. 
Exocrine granules immunohistochemically stained for -amylase. Polymerised 4,5-
diBr-OPD at low (g) and high power (h), both without gamma correction. 
g 
h 
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Figure 5.8 (continued). 80 nm thick sections of LR White-embedded rat pancreas. 
Exocrine granules immunohistochemically stained for -amylase. Polymerised 4-I-
OPD at low (i) and high power (j), both without gamma correction, showing 
inherent electron opacity. 
i 
j 
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Figure 5.8 (continued). 80 nm thick sections of LR White-embedded rat pancreas. 
Exocrine granules immunohistochemically stained for -amylase. Polymerised 4,5-
diI-OPD at low (k) and high power (l), both without gamma correction, showing 
inherent electron opacity. 
k 
l 
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Figure 5.8 (continued). 80 nm thick sections of LR White-embedded rat pancreas. 
Exocrine granules immunohistochemically stained for -amylase. Polymerised 4,5-
diI-OPD showing occasional background deposits at low power (m) and high 
power (n), both images without automatic gamma correction. 
 
m 
n 
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5.4.2.4 Analytical Transmission Electron Microscopy 
Of the 5 halogenated compounds that were examined by TEM, only two 
appeared suitable as potential markers for AEMT, namely 4-Br-OPD and 4,5-diI-
OPD (4,5-diCl-OPD was excluded until the reason for the variable morphology of 
deposits produced by different sources of the monomer was understood).  
When TEM spot size was 600 nm, 4-Br-OPD was easily detected in 5 seconds 
(figure 5.8a) and when spot size was reduced to 40 nm, it could just be detected 
within 2 seconds (figure5.8b) 
Iodine in deposits of 4,5-diI-OPD could be detected within just 1 second, with a 
600 nm spot size (figure 5.8c). When spot size was reduced to 40 nm, I could just be 
detected within 1 second (figure 5.8d). 
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Figure 5.8. X-ray spectra of polymerised halogenated compounds on 80 nm thick 
sections of LR-White-embedded rat pancreas. Exocrine granules 
immunohistochemically stained for -amylase. Polymerised 4-Br-OPD signal from 
600 nm spot with 5 seconds acquisition (a), and 40 nm spot with 2 seconds 
acquisition (b). 
a 
b 
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Figure 5.8 (continued). X-ray spectra of polymerised halogenated compounds on 80 
nm thick sections of LR-White-embedded rat pancreas. Exocrine granules 
immunohistochemically stained for -amylase. Polymerised 4,5-diI-OPD signal 
from 600 nm spot with 1 second acquisition (c), and 40 nm spot with 1 seconds 
acquisition (d).  
c 
d 
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5.5 Discussion 
Synthesis of halogenated compounds presented few problems, and where these 
occurred, they were mainly centred on the instability of iodinated products, 
particularly 4-I-OPD, which appeared to be particularly air/light sensitive. Other 
problems were associated with low overall yield, and these could usually be traced 
to poor extraction of N-acetylated derivatives, the low solubility of which were not 
fully appreciated at the time. 
Purity of product, rather than maximisation of yield, was considered of greater 
importance and the inclusion of additional re-crystallisation steps at each stage of 
the syntheses lowered overall yield to values below those published elsewhere e.g.  
the yields of 4-Br-OPD and 4,5-diBr-OPD were 17% compared with 94% 
(uncharacterised) (Rangarajan et al., 2000) and 63% (Moje, 1964) respectively. 4,5-
diI-OPD was, however, recovered in better yield (26.8% cf. 20.78%) than those of 
Youngblood (2006). 
Attempts to prepare 2,2′ diiodo derivatives of 4,4′-dinitrobiphenyl by direct 
iodination were unsuccessful, even though preliminary results using toluene 
surrogates gave encouraging results, and steric hindrance from the  bulky phenyl 
ring was the most  likely explanation. Unfortunately, time did not allow for 
completion of the synthesis of the 2,2′ dibromo analogue, since this might have 
provided not only another compound for examination, but also an alternative route 
to the synthesis of the diiodo compound via halogen exchange. Both compounds 
might be expected to have properties similar to those of DAB and thus form more 
insoluble and localised derivatives. 
That all halogenated compounds produced visible deposits in preliminary dot 
blot and light microscopical immunohistochemistry experiments was particularly 
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encouraging, since 1,2-diaminobenzene (OPD) does not; it is for this reason that it 
is widely used as a colorimetric reagent in enzyme immunoassay (Wolters et al., 
1976). Their solubility in organic solvents was disappointing, however, since this 
limits their applicability. There was a general trend in the colour of the final 
polymerised deposits, from yellow-brown, in the case of the fluorinated 
compounds, through orange-brown and red-brown for the chlorinated compounds, 
to red-brown for the brominated analogues and finally purple-brown and red-purple 
(dusky pink) in the case of the iodinated compounds. 
Analytical SEM produced some surprising results, particularly for the 
fluorinated products; no fluorine could be detected in any, with the exception of F6, 
which produced a particularly strong signal. The chlorinated compounds could be 
demonstrated in varying amounts which showed little relationship to the intensity 
of the dot blots that they produced. Similarly, 4-Br-OPD, which produced 
moderately intense dots, had considerably lower amounts of detectable bromine 
that that of 4,5-diBr-OPD, which only produced pale dots.  Both iodinated 
compounds produced intense dots and strong X-ray signals for iodine. X-ray signal 
strength appeared roughly equivalent to BSI signal, as might be expected. 
Light microscopy produced generally similar results to those seen on dot blots, 
with a few notable exceptions and this probably reflects the difference in the nature 
of the material to which the polymerised products adhered, as well as some 
influence from the aqueous mountant. In some cases, unexpected background 
staining was present, which may have reflected problems of substrate solubility as 
well as additional and unexpected catalytic affects of tissue components on some, 
but not all of the halogenated compounds. The discovery of fluorescence associated 
with polymerised F6 was surprising, but attempts to determine whether this was 
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related to the presence of the two trifluoromethyl residues or the methylene bridge 
separating the two phenyl rings, by synthesising the non-halogenated analogue were 
unsuccessful. 
 Analytical SEM provided a useful and rapid tool for evaluating 
immunohistochemically deposited products, since shorter pixel-dwell times could 
be achieved than in the TEM. In addition, several samples could be inserted into 
the instrument at one time and rapidly examined. 4,5-diCl-OPD, both brominated 
and both iodinated compounds produced striking results, with bright BSI images 
and strong X-ray signals which could all be detected in short time frames. 
It is the TEM, however, that is the final arbiter for evaluating the utility of the 
halogenated substrates, and of the 5 compounds that were selected for examination, 
only 2 approached the requirements for use in AEMT, namely 4-Br-OPD and 4,5-
diI-OPD. The software used for the analytical instrumentation on the TEM did not 
allow acquisition times shorter than 1 second, but the spectra suggested that 4,5-diI-
OPD might be detectable in sub-second acquisitions. 
 
5.6 Summary and conclusions 
The successive application of progressively more stringent technologies 
facilitated the rapid selection of promising compounds whilst, at the same time, 
excluding those that performed poorly. 
Of the 16 halogenated compounds that were tested, only 1 compound, 4,5-diI-
OPD, approached the requirements for AEMT, namely good localisation of 
immunohistochemically deposited product, inherent electron  opacity, and a 
sufficiently high concentration of specific element to permit sub-second detection of 
X-ray signal. 
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Chapter 6 
Electron Microscopical Visualisation of 
Fluorochromes 
 
344 
 
6.1 Introduction 
Previous chapters have focussed on the immunohistochemical aspects of 
marker chemistry, but DAB can also be polymerised by the action of excited 
fluorochromes in a process called photooxidation (Maranto, 1982) or 
photoconversion (Sandell and Masland, 1988). This has facilitated fluorescent 
markers, used at the light microscopic level, to be visualised in the TEM, a 
technique that has recently come to be known as correlative light and electron 
microscopy (CLEM). Correlating fluorescence microscopy with TEM examination 
is not, of course, new; in the late 1970s, the cytoskeletons of single cells were 
visualised for light microscopy by immunofluorescence labelling and subsequently 
identified in the TEM, albeit by morphological criteria (Osborn et al., 1978). For 
the majority of CLEM studies, however, unequivocal localisation in the EM can 
only be achieved by rendering the fluorochrome electron opaque. 
Early studies examined injected fluorescent dyes (Maranto, 1982), but later 
techniques employed fluorescent antibody and streptavidin conjugates for electron 
microscopical localisation by immunohistochemical and in-situ hybridisation 
methods (Deerinck et al., 1994). A refinement of this technique coupled both 
fluorochromes and gold particles to the same antibody (Powell et al., 1997). 
For live cell studies, immunocytochemical techniques are impractical. 
Commonly available antibodies are bivalent, leading to concerns about the 
perturbing effects of cross-linking their respective antigens, and are difficult to 
introduce into cells. It is more usual to employ molecular biological techniques to 
generate cellular proteins with either a fluorescent tag, i.e. a fluorescent protein, or 
a shorter peptide sequence that acts as a coordination host for metal-fluorochrome 
complexes. 
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Since the introduction of fluorescent proteins, initially as markers of gene 
expression (Chalfie et al., 1994) and subsequently as cytochemical markers 
(Kaether and Gerdes, 1995; Marshall et al., 1995; Rizzuto et al., 1995) in the mid 
1990s, attempts to localise them at the ultrastructural level by photoconversion of 
DAB have proved difficult. It was eventually achieved and employed in electron 
tomography (Grabenbauer et al., 2005), but alternative systems, using metal-
fluorochrome complexes have been more successful. An arsenic-fluorescein 
complex, binding to tetracysteine motifs of proteins in transfected cells (Griffin et 
al., 1998), has been used in the photoconversion of DAB for electron microscopical 
localisation (Gaietta et al., 2002). Fluorochromes labelled with tris-nitrilotriacetic 
acid-Ni complexes have been successfully employed for localising proteins in cells 
(Lata et al., 2006) but do not appear to have been used to visualise proteins at the 
ultrastructural level. 
The observation that nanocrystalline semiconductor materials have narrow 
emission spectra (Hines and Guyot-Sionnest, 1996) and that this is size-dependent 
(Dabbousi et al., 1997) prompted the development of a novel class of fluorescent 
labels for light microscopic immunocytochemistry (Bruchez et al., 1998; Chan and 
Nie, 1998).  Their inherent electron opacity has made them compatible with 
subsequent electron microscopical localisation, either alone (Giepmans et al., 2005) 
or following silver enhancement (Dahan et al., 2003; Danscher and Stoltenberg, 
2006). Furthermore, differences in their size and morphology have permitted 
multiple labels to be identified in thin sections in the TEM (Giepmans et al., 2005). 
Problems associated with toxicity, conjugation, size and high cost have limited their 
broad applicability. In addition, broad and overlapping excitation spectra preclude 
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selective excitation and thus marker deposition and subsequent facile differentiation 
by analytical electron tomography. 
Multiple labelling by immunohistochemical techniques in an analytical 
tomographic setting can be achieved by utilising different enzyme conjugates to 
deposit different markers, or by sequential immunohistochemical staining with 
different markers using the same enzyme, where product inhibition occurs. 
Alternatively, selective marker deposition can be achieved by histochemical 
techniques. Since photoconversion of DAB has been successfully applied in a wide 
range of contexts, it is reasonable to suppose that similar compounds might be 
selectively polymerised by excitation of specific fluorochromes. The mechanism of 
photooxidation is unknown, but does not appear to require H2O2 in the reaction 
mixture. It may, however, utilise molecular oxygen as a radical source (Sandell and 
Masland, 1988). 
The immunohistochemical reduction and deposition of silver has been 
achieved by the action of horseradish peroxidase (Hainfeld et al., 2002) in 
conjunction with a proprietary physical developer (Professor Bharat Jasani, 
personal communication). This technique, coupled with the polymerisation of DAB 
by both enzymatic and photoconversion pathways, suggests the possibility of a 
common link between the two. This is further supported, albeit indirectly, by the 
observation that common reagents can suppress both the unwanted reduction of 
silver by tissue (type 1 argyrophilia (Gallyas, 1982)) (Gallyas and Wolff, 1986) and 
tissue autofluorescence (Kelly, 2010). Thus, the intriguing possibility exists of 
reducing silver from a physical developer by the photoconversion process, a 
technique predicted by the late Dr. Geoff Newman. 
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6.1.1 Model Systems 
Tissue culture chamber slides provide a convenient system for preliminary 
evaluation of the photoconversion process. They comprise a series of wells that are 
sealed to a glass microscope slide with a silicone gasket. Ordinarily, the plastic wells 
are removed for staining, the gasket forming a reservoir for staining solutions. Once 
stained, the gasket is removed and the cell culture preparation is mounted for 
microscopic examination. The gasket presents a shallow well of uniform depth and, 
once covered with a thin glass window such as a glass cover slip, allows solutions to 
be tested and examined under comparable conditions; the microscopical equivalent 
of the spectrophotometer cuvette. 
Fluorescein and tetramethylrhodamine are both xanthene dyes with 
absorption/emission maxima, in water, at 494 nm/521 nm and 557 nm/576 nm, 
respectively (figure 6.1). They have been used as fluorescent markers for many 
years and are both cheap and readily available. Furthermore, their structural 
similarity improves the comparability of results compared to chemically dissimilar 
fluorochromes. 
Immunofluorescent staining for SMA provides a simple tissue model system for 
the reasons mentioned in Chapter 4, namely ubiquity and abundance.  
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Figure 6.1. Structures and absorption/emission spectra of fluorescein and 
tetramethylrhodamine. 
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6.2 Materials 
Lab-Tek  Chamber slides  were supplied by Nalge Nunc International 
(Rochester, New York, U.S.A). Goat anti-mouse Ig fluorescein isothiocyanate 
(GAM IgFITC) and goat anti-mouse Ig tetramethylrhodamine isothiocyanate 
(GAM IgTRITC) conjugates were supplied by Autogen Bioclear (Calne, Wiltshire, 
U.K.). Fluorescein and tetramethylrhodamine were purchased from BDH 
(Lutterworth, Leicestershire, U.K.) and Sigma-Aldrich (Poole, Dorset, U.K.), 
respectively. Newman and Jasani’s developer was prepared according to sections 
2.2.3.2 of Chapter 2. 
 
6.3 Methods 
6.3.1 Model Systems 
6.3.1.1 Homogeneous Model System  
The plastic wells from Lab-Tek  Chamber slide  were removed to leave the 
silicone gasket. 
Fluorescein or tetramethylrhodamine was added to DAB-Tris and Newman 
and Jasani’s developer to a final concentration of 0.005%. Chamber slide wells were 
filled with test solutions and covered with a piece of glass coverslip (cut to size by 
scoring with a diamond pen and gently applying pressure) before being irradiated 
with either green (520-550 nm) or blue (460-490 nm) light, for 
tetramethylrhodamine or fluorescein excitation respectively, from a 100W mercury 
lamp through the x2 (0.05 N.A.) objective lens of an Olympus BX51 light 
microscope (Olympus Optical Co. (U.K.) Ltd, London, U.K.). 
Progress was monitored at 5 minute intervals, up to 30 minutes, by capturing 
digital images through a x10 (0.3 N.A.) objective lens, under ordinary bright field 
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conditions, with an Zeiss Axiocam digital camera and Axiovision software (Carl 
Zeiss Vision GmbH, Hallbergmoos, Germany) without white background colour 
correction, so that images could be easily seen when printed. Control solutions of 
DAB and developer, with or without fluorochromes were kept in the dark for 30 
minutes for comparison with green and blue light-exposed solutions. 
 
6.3.1.2 Tissue Model System 
4 m thick sections of archival, paraffin wax-embedded, normal human 
kidney (collected prior to the introduction of the Human Tissue Act, 2004), were 
immunohistochemically stained for smooth muscle actin as previously described, 
but with the primary antibody applied at 
1/50 to achieve clear positivity, and 
visualised with either GAM IgFITC or GAM IgTRITC conjugates. Sections were 
irradiated with green and blue light, respectively, in the presence of DAB-PO4 or 
Newman and Jasani’s developer. 
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6.4 Results 
6.4.1 Homogeneous Model System 
6.4.1.1 DAB 
6.4.1.1.1 Fluorescein 
Exposure of the DAB solution to blue light for up to 30 minutes did not cause 
the formation of any observable polymer (figures 6.1a and b). The presence of 
0.005% fluorescein imparted a slight yellow/green tint to the DAB solution (figure 
6.1c). Exposure of this solution to blue light (460–490 nm) caused the formation of 
polyDAB, that could just be discerned as a darkening of the solution by 5 minutes 
(figure 6.1d) and clearly seen by 10 minutes (figure 6.1e). After this time, the 
solution became progressively darker and the size and number of particles increased 
(figures 6.1f – h). 
 
6.4.1.1.2 Tetramethylrhodamine 
Exposure of DAB solution to green light for up to 30 minutes did not cause the 
formation of any observable polymer (figures 6.2a and b). The presence of 0.005% 
tetramethylrhodamine imparted a slight pink tint to the DAB solution (figure 6.2c). 
Exposure of this solution to green light (520–550 nm) for up to 30 minutes failed to 
produce any discernable deposit (figure 6.2d). 
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Figure 6.1. Effects of exposure to blue light on solutions of DAB. DAB alone at 0 
(a) and 30 minutes (b). 
a 
b 
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Figure 6.1 (continued). Effects of exposure to blue light on solutions of DAB.  
DAB + 0.005% fluorescein at 0 (c) and 5 minutes (d). 
c 
d 
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Figure 6.1 (continued). Effects of exposure to blue light on solutions of DAB.  
DAB + 0.005% fluorescein at 10 (e) and 15 minutes (f). 
e 
f 
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Figure 6.1 (continued). Effects of exposure to blue light on solutions of DAB.  
DAB + 0.005% fluorescein at 20 (c) and 30 minutes (d). 
g 
h 
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Figure 6.2. Effects of exposure to green light on solutions of DAB. DAB alone at 0 
(a) and 30 minutes (b). 
a 
b 
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Figure 6.2 (continued). Effects of exposure to green light on solutions of DAB. 
DAB + 0.005% tetramethylrhodamine for 0 (c), and 30 minutes (d). 
c 
d 
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6.4.1.2 Newman and Jasani’s Physical Developer 
6.4.1.2.1 Fluorescein 
Exposure of Newman and Jasani’s physical developer to blue light caused a 
slight but noticeable darkening of the solution by 5 minutes (figures 6.3a and b). 
The solution became progressively darker with time until, by 20 minutes, the 
solution had taken on a grey appearance (figure 6.3c). Individual silver grains 
became apparent by 25 minutes and were clearly visible and numerous by 30 
minutes (figure 6.3d). In the case of solutions containing fluorescein, a similar tint 
to that seen with DAB was present (figure 6.3e). Exposure to blue light (460–490 
nm) caused a darkening of the solution within 5 minutes (figure 6.3f). The solution 
progressively darkened with increasing exposure time, as silver grains became larger 
and more numerous (figures 6.3g and h). 
 
6.4.1.2.2 Tetramethylrhodamine 
The developer solution appeared slightly brighter than that containing DAB in 
the previous sections due to the higher refractive index of the former (figure 6.4a). 
Exposure of Newman and Jasani’s physical developer to green light (520-550 nm) 
for 30 minutes did not cause any noticeable darkening of the solution (figures 6.4b). 
The presence of tetramethylrhodamine in the developer solution imparted a slight 
reddish tint (figure 6.4c) Illumination of the solution resulted in the appearance of 
silver grains by 10 minutes (figure 6.4d) that became progressively more abundant 
and larger with time (figures 6.4e – h). 
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Figure 6.3. Effects of exposure to blue light on Newman & Jasani’s developer. 
Developer alone at 0 (a) and 5 minutes (b). 
a 
b 
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Figure 6.3 (continued). Effects of exposure to blue light on Newman & Jasani’s 
developer. Developer at 20 (c) and 30minutes (d). 
c 
d 
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Figure 6.3 (continued). Effects of exposure to blue light on Newman & Jasani’s 
developer. Developer + 0.005% fluorescein at 0 (e) and 5 minutes (f). 
e 
f 
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Figure 6.3 (continued). Effects of exposure to blue light on Newman & Jasani’s 
developer. Developer + 0.005% fluorescein at 20 (g) and 30 minutes (h). 
 
g 
h 
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Figure 6.4. Effects of exposure to green light on Newman & Jasani’s developer. 
Developer at 0 (a) and 30 minutes (b). 
a 
b 
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Figure 6.4 (continued). Effects of exposure to green light on Newman & Jasani’s 
developer. Developer + 0.005% tetramethylrhodamine at 0 (c) and 10 minutes (d). 
 
c 
d 
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Figure 6.4 (continued). Effects of exposure to green light on Newman & Jasani’s 
developer. Developer + 0.005% tetramethylrhodamine at 15 (e) and 20 minutes (f). 
 
e 
f 
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Figure 6.4 (continued). Effects of exposure to green light on Newman & Jasani’s 
developer. Developer + 0.005% tetramethylrhodamine at 25 (g) and 30 minutes (h). 
  
g 
h 
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6.4.1.3 Control Solutions 
Solutions of either DAB or developer, with or without fluorochromes, which 
were kept in the dark for 30 minutes were identical in appearance to corresponding 
solutions at the beginning of light-exposure experiments. 
 
6.4.2 Tissue Model System 
6.4.2.1 DAB 
6.4.2.1.1 Fluorescein 
Immunofluorescence staining of kidney blood vessels was clear and localised, 
although background autofluorescence was evident (figure 6.5a). Compared to 
tissue at the beginning of the experiment (figure 6.5b), irradiation of the section 
with blue light (460–490 nm) for up to 30 minutes resulted in visible deposits of 
polyDAB in the background tissue and barely noticeable deposition of polyDAB in 
the immunopositive areas (figure 6.5c).   
 
6.4.2.1.2 Tetramethylrhodamine 
In the case of tissue sections that had been immunofluorescently stained using 
the tetramethylrhodamine conjugate, immunopositivity was clearly visible and 
background autofluorescence was present (figure 6.6a). No deposition of polyDAB 
in any part of the section was visible after irradiation with green light (520-550 nm) 
for 30 minutes (figures 6.6b and c). 
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Figure 6.5. Effects of blue light on the deposition of polyDAB on 4 m thick 
sections of paraffin wax-embedded kidney immunofluorescently stained for SMA. 
Fluorescence micrograph of fluorescein-labelled blood vessels (a) and bright field 
images, in the presence of DAB solution at t = 0 (b). 
a 
b 
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Figure 6.5 (continued). Effects of blue light on the deposition of polyDAB on 4 m 
thick sections of paraffin wax-embedded kidney immunofluorescently stained for 
SMA. Bright field images, in the presence of DAB solution after 30 minutes 
irradiation with blue light (c).  
  
c 
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Figure 6.6. Effects of green light on the deposition of polyDAB on 4 m thick 
sections of paraffin wax-embedded kidney immunofluorescently stained for SMA. 
Fluorescence micrograph of tetramethylrhodamine-labelled blood vessels (a) and 
bright field images, in the presence of DAB solution at t = 0 (b). 
a 
b 
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Figure 6.6 (continued). Effects of green light on the deposition of polyDAB on 4 
m thick sections of paraffin wax-embedded kidney immunofluorescently stained 
for SMA. Bright field images, in the presence of DAB solution after 30 minutes 
irradiation with green light (c). 
 
 
c 
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6.4.2.2 Newman and Jasani’s Developer 
6.4.2.2.1 Fluorescein 
Immunofluorescence staining was clearly visible against a yellow-green tissue 
autofluorescence (figure 6.7a). Irradiation of the tissue section with blue light (460–
490 nm) in the presence of Newman & Jasani’s developer resulted in a progressive 
darkening of the tissue which was clearly evident by 10 minutes (figure 6.7b), and 
intense by 15 minutes (figure 6.7c). Specific deposition of silver at the 
immunopositive sites could be discerned, but background staining was strong. 
 
6.4.2.2.2 Tetramethylrhodamine 
Immunofluorescent staining of kidney blood vessels was clearly visible against 
the pale red autofluorescence of the tissue (figure 6.8a), and after just 5 minutes 
irradiation with green light (520-550 nm) in the presence of Newman & Jasani’s 
developer, clear and intense deposition of silver was evident at immunopositive 
sites. A light background deposit in the tissue was also evident (figure 6.8b). 
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Figure 6.7. Effects of blue light on the deposition of silver on 4 m thick sections of 
paraffin wax-embedded kidney immunofluorescently stained for SMA. 
Fluorescence micrograph of fluorescein-labelled blood vessels (a) and bright field 
images, in the presence of Newman and Jasani’s developer, at t = 0 (b). 
a 
b 
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Figure 6.7 (continued). Effects of blue light on the deposition of silver on 4 m 
thick sections of paraffin wax-embedded kidney immunofluorescently stained for 
SMA. Bright field images, in the presence of Newman and Jasani’s developer, after 
irradiation with blue light for 10 minutes (c) and 15 minutes (d). 
c 
d 
375 
 
 
 
Figure 6.8. Effects of green light on the deposition of silver on 4 m thick sections 
of paraffin wax-embedded kidney immunofluorescently stained for SMA. 
Fluorescence micrograph of tetramethylrhodamine-labelled blood vessels (a), and 
bright field images, in the presence of Newman and Jasani’s developer, after 
irradiation with green light for 5 minutes (b). 
a 
b 
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6.5 Discussion 
Photoconversion of DAB was clearly demonstrated in the homogeneous model 
system, when conducted in the presence of fluorescein and irradiation with blue 
light. In contrast, no photoconversion was seen when the same technique was 
applied to tetramethylrhodamine. In the tissue model system, only a very slight 
deposition of polyDAB was observed in the fluorescein-labelled tissue, together 
with a stronger background staining, whereas no deposition was seen at all in the 
tetramethylrhodamine-labelled preparation. This failure of DAB to undergo 
photoconversion in the tissue model system was disappointing, and postponed 
further exploration of this process with halogenated compounds until the cause had 
been elucidated. The solubility of the polymerised halogenated 1,2-diamines in 
organic solvents  would preclude their application in pre-embedding 
photoconversion techniques, but they should, in principle, work well in post-
embedding, i.e. on-section, techniques. 
Photoconversion of DAB by both fluorescein and tetramethylrhodamine, in a 
tissue model system, has been reported to occur on similar timescales (30 minutes) 
(Sandell and Masland, 1988). The reason for the discrepancy seen here might be 
due to the choice of buffer system; in the homogeneous model, and in Sandell and 
Masland’s study, DAB-Tris was used, whereas in the tissue model here, DAB-PO4 
was employed. This was not expected to have any major influence on the 
photoconversion process, but a recent report indicates that the two buffer systems 
can have different effects on fluorophore photochemistry, at high concentrations 
(>20 mM), PO4 engages in excited-state proton transfer that competes with 
radiative decay, whereas Tris does not (Peredes et al, 2011). 
377 
 
 In contrast to the poor results for DAB, the photoconversion of silver from 
Newman & Jasani’s developer was much more consistent. In the case of blue light 
irradiation, both control and experimental solutions began to darken within 5 
minutes. The number and size of silver grains increased progressively in both cases, 
but occurred more rapidly in the solution containing fluorescein. In the tissue 
model system, a similar result was seen, with silver being clearly deposited on the 
tissue section within 10 minutes. The specificity of the reaction was poor and 
background staining was clearly present, presumably due to both blue light-
catalysed reduction of silver and photoconversion due to tissue autofluorescence. In 
the homogeneous system, irradiation of the developer with green light caused no 
obvious reduction of silver in the control experiment, and required 10 minutes for 
visible darkening of the solution to occur when tetramethylrhodamine was present. 
There thus existed a short temporal window in which photoconversion of silver 
might be selectively achieved, and this was borne out in the tissue model system, 
where silver was deposited in large amounts at specific sites within just 5 minutes. 
Background staining was still problematic and may have reflected tissue 
autofluorescence-induced photoconversion. Better temporal control of silver 
deposition might be achieved by manipulating the composition of the developer, 
such as lowering the concentration of the reducing agent, pyrogallol. 
The specificity of any photoconversion process in tissue is restricted by 
autofluorescence, which is particularly problematic in aldehyde-fixed tissue. It has 
also been reported to occur in some embedding resins (Haraguchi and Yokota, 
2002; Singhrao et al., 2009,) and this might restrict the circumstances under which 
photoconversion can be performed i.e. prior to resin embedding. 
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The suppression of tissue autofluorescence has been achieved with a number of 
agents, such as sodium borohydride (Weber et al., 1978), Cu(II) (Schnell et al., 
1999) and Cu(II) + H2O2 (Kelly, 2010), and such techniques might have some 
utility here. Treatment of tissue sections with Cu(II) had been shown to catalyse the 
polymerisation of DAB when combined with H2O2 (Kelly, 2010), but whether the 
same occurs without H2O2 remains to be determined. That Cu(II) does not catalyse 
silver reduction, unless treated with sulfide, was described in Chapter 2. It is 
possible, then, that the specificity of the photoconversion process might be 
enhanced be a number of simple manoeuvres. 
The underlying mechanism of the photoconversion process by fluorochromes 
has not been described, and the results presented here suggest a paradox; on the one 
hand, polymerisation of aromatic diamines is generally believed to be an oxidative 
process (Li et al., 2002), but the deposition of metallic silver from the physical 
developer is clearly reductive. 
Photobleaching of fluorochromes, associated with the triplet state, can be 
suppressed by reducing agents such as p-phenylenediamine (Johnson and Nogueira-
Araujo, 1981) or thiols (Song et al, 1996) and this might provide an explanation for 
the polymerisation of DAB by the photoconversion process; reduction of the 
fluorophore is accompanied by the oxidation, and subsequent polymerisation, of 
DAB. 
The reduction of silver, in contrast, might be achieved by electron donation by 
fluorophores in the excited state by virtue of having a higher reduction potential 
than in the ground state i.e. an electron transfer process, possibly following co-
ordination of Ag(I) to the fluorophore or via the reducing agent, pyrogallol. 
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Whether DAB, or indeed any aromatic diamine, can be reductively 
polymerised remains to be determined, but the existence of the autometallographic 
technique, for depositing silver with HRP (Hainfeld et al., 2002) lends some support 
to this. 
The application of the photoconversion process has been circumvented, to a 
certain extent, by the introduction of quantum dots, which have been discriminated 
in the TEM based on morphological criteria (Giepmans et al., 2005). That quantum 
dots can be prepared with different elemental compositions, such as CdSe and 
CdTe, suggests that analytical approaches can be applied to facilitate their 
discrimination in a tomographic setting, but this does not appear to have been 
undertaken. 
 
6.6 Summary and Conclusions 
While the photoconversion of DAB was largely unsuccessful, the 
photoconversion of silver from a physical developer gave very encouraging results 
that deserve further exploration. Since the final deposit is pure metal, identification 
by analytical TEM should prove facile. Once the problem associated with DAB is 
resolved, multiple demonstration of fluorochromes by analytical TEM and, 
ultimately, AEMT may become a practical and affordable reality. 
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Chapter 7 
Polymer Characterisation 
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7.1 Introduction 
The complexity of the most powerful marker amplification techniques, as 
explored and developed in Chapters 2 and 3, preclude their use in high throughput 
automated laboratories and are unattractive even to workers in research 
laboratories.  
For the full potential of marker amplification to be realised, when combined 
with other amplification techniques, there is a need for considerable simplification. 
This can be aided by an understanding of the structure of polyDAB and the co-
ordination chemistry of its d-block metal complexes, which might provide useful 
insights into the rational design of novel catalytic markers. As noted in Chapter 1, 
however, current knowledge regarding the nature of polyDAB is confined to a 
single infra-red spectrum (Seligman et al. 1968). 
A number of complementary analytical techniques exist that might provide 
sufficient information, including mass spectrometry, gel permeation 
chromatography, various spectroscopic methods and quantitative elemental 
analysis. 
 
7.2 Materials 
Mesitylene, chlorobenzene, toluene, ethyl acetate, dichloromethane (DCM), 
acetonitrile, dimethylsulfoxide (DMSO), dimethylformamide (DMF), conc. HCl, 
H2SO4, tetrahydrofuran (THF), KOAc, Pd(OAc)2, α-cyano-4-hydroxycinnamic 
acid (CHCA), PEG 1000, 2000 and 3000, trifluoroacetic acid (TFA) and glacial 
acetic acid were supplied by Fisher Scientific (Loughborough, Leicestershire, U.K.). 
[
15
N] KNO3, CDCl3 and D6-DMSO were supplied by Goss Scientific (Nantwich, 
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Cheshire, U.K.). N,N'-biphenyl-4,4'-diyldiacetamide was purchased from Tokyo 
Chemical Industry UK Ltd (Oxford, Oxfordshire, U.K.). 
 
7.3 Methods 
7.3.1 Preparation of PolyDAB 
7.3.1.1 Determination of Optimum Conditions for DAB Polymerisation 
In initial experiments, to determine the optimum concentration of peroxidase 
needed to deposit polyDAB in an acceptable timeframe, 10 l 10-fold dilutions of 
GAM IgPC, from neat to 
1/10,000 in ddH2O, were added to 1 ml aliquots of DAB-
Tris + 15 l/ml 30% H2O2 and the time taken for the solution to darken and the 
appearance of a polymer precipitate noted. Scaling up the preparation to determine 
yield, 1.5 ml 30% H2O2 was added to 1 l of DAB-Tris followed by 10 ml 
1/100 
GAMIgPC. After 40 minutes, the preparation was filtered through Whatman No.1 
filter paper, the cake thoroughly washed with ddH2O and dried in an oven at 
150
o
C. 
 
7.3.1.2 Determination of the Solubility of PolyDAB 
The solubility of dry polyDAB was examined in the following solvents: 
mesitylene, chlorobenzene, toluene, ethyl acetate, acetonitrile, DMSO, DMF, 
THF, DCM, conc. HCl, conc. H2SO4 and glacial acetic acid. 
 
7.3.1.3 Polymerisation of DAB in DMSO 
Given the poor solubility of polyDAB in the various solvents tested above, an 
attempt was made to enzymatically polymerise polyDAB in DMSO. 5 mg DAB 
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was dissolved in 10 ml DMSO and 15 l 30% H2O2 added followed by 100 ml 
1/100 
GAM IgPC. 
 
7.3.1.4 Solubility of Wet PolyDAB in Polar Solvents 
In a preliminary experiment, the possibility of dissolving freshly prepared wet 
polyDAB in polar solvents was examined. PolyDAB from a 100 ml 0.05% solution 
was prepared as above and the precipitate recovered by initial centrifugation at 200 
g for 2 minutes. The pellet was washed 3 times by resuspension in ddH2O and 
centrifugation at 1000 g. The pellet was resuspended in 1 ml DMSO and 
ultrasonicated for 5 minutes in an ultrasonic bath followed by centrifugation at 
10,000 g for 10 minutes. 
PolyDAB was prepared from 1 l of DAB-Tris as above and resuspended in 10 
ml DMSO. 4 ml of the suspension was centrifuged at 10,000 g for 10 minutes and 2 
ml supernatant dried in a pre-weighed glass vial at 150
o
C. The experiment was 
repeated using DMF as solvent. For gel permeation chromatography, polymer 
solutions need to be dry. In a further experiment, standing a solution of wet 
polymer over pre-dried molecular sieve was explored. Solvent was evaporated from 
the supernatant as above. 
 
7.3.1.5 Solubility of Freeze-Dried polyDAB in Polar Solvents 
PolyDAB was prepared as above, resuspended by ultrasonication in ddH2O, 
and rapidly frozen in liquid nitrogen. The preparation was freeze-dried at -40oC and 
dissolved in DMSO, DMF and conc. H2SO4. Solubility was determined as above. 
In the case of conc. H2SO4, polyDAB was precipitated by addition of ddH2O.  
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7.3.2 Characterisation of polyDAB 
7.3.2.1  Infra-red Spectroscopy 
For infra-red spectroscopy, oven-dried polyDAB was prepared as KBr discs. 
 
7.3.2.2 MALDI-TOF 
A final concentration of 1 pM is recommended for analysis by MALDI-TOF 
but since the molecular weight of polyDAB is unknown, a preliminary assumption 
of 10 kD was chosen. A stock solution of approximately 10 mg/ml polyDAB in 
DMSO was diluted with 0.1% aqueous TFA to a 10-fold dilution series of 2 nM to 
200 fM. Each dilution was mixed 1:1 with 5 mg/ml α-cyano-4-hydroxycinnamic 
acid (CHCA) in 1:1 acetonitrile:methanol. 1 l of each solution was applied to a 
MALDI-TOF plate and allowed to air dry at RT. 
To compare polyDAB produced from solution with that deposited in situ, a 
MALDI-TOF plate was glow discharged for 30 seconds in a Balzers vacuum coater 
(Oerlikon Balzers Coating UK Ltd, Milton Keynes, U.K.) and 1 l droplets of 
GAM IgPC applied as 10-fold dilutions in ddH2O from neat to 
1/10,000,000. After 1 
minute, surplus solution was removed with a pipette, and 1 l drops of DAB-Tris 
applied for 3 minutes. The plate was thoroughly washed with de-ionised water and 
allowed to air dry. 1 l 1:1 with 5 mg/ml CHCA in 1:1 acetonitrile:methanol + 1 
pM each of PEG 1000, 2000 and 3000 was applied to each preparation and air 
dried. 
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7.3.2.3  Gel Permeation Chromatography 
For molecular weight characterisation, samples of polyDAB (both molecular 
sieve-dried and freeze-dried) were dissolved in DMSO and analysed by Dr. Steve 
Holden (Smithers RAPRA, Shrewsbury, Shropshire, U.K.) by gel permeation 
chromatography with pollulan polysaccharides as  molecular weight standards. 
 
7.3.2.4 
1
H, 
13
C and 
15
N NMR Spectroscopy 
PolyDAB was dissolved in D6-DMSO by ultrasonication for 15 minutes. 
Following centrifugation in a glass eppendorf vial (to avoid solution of 
polypropylene) at 10,000 g for 10 minutes, the supernatant was removed for 
subsequent analysis. 
 
7.3.3 Synthesis of 
15
N-labelled 3,3΄-4,4΄-tetraaminobiphenyl (DAB) 
The relatively high cost of N,N'-biphenyl-4,4'-diyldiacetamide prompted an 
attempt to prepare 4,4'-dinitrobiphenyl by biaryl coupling of 4-nitro-iodobenzene 
(Yu, Tang and Li 2009). 1 g (4.00 mmol) 4-nitro-iodobenzene was dissolved in 20 
ml acetone and 0.089 g (0.4 mmol) Pd(OAc)2 and 1.96 g (10.8 mmol) KOAc added. 
The mixture was refluxed under a nitrogen blanket at 100
o
C over night. The cooled 
mixture was extracted twice with diethyl ether, and the product recrystallised from 
chloroform/hexane. 
1
H NMR was not consistent with the expected product, which 
should have produced two doublets. Instead, an additional peak was seen, and 
interpretation was more consistent with 2,6-dinitrobiphenylene. 
1
H NMR (400 
MHz, CDCl3) 7.32 (d, 
3
JHH = 8.48, 2H; C4 and C8), 8.05 (dd, 
3
JHH = 8.48, 
4
JHH 
= 2.34, 2H; C3 and C7 ), 8.58 (d, 
4
JHH = 2.34, 2H; C1 and C5) ppm. 
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0.5 g (1.877 mmol) N,N'-biphenyl-4,4'-diyldiacetamide was dissolved in 10 ml 
conc. H2SO4, cooled on ice, and 0.38 g (3.77 mmol) 50% [
15
N] KNO3 added with 
stirring for 2 hours. Work-up was performed as previously described. 0.5 g (1.877 
mmol) N,N'-biphenyl-4,4'-diyldiacetamide yielded 0.438 g (1.22 mmol) N,N'-(3,3'-
dinitrobiphenyl-4,4'-diyl)diacetamide (64.99%). 1H NMR (400 MHz, CDCl3) 2.18 
(s, 6H; acetyl), 2.28 (s, 6H; acetyl), 7.58 (d, 
3
JHH = 8.48, 2H), 7.70 (dd, 
3
JHH = 8.77, 
4
JHH = 2.05, 2H), 7.93 (td, 
3
JHH = 8.48, 
4
JHH = 2.05, 
5
JHH = 1.46, 2H) 8.13 (d, 
5
JHH 
= 1.17, 2H), 8.51 (d, 
5
JHH = 1.46, 2H), 8.54 (dd, 
3
JHH = 8.77, 
4
JHH = 4.97, 2H), 
9.71 (s, broad, 1H) and 10.07 (s, broad, 1H) ppm. The 
1
H NMR spectrum indicated 
either the presence of at least two species or, possibly, mononitration. TLC with 
20% hexane in ethyl acetate resolved only a single species. Mass spectroscopy 
confirmed successful dinitration (clear triple peaks (differing by 1 mass unit) centred 
on 359 (mass ion), 317 (the monoacetamide) and 275 (the dinitrodianiline)). The 
1
H 
NMR spectrum was difficult to reconcile with the other data, even if considerable 
15
N - 
1
H coupling was invoked (more than occurs between 
15
N amine nitrogen and 
amine protons; usually around 95Hz). Time did not allow further investigation of 
this phenomenon. 
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7.4 Results 
7.4.1 Preparation of PolyDAB 
7.4.1.1 Determination of Optimum Conditions for DAB Polymerisation 
Following addition of H2O2 to DAB solutions, a slight darkening was evident, 
prior to addition of GAMIgPC. Results of the optimisation experiment are 
summarised in Table 7.1, below: 
 
Table 7.1. DAB solution darkening and precipitation times following addition of 
varying concentrations of GAM IgPC. 
 
Concentration of  
GAM IgPC 
Time until solution 
darkened (minutes) 
Time until precipitate 
appeared (minutes) 
 
Neat Immediate 2 
1/10 Immediate 5 
1/100 Immediate 35 
1/1000 3 >180 
1/10,000 20 >180 
1/100,000 >180 >180 
 
1/100 GAMIgPC was chosen for subsequent preparations, and produced 
polyDAB in moderate yield (34%). 
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7.4.1.2 Determination of the Solubility of PolyDAB 
PolyDAB was insoluble, as judged by the colour of supernatants in almost all 
the solvents tested, with the exception of DMSO and DMF, where only a pale 
colouration was evident. 
 
7.4.1.3 Polymerisation of DAB in DMSO 
No polymerisation was observed, as judged by darkening on the solution, even 
after 60 minutes. 
 
7.4.1.4 Solubility of Wet PolyDAB in Polar Solvents 
Wet polyDAB dissolved to a concentration of 9.45 mg/ml in DMSO and 6.45 
mg/ml in DMF. After storage over molecular sieve, however, final concentration of 
polyDAB were reduced to 0.9 mg/ml and 0.4 mg/ml respectively. 
 
7.4.1.5 Solubility of Freeze-dried PolyDAB in Polar Solvents 
Freeze-drying of polyDAB increased the polymer’s solubility to 12.35 mg/ml 
in DMSO and to 8.66 mg/ml for DMF. Solubility in conc. H2SO4 was 11.25 
mg/ml. 
 
7.4.2 Characterisation of polyDAB 
7.4.2.1 Infra Red Spectroscopy 
PolyDAB exhibited broad absorption bands centred on 1621 cm
-1
 (C-N or C=N 
stretch) and 3433 cm
-1
 (broad;  N-H stretch), and additional, narrower bands at 803 
cm
-1
, 1099 cm
-1
, 1261 cm
-1
 and 1500 cm
-1
 (N=N stretch). 
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Prominent absorption bands of DAB.4HCl were 2566 cm
-1
, 2846 cm
-1
 and 3389  
cm
-1
 (broad;  N-H stretch), and 1498 cm
-1
  (narrow; C=C stretch). In addition, there 
were a number of smaller, narrow bands at 543 cm
-1
, 827 cm
-1
, 868 cm
-1
, 1108 cm
-1
 
(N-H wag), 1193 cm
-1
, 1248 cm
-1
 (C-N stretch), 1336 cm
-1
 (C-N stretch), 1398 cm
-1
 
and 1618 cm
-1
. Assignments are tentative. 
 
7.3.2.2 MALDI-TOF 
Preliminary attempts to acquire spectra by MALDI-TOF revealed a larger 
series of peaks that were separated by 44 mass units, and consistent with 
polypropylene fragments derived from the eppendorf tube in which polyDAB 
solution had been prepared. Repetition of the preparative procedure using glass 
tubes failed to produce any signal that was consistent with DAB polymer. 
 
7.4.2.3  Gel Permeation Chromatography 
Gel permeation chromatography indicated that polyDAB, prepared as 
molecular sieve-dried samples, had a molecular weight range of approximately 600 
(trimer) to 130,000, with an average molecular weight calculated at 9180. 
Ultrasonicated, freeze-dried samples gave less reproducible results than the initial 
preparations, and had lower molecular weight values (mean 2210). 
 
7.4.2.4 
1
H and 
13
C NMR Spectroscopy 
1
H NMR of polyDAB revealed a complex spectrum of peaks between 6.3 and 
7.5 which could not be interpreted. No peaks could be identified with 
13
C NMR. 
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7.5 Discussion 
In preliminary optimisation experiments, darkening of the DAB solution upon 
addition of H2O2 was noted. Ordinarily, this goes unnoticed, since small volumes 
of solution are employed for immunohistochemical staining. A similar 
phenomenon has been observed during the early stages of melanin bleaching by 
H2O2, where oxidation was postulated to lead to a quinone-type intermediate 
(Korytowski and Sarna, 1990) (figure 7.1a). Whether DAB undergoes conversion to 
an imine intermediate remains to be determined (figure 7.1b). 
Characterisation of polyDAB presented a number of challenges, mainly centred 
on solubility. Dry polyDAB was remarkably insoluble in a wide number of 
solvents, and even when wet, only dissolved in high polarity compounds or strong 
acid. It is both the insolubility and ‘stickiness’ of polyDAB that makes it so 
attractive a marker and it was this latter property that was probably responsible for 
the failure of the MALDI-TOF experiments. The limited solubility precluded 
separation of the mixture of polymers that gel permeation chromatography 
revealed. The use of ultrasonication to facilitate the solution of polyDAB in polar 
solvents resulted in poor reproducibility, but this problem might be overcome by 
avoiding ultrasonication prior to freeze-drying of samples. 
The results from molecular weight characterisation should be interpreted with a 
certain amount of caution, since the molecular weight standards were chemically 
dissimilar and unpredictable adsorption effects of polyDAB may have occurred. 
That a mixture of polymers was being examined placed constraints on the 
amount of data that infrared spectroscopy could reveal. Tentative assignment of 
absorption bands suggested the presence of azo or azine linkages. The results are
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Figure 7.1. Proposed mechanism for the early stages of melanin bleaching by H2O2 
(Korytowski and Sarna, 1990) (a), a suggested mechanism for the darkening of 
DAB solution following addition of H2O2 (b), and a proposed indamines structure 
for polyDAB (Seligman et al, 1968) (c). 
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broadly similar to, and not inconsistent with the formation of an indamines-type 
polymer, as suggested by Seligman et al (1968) (figure 7.1c). The purchase or 
preparation of standard compounds, such as azobenzene, phenazine etc., might 
provide some useful information in this regard. 
Given the limited information that the various techniques supplied, an attempt 
to prepare 
15
N-enriched DAB was made. The unexpected results from the initial 
attempt to prepare 4,4'-dinitrobiphenyl necessitated the purchase of acetylated 
benzidine from a commercial source. Benzidine, which would have been an 
intermediate in the synthesis, is a known carcinogen and is best avoided if possible. 
Alternative synthetic routes might be possible via 
15
N-enriched 1,2-dinitro-4-
halobenzene precursors. 
15
N-enrichment might thus be achieved at either the 3,3' or 
4,4' position of the final product, which might provide some useful insights into the 
structure of the final polymer. The preparation of 
13
C-enriched DAB would also be 
useful, given the poor solubility of the final polymer, but the cost would be very 
high since such compounds would have to be prepared from either 
13
C-enriched 
benzene or aniline. 
Nitration had not presented any difficulties in previous syntheses, but the 
1
H 
NMR spectrum was difficult to interpret, even though TLC and mass spectrometry 
suggested the presence of a single compound of expected molecular weights (un-, 
mono-, and doubly 
15
N nitrated). Time limitations did not permit an investigation 
of these conflicting results, nor the eventual preparation of 
15
N-labelled polyDAB. 
The low solubility of polyDAB, together with the existence of a wide range of 
sizes, ranging from trimers to <100,000 mw polymers placed constraints on the 
information that could be gleaned from the various analytical techniques. The low 
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molecular weight oligomers may be more soluble in a greater range of organic 
solvents and might be prepared by stopping the polymerisation reaction by addition 
of either strong acid or base. The latter would be expected to deprotonate the 
oligomer and increase its solubility in organic solvents such as ethyl acetate. 
Alternatively, far greater control of polymerisation may be achieved by the 
photoconversion process (once the problems that were encountered in Chapter 6 
have been resolved), since all that is required is an intense light source, such as a 
mercury lamp. 
Characterisation of polyDAB-metal complexes was not undertaken, since 
many of the techniques used for characterising polyDAB provided only limited 
information. CHN-metal and CHN-metal-sulfide analysis would have been useful, 
but was prohibitively expensive, particularly when the influence of different 
concentrations of metal and sulfide on marker amplification was considered. CHN-
halide analysis would have been similarly useful for characterising the various 
halogenated aromatic amine polymers, but, again, the cost was prohibitive. The 
solubility of the halogenated polymers in organic solvents, such as ethyl acetate and 
chloroform, might provide a means of chromatographic separation prior to 
characterisation by various spectroscopic techniques such as NMR, UV/visible and 
infrared spectroscopy. Synthesis of substrates from halonitroaniline precursors 
would supply material of higher purity than those that are commercially available, 
all of which have suffered from some degree of oxidation, as judged by their 
brown/black appearance. Preparation of 
15
N-enriched substrates could similarly be 
prepared from haloaniline precursors. 
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7.6  Summary and Conclusions 
The mechanism of aromatic diamine polymerisation and the subsequent 
characterisation of the polymers has been the preserve of material scientists, since a 
wide variety of useful composites can be derived from them (Li et al, 2002). That 
polyDAB has remained largely uncharacterised since its introduction (Graham and 
Karnovsky, 1966), is perhaps surprising. This paucity of information might be 
explained in two ways, namely its poor solubility in a wide variety of solvents,  and 
the fact that biologists are much more interested in the information that 
(immuno)histochemically deposited polyDAB reveals than they are in the polymer 
itself. 
The attempt to characterise polyDAB was driven by a desire to apply the 
knowledge of its structure and coordination chemistry to the design of novel 
markers, but the results of this limited study were more instructive than revelatory, 
in that they indicated what might be more fruitful avenues for exploration rather 
than providing many insights. Clearly, much work still needs to be done. 
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Chapter 8 
Additional Applications of Halogenated 
Aromatic Diamines 
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8.1 Introduction 
One of the major weaknesses of the peroxidase/DAB system at the light 
microscopic level, as mentioned in Chapter 2, is that the reaction ceases after about 
3 minutes, making the visualisation of very small amounts of target molecule 
impossible without recourse to either reporter or marker amplification.  
As seen in Chapter 5, 4,5-diCl-OPD, from one commercial source at least, 
produced a polymer of fibrillary appearance. The morphology suggested that the 
fibres might continue to grow from the site of enzyme-catalysed reaction for some 
time before enzyme inhibition occurred. While clearly unsuitable for use in AEMT, 
this phenomenon might have some utility as an alternative light microscopical 
marker to polyDAB, and possibly obviate the need for either reporter or marker 
amplification. If successful, such a technology would greatly simplify current 
immunohistochemical staining procedures, particularly where extremely small 
quantities of target molecule required demonstration and localisation. 
Polymer growth might occur from either the proximal (enzyme-catalysed) or 
distal end (autocatalytic) of the fibre, or both. Inhibition of HRP, following an 
initial period of polymerisation would allow dissection of this process. A number of 
inhibitors of endogenous peroxidase have been described including H2O2 (Van 
Duijn, 1957), phenylhydrazine (Straus, 1972), sodium azide (Li et al., 1987; 
Klapper and Hackett, 1963), phenol (Baynton et al., 1994) and cyanide (Klapper 
and Hackett, 1963). The inclusion of aromatic compounds in the reaction mixture 
is probably best avoided since there exists the possibility of copolymer formation. 
The solubility of the polymer in organic solvents necessitates the use of aqueous 
mountants, the use of which does not fit easily into high-throughput automated 
procedures. This restriction might be addressed by fixation with, for example, 
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glutaraldehyde, since free amines on adjacent polymer fibres could be cross-linked. 
An alternative might be air-, or heat-drying, since the latter was noted, in Chapter 
7, to severely reduce the solubility of polyDAB compared to wet, or freeze dried 
preparations. Some proprietary automated procedures use air drying of slides, 
rather than solvent dehydration, prior to mounting, so this latter technique may 
well be preferable. 
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8.2 Materials 
4,5-diCl-OPD was purchased from Acros (Fisher Scientific, Loughborough, 
Leicester, U.K.). The sources of other materials are as previously described. 
 
8.3 Methods 
8.3.1 Determination of the Sensitivity of Poly4,5-diCl-OPD 
Sections of paraffin wax-embedded pancreatic or adrenal tissue were prepared 
and immunohistochemically stained with MAH SMA at 
1/5000, 
1/10,000, 
1/20,000 
and 
1/50,000 as previously described,  and incubated in 0.05% solutions of 4,5-diCl-
OPD for 3, 10, 20 and 60 minutes. Following thorough washing in ddH2O, sections 
were mounted in Fluorsave™. Similarly immunohistochemically stained sections 
were prepared using DAB as substrate for comparison. 
 
8.3.2 Inhibition of Horseradish Peroxidase 
Preliminary studies, to determine the optimum inhibitor concentration, were 
performed with MAH SMA at 
1/500 and DAB as substrate. Inhibitors were used for 
the following times and concentrations: 
H2O2 0.3% for 5 minutes prior to addition of DAB-Tris 
NaN3 0.02%, 0.2% and 2% both prior to (5 minutes application) and during 
incubation with DAB-Tris  
NaCN 0.1 M to 1 mM in 10-fold increments, as for NaN3 
Further sections were stained with 
1/20,000 MAH SMA and incubated in 4,5-
diCl-OPD solution for 3 minutes followed by thorough washing and further 
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incubation in the 4,5-diCl-OPD solution with or without 1 mM NaCN for 7, 27 or 
57 minutes. 
 
8.3.3 Fixation of Poly4,5-diCl-OPD 
Sections, immunohistochemically stained with MAH SMA at 
1/5000 and 
incubated in 4,5-diCl-OPD for 3 minutes, were fixed with either  0.5% 
glutaraldehyde as for immunocolloidal gold in Chapter 2, or air dried, and 
dehydrated and mounted as previously described. 
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8.4 Results 
8.4.1 Determination of the Sensitivity of Poly4,5-diCl-OPD 
In blood vessels that were immunohistochemically stained with MAH SMA at 
1/5000, staining was clearly seen by 3 minutes (figure 8.1a) and intensity increased 
further by 10 minutes (figure 8.1b). No further increase in staining intensity was 
observed at 20 minutes (figure 8.1c) or 60 minutes. At 
1/10,000 (figures 8.1d - f) and 
1/20,000 (figures 8.1g – i) MAH SMA, staining intensity continued to increase until 
the full 60 minutes, whereas at 
1/50,000 maximum staining was complete by 20 
minutes (figures 8.1j - l). In contrast, staining with DAB as substrate could be 
clearly seen by 3 minutes at 
1/500 and 
1/1,000 (figure 8.1m) but no further increase in 
staining intensity was observed after 60 minutes (figure 8.1n). Similarly, at 
1/2,000, 
only the faintest staining could be discerned (figure 8.1o), which did not improve 
with prolonged incubation (figure 8.1p). No staining could be seen at 
1/5,000 SMA. 
 
8.4.2 Inhibition of Horseradish Peroxidase 
8.4.2.1 Preliminary Studies with DAB 
8.4.2.1.1 H2O2 
In untreated sections, deposits of polyDAB were seen in both the smooth 
muscle cells of the arterioles and venules, and in the erythrocytes (figure 8.2a). Pre-
incubation with 0.3% H2O2 for 5 minutes abolished erythrocyte staining but only 
resulted in minor inhibition of HRP (figure 8.2b). 
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Figure 8.1. 4 m thick sections of paraffin wax-embedded pancreas 
immunohistochemically stained for SMA using MAH SMA at 
1/5,000 and 
incubating in 4,5-diCl-OPD for 3 minutes (a) and 10 minutes (b). 
a 
b 
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Figure 8.1 (continued). 4 m thick sections of paraffin wax-embedded pancreas 
immunohistochemically stained for SMA using MAH SMA at 
1/5,000 and 
incubating in 4,5-diCl-OPD for 20 minutes (c) or at 
1/10,000 and incubating in 4,5di-
Cl-OPD for 3 minutes (d). 
c 
d 
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Figure 8.1 (continued). 4 m thick sections of paraffin wax-embedded pancreas 
immunohistochemically stained for SMA using MAH SMA at 
1/10,000 and 
incubating in 4,5-diCl-OPD for 20 minutes (e) and 60 minutes (f). 
e 
f 
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Figure 8.1 (continued). 4 m thick sections of paraffin wax-embedded pancreas 
immunohistochemically stained for SMA using MAH SMA at 
1/20,000 and 
incubating in 4,5-diCl-OPD for 3 minutes (g) and 20 minutes (h). 
g 
h 
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Figure 8.1 (continued). 4 m thick sections of paraffin wax-embedded pancreas 
immunohistochemically stained for SMA using MAH SMA at 
1/20,000 and 
incubating in 4,5-diCl-OPD for 60 minutes (i), or at 
1/50,000 and incubating in 4,5-
diCl-OPD for 3 minutes (j). 
i 
j 
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Figure 8.1 (continued). 4 m thick sections of paraffin wax-embedded pancreas 
immunohistochemically stained for SMA using MAH SMA at 
1/50,000 and 
incubating in 4,5-diCl-OPD for 3 minutes (k) and 20 minutes (l). 
k 
l 
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Figure 8.1 (continued). 4 m thick sections of paraffin wax-embedded pancreas 
immunohistochemically stained for SMA using MAH SMA at 
1/500 and incubating 
in DAB for 3 minutes (m) and 60 minutes (n). 
m 
n 
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Figure 8.1 (continued). 4 m thick sections of paraffin wax-embedded pancreas 
immunohistochemically stained for SMA using MAH SMA at 
1/1,000 and 
incubating in DAB for 3 minutes (o) and 60 minutes (p). 
o 
p 
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Figure 8.2. 4 m thick sections of paraffin wax-embedded adrenal cortex 
immunohistochemically stained for SMA  using 
1/500 MAH SMA followed by 
DAB alone (a) or following 5 minutes pre-treatment with 0.3% H2O2 for  
5 minutes (b). 
a 
b 
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8.4.2.1.2 NaN3 
Compared to untreated controls (figure 8.3a), pre-treatment of sections with 
NaN3 at 0.02% resulted in partial inhibition of both HRP activity and erythrocyte 
staining (figure 8.3b). No further inhibition was observed at higher (0.2% and 2%) 
concentrations of NaN3 (figure 8.3c and d respectively), even when included in the 
DAB-Tris incubation mixture (Figure 8.4a - d). 
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Figure 8.3. 4 m thick sections of paraffin wax-embedded adrenal cortex 
immunohistochemically stained for SMA using 
1/500 MAH SMA followed by DAB 
alone (a) or following 5 minutes pre-treatment with NaN3 at 0.02% (b). 
a 
b 
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Figure 8.3 (continued). 4 m thick sections of paraffin wax-embedded adrenal 
cortex immunohistochemically stained for SMA using 
1/500 MAH SMA following 
5 minutes pre-treatment with NaN3 at 0.2% (c) or 2% (d). 
c 
d 
419 
 
 
 
Figure 8.4. 4 m thick sections of paraffin wax-embedded adrenal cortex 
immunohistochemically stained for SMA using 
1/500 MAH SMA followed by DAB 
alone (a) or following 5 minutes pre-treatment and including NaN3 in the DAB-Tris 
at 0.02% (b). 
a 
b 
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Figure 8.4 (continued). 4 m thick sections of paraffin wax-embedded adrenal 
cortex immunohistochemically stained for SMA using 1/500 MAH SMA followed 
by 5 minutes pre-treatment and including NaN3 in the DAB-Tris at 0.2% (c)  
or 2% (d).  
c 
d 
421 
 
8.4.2.1.3 NaCN 
Compared to untreated controls (figure 8.5a), pre-treatment of sections with 
NaCN at either 1 mM (figure 8.5b) or 10 mM (figure 8.5c) caused only slight 
inhibition of both HRP and erythrocyte staining. Including NaCN in the reaction 
mixture slightly inhibited HRP at 10
-4 M, and almost completely abolished HRP 
activity at 10
-3
 M, although erythrocyte staining remained (Figure 8.6a - f). 
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Figure 8.5. 4 m thick sections of paraffin wax-embedded adrenal cortex 
immunohistochemically stained for SMA using 
1/500 MAH SMA followed by DAB 
alone (a) or following 5 minutes pre-treatment with NaCN at 1 mM (b). 
a 
b 
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Figure 8.5 (continued). 4 m thick sections of paraffin wax-embedded adrenal 
cortex immunohistochemically stained for SMA using 
1/500 MAH SMA followed 
by 5 minutes pre-treatment with NaCN at 10 mM (c). 
c 
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Figure 8.6. 4 m thick sections of paraffin wax-embedded adrenal cortex 
immunohistochemically stained for SMA using 
1/500 MAH SMA followed by DAB 
alone (a) or including NaCN in the reaction mixture at 10
-7
 M (b). 
a 
b 
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Figure 8.6 (continued). 4 m thick sections of paraffin wax-embedded adrenal 
cortex immunohistochemically stained for SMA using 1/500 MAH SMA and 
including NaCN in the reaction mixture at 10
-6 M (c) or 10
-5 M (d). 
c 
d 
426 
 
 
 
Figure 8.6 (continued). 4 m thick sections of paraffin wax-embedded adrenal 
cortex immunohistochemically stained for SMA using 1/500 MAH SMA and 
including NaCN in the reaction mixture at 10
-4 M (e) or 10
-3 M (f). 
e 
f 
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8.4.2.2 Studies with 4,5-diCl-OPD 
8.4.2.2.1 Preliminary Studies of Inhibition with NaCN 
In the absence of inhibition, incubation in 4,5-diCl-OPD for 3 minutes resulted 
in intense staining in smooth muscle cells of arterioles and venules along with light 
staining of erythrocytes (figure 8.7a). Slight inhibition of immunohistochemical 
staining was observed when NaCN was included in the reaction mixture at 10
-4 M 
(figure 8.7b) and complete inhibition of staining occurred at 10
-3 M and 10
-2 M 
(Figure 8.7c and d). 
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Figure 8.7. 4 m thick sections of paraffin wax-embedded adrenal cortex 
immunohistochemically stained for SMA using 
1/500 MAH SMA followed by 4,5-
diCl-OPD for 3 minutes either alone (a), or including NaCN in the reaction 
mixture at 10
-4 M (b). 
a 
b 
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Figure 8.7 (continued). 4 m thick sections of paraffin wax-embedded adrenal 
cortex immunohistochemically stained for SMA using 1/500 MAH SMA followed 
by 4,5-diCl-OPD for 3 minutes, including NaCN in the reaction mixture at 10
-3 M 
(c) or 10
-2 M (d). 
c 
d 
430 
 
8.4.2.2.2 Effects of HRP Inhibition with NaCN Following Re-incubation in 
Staining Solution 
Re-incubation of immunohistochemically stained sections, that had been pre-
incubated in 4,5-diCl-OPD solution for 3 minutes (figure 8.8a), for a further 7, 27 or 
57 minutes resulted in a progressive increase in staining intensity (figures 8.8b – d). 
A similar effect was observed when re-incubation was performed with 4,5-diCl-
OPD solution containing 1 mM NaCN, although staining intensity was slightly 
lessened (Figure 8.8e - g). 
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Figure 8.8. 4 m thick sections of paraffin wax-embedded adrenal cortex 
immunohistochemically stained for SMA using 
1/20,000 MAH SMA followed by 
4,5-diCl-OPD for 3 minutes (a) and further incubated in 4,5-diCl-OPD for a further 
7 minutes (b). 
a 
b 
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Figure 8.8 (continued). 4 m thick sections of paraffin wax-embedded adrenal 
cortex immunohistochemically stained for SMA using 
1/20,000 MAH SMA followed 
by 4,5-diCl-OPD for 3 minutes and further incubated in 4,5-diCl-OPD for 27 
minutes (c) or 57 minutes (d). 
c 
d 
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Figure 8.8 (continued). 4 m thick sections of paraffin wax-embedded adrenal 
cortex immunohistochemically stained for SMA using 
1/20,000 MAH SMA followed 
by 4,5-diCl-OPD for 3 minutes and further incubated in 4,5-diCl-OPD with 10
-3 
M 
NaCN in the reaction mixture for 7 minutes (e) or 27 minutes (f). 
e 
f 
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Figure 8.8 (continued). 4 m thick sections of paraffin wax-embedded adrenal 
cortex immunohistochemically stained for SMA using 
1/20,000 MAH SMA followed 
by 4,5-diCl-OPD for 3 minutes and further incubated in 4,5-diCl-OPD with 10
-3 M 
NaCN in the reaction mixture for 57 minutes (g). 
  
g 
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8.4.2.2.3 Determination of the Concentration of NaCN Required to Inhibit 
HRP for 60 Minutes 
The inclusion of NaCN in the 4,5-diCl-OPD reaction mixture caused a 
concentration-dependent reduction in staining intensity that only completely 
abolished immunohistochemical staining at 50 mM (figure 8.9a-f). 
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Figure 8.9. 4 m thick sections of paraffin wax-embedded adrenal cortex 
immunohistochemically stained for SMA using 
1/20,000 MAH SMA followed by 
4,5-diCl-OPD for 60 minutes containing NaCN at 1 mM (a) or 2 mM (b). 
a 
b 
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Figure 8.9 (continued). 4 m thick sections of paraffin wax-embedded adrenal 
cortex immunohistochemically stained for SMA using 
1/20,000 MAH SMA 
followed by 4,5-diCl-OPD for 60 minutes containing NaCN at 5 mM (c)  
or 10 mM (d). 
c 
d 
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Figure 8.9 (continued). 4 m thick sections of paraffin wax-embedded adrenal 
cortex immunohistochemically stained for SMA using 
1/20,000 MAH SMA followed 
by 4,5-diCl-OPD for 60 minutes containing NaCN at 20 mM (e) or 50 mM (f). 
e 
f 
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8.4.2.2.4 Effects of HRP Inhibition Following Re-incubation in Staining 
Solution containing 50 mM NaCN 
Following an initial 3 minute incubation in 4,5-diCl-OPD solution (figure 
8.10a), subsequent incubation in the same solution resulted in a progressive 
increase in staining intensity that was similar to that observed in section 8.4.2.2.2, 
above (figure 8.10b – d). Inclusion of 50 mM NaCN in the re-incubation solution 
completely inhibited any further increase in staining intensity (figure 8.10e – g).  
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Figure 8.10. 4 m thick sections of paraffin wax-embedded adrenal cortex 
immunohistochemically stained for SMA using 
1/20,000 MAH SMA followed by 
4,5-diCl-OPD for 3 minutes (a) and further incubation for 7 minutes in 4,5-diCl-
OPD (b). 
a 
b 
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Figure 8.10 (continued). 4 m thick sections of paraffin wax-embedded adrenal 
cortex immunohistochemically stained for SMA using 
1/20,000 MAH SMA followed 
by 4,5-diCl-OPD for 3 minutes and further incubated for 27 minutes (c) or 57 
minutes in 4,5-diCl-OPD ( d). 
c 
d 
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Figure 8.10 (continued). 4 m thick sections of paraffin wax-embedded adrenal 
cortex immunohistochemically stained for SMA using 
1/20,000 MAH SMA followed 
by 4,5-diCl-OPD for 3 minutes and further incubated in 4,5-diCl-OPD with 50 mM 
NaCN for 7 minutes (e) or 27 minutes (f). 
e 
f 
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Figure 8.10 (continued). 4 m thick sections of paraffin wax-embedded adrenal 
cortex immunohistochemically stained for SMA using 
1/20,000 MAH SMA 
followed by 4,5diCl-OPD for 3 minutes and further incubated in 4,5-diCl-OPD 
with 50 mM NaCN for 57 minutes (g). 
  
g 
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8.4.3 Fixation of Poly4,5-diCl-OPD 
The intense staining that was preserved by mounting in Fluorsave (figure 8.11a) 
was almost completely lost following dehydration and mounting (figure 8.11b). 
What little that was retained, slowly faded over the following few hours until no 
staining could be seen. Fixation with glutaraldehyde had no effect on this (figure 
8.11c), whereas air drying resulted in retention of the majority of staining intensity 
(figure 8.11d). At higher dilutions of antibody, however, this affect was lost. 
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Figure 8.11. 4 m thick sections of paraffin wax-embedded adrenal cortex 
immunohistochemically stained for SMA using 
1/5,000 MAH SMA followed by 4,5-
diCl-OPD for 3 minutes and mounted in Fluorsave (a) or dehydrated, cleared and 
mounted in Gurr’s neutral mountant (b). 
a 
b 
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Figure 8.11 (continued). 4 m thick sections of paraffin wax-embedded adrenal 
cortex immunohistochemically stained for SMA using 
1/5,000 MAH SMA followed 
by 4,5-diCl-OPD for 3 minutes followed by fixation with 0.5% glutaraldehyde (c), 
or air-dried (d) and dehydrated, cleared and mounted in Gurr’s neutral mountant. 
c 
d 
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8.5 Discussion 
The possibility of exploiting the progressive growth of poly4,5-diCl-OPD fibres, 
suggested by transmission electron micrographs, for light microscopical 
immunohistochemistry was successful, with sensitivity being increased by nearly an 
order of magnitude compared to DAB. That this improvement mirrored what was 
achieved in Chapter 3 may, again, have reflected the practical limits of sensitivity of 
the peroxidase system. 
That little increase in staining intensity was observed beyond 20 minutes at the 
highest primary antibody dilution was surprising, given that this did not occur at 
slightly lower dilutions. 
Attempts to inhibit HRP indicated that the enzyme was surprisingly resilient, 
and very high concentrations of either H2O2 or NaN3 would probably be required 
to achieve complete inhibition, and only when included in the reaction mixture. 
Only NaCN was able to completely inhibit HRP for the full 60 minutes, and only 
when included in the substrate solution at a final concentration of 50 mM, a nearly 
20-fold higher concentration than 4,5-diCl-OPD. Inhibition of HRP has been 
reported to be 95% with 10
-4 M cyanide, an order of magnitude lower than required 
here (Klapper and Hackett, 1963) but conjugation to an antibody may affect the 
enzyme in an analogous way to that observed for the antibody in Chapter 3. The 
reversibility of HRP inhibition by peroxide, azide and cyanide has also been 
reported (Keilin et al., 1951). The results suggested that enzymatic activity was 
required for fibre growth, and that the polymerisation of 4,5-diCl-OPD was not 
autocatalytic, although interference from such a high concentration of inhibitor 
cannot be ruled out. Fibre growth from the proximal end raises the question of how 
the fibre remains attached to the enzyme, since dissociation of product molecule 
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from the enzyme must occur for the catalytic cycle to continue. Given the solubility 
of the polymer, it is possible that the fibre becomes loosely adsorbed onto a non-
catalytic part of the enzyme and only briefly dissociates when fresh product reacts 
with it, only becoming attached, itself. Another site of adsorption might be adjacent 
fibres, and this might explain why increased staining was not seen beyond 20 
minutes at the highest primary antibody titre in the preliminary experiments. The 
insolubility and ‘stickiness’ of polyDAB lends some support to this; adsorption is 
stronger, but the presence of two aromatic rings allows reaction at more sites 
without the need for dissociation, thus the enzyme becomes rapidly buried in 
polymer product, and eventually the substrates are unable to gain access to the 
catalytic site. 
Attempts to reduce the solubility of poly4,5-diCl-OPD with glutaraldehyde 
were unsuccessful, suggesting that the polymer may be predominantly phenazine-
like in structure, with few available amines. Air drying was more successful, but 
only when high concentrations of primary antibody were used and thus large 
amounts of fibre were present. At low primary antibody titres, air drying did not 
prevent solution of the polymer. These results can be accounted for by invoking 
entanglement of fibres and interaction, in the absence of solvent, by dispersive 
forces. At low fibre concentrations, interaction is substantially reduced or absent, 
and fibres are more amenable to solvation. 
The formation of the fibrillary form of poly4,5-diCl-OPD was only observed 
with one commercial source and suggested that a minor contaminant or oxidation 
product might be responsible. Identification of this substance or substances and the 
mechanism of fibrillary polymer formation might prove extremely useful in 
developing novel immunohistochemical markers for use at the light microscopic 
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level, since staining intensity and sensitivity could be controlled by simple 
manipulation of incubation time or substrate concentration. Such technology would 
be easily incorporated into high throughput automated procedures and might 
largely obviate the need for reporter and marker amplification. Target retrieval 
would probably still have some utility, however, since it has broadened the range of 
antibodies that can be used in immunohistochemical staining. 
An additional, albeit specialised, application of halogenated diamines would be 
the visualisation of carbohydrates (specifically 1,2-diols) in the TEM. Currently, 
this is achieved using periodic acid and thiocarbohydrazide, followed by either 
osmium (Seligman et al., 1965) or silver (Seligman et al., 1965; Thiery, 1967; Neiss, 
1988,). Thiocarbohydrazide is highly toxic and the multi-step procedures require 
prolonged staining times. N,N-dimethyl-p-phenylenediamine has been successfully 
used as a substitute (Spicer and Jarrels, 1961) for the more commonly employed 
pararosaniline (Hotchkiss, 1948) at the light microscopic level, and thus provides 
additional support to the proposition. The substitution of iodinated aromatic 
diamines as the nucleophile should impart electron opacity and greatly simplify this 
procedure. 
 
8.6 Summary and Conclusions 
The potential for developing a simple alternative to current marker 
amplification technology has been demonstrated. The technique suffers from 
marker solubility, but identification of substance(s) responsible for producing the 
fibrillary polymer may provide a means of generating living polymers with greater 
insolubility. Such technology could be easily incorporated into automated 
procedures and might also render reporter amplification obsolete. 
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Chapter 9 
General Discussion and Conclusions 
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9.1 General Discussion 
Light and electron microscopy have traditionally been regarded as separate 
technologies, but the development of fixatives (Karnovsky, 1965), embedding 
media (Newman and Hobot, 2001) and staining techniques (Hanker et al., 1964; 
1966; Graham and Karnovsky, 1966; Holgate et al., 1983; Wynford-Thomas et al., 
1986; Bowdler et al., 1989) that are applicable to both are testament to the 
artificiality of this distinction, in the biological sciences, at least. 
The work presented in this thesis has, for practical purposes, been broadly 
divided along traditional lines i.e. into the visualisation of trace amounts of target 
by marker amplification at the light microscopic level and the demonstration of 
multiple markers, by analytical methods, in the electron microscope. The capacity 
of polyDAB to form catalytic complexes with d-block metal compounds, for the 
former purpose, led logically to an exploration of this phenomenon for 
discriminating multiple markers using analytical electron microscopy, thus 
reinforcing the link between the two microscopy modes. 
In practical terms, the approach for refining existing marker technologies, as 
well as developing novel ones, has been one of empiricism, or what might be called 
‘applied ignorance’. This has, to a certain extent, been unavoidable, since almost 
nothing is known regarding the co-ordination chemistry of polyDAB, and the 
success or failure of novel marker chemistries, when applied to biological systems, 
is largely unpredictable. 
This unpredictability was particularly evident in Chapter 2, where, for example, 
Fe(II) and Cu(II) both produced encouraging results in the dot blot model system 
but when applied in the tissue model system, catalysed the rapid and widespread 
background deposition of silver. What was also surprising was the extraction of 
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probably all complex-forming metals from polyDAB by Newman and Jasani’s 
developer. That ethylenediamine is displaced from Ni(II) complexes by pyrogallol 
has been known for some time (Patel and Bhattach, 1971) and a similar mechanism 
presumably occurs in the case of polyDAB. Another surprise was that the 
gold/sulfide/silver method (Newman et al., 1983) remained the most powerful and 
controllable system of all. Had other metals, like platinum, not been subject to 
extraction by the developer, more powerful amplification may have been observed. 
Manipulation of this particular amplification system, together with the 
application of additional methods for suppressing background staining, extended 
the limit of immunohistochemical sensitivity by an order of magnitude, when 
compared with polyDAB alone. While this, in itself, was impressive, the colloidal 
gold/silver method still outperformed the peroxidase system by a further order of 
magnitude. This was probably due, in part, to the presence of solid metal as the 
catalytic surface, but also to the antibody being in a more native state. This 
observation raised an important issue regarding the ultimate sensitivity of reporter-
marker systems, namely, that current conjugation methods might lower antibody 
affinity to a considerable extent. 
The capacity of polyDAB to form d-block metal complexes allowed their 
demonstration in both the SEM and TEM within relatively short time frames. 
Furthermore, immunohistochemical deposits were also demonstrated by elemental 
mapping in the SEM.  Unfortunately, the concentrations of metals were too low for 
AEMT to be realistically achievable in the majority of laboratories using this 
method. AEMT, using polyDAB-metal complexes, may well be possible in 
laboratories with sufficiently sophisticated equipment such as field emission guns, 
electron energy loss spectrometers or in-column energy filters and it surprising that 
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such technologies have not been applied to quantum dots. It is possible that it 
already has, and was unsuccessful. Alternatively, the belief that sections thicker 
than about 50 nm are unsuitable for energy filtering techniques, since such 
techniques rely on single electron-atom interaction events, may have dissuaded 
worker from exploring this possibility, even though analytical tomography has been 
successfully demonstrated in 70 nm sections at high tilts at only 120 kV (Leapman 
et al., 2004). 
It was not, however, the purpose of these investigation to develop technologies 
that could only be exploited in the best equipped laboratories, but to broaden the 
applicability of marker systems. The limitations imposed by polyDAB-metal 
complexes in AEMT led to an exploration of the utility of halogenated compounds 
as potential AEMT markers. By the process of elimination, using progressively 
more stringent technologies, the range of potential markers was narrowed to just 
one compound, namely 4,5-diI-OPD, which was demonstrable within the shortest 
timeframe that was achievable with the available analytical equipment. 
Once again, a number of unexpected results were obtained with the 
halogenated compounds, not least the loss of fluorine from all the fluorinated 
diamines upon polymerisation. The C-F bond is one of the strongest, but the high 
electronegativity of fluorine may have allowed it to behave as a leaving group if the 
electron density of the aromatic system increased sufficiently. This proposition is 
lent tentative support by the observation that both DAB (Maranto, 1982; Sandell 
and Masland, 1988; Gaietta et al., 2002; Grabenbauer et al., 2005) and silver are 
deposited by the photoconversion process, a process that may, in part, be reductive. 
The appearance of some of the polymers, notably the fibrillary poly4,5-diCl-OPD 
and the bizarre poly4,5-diBr-OPD was, again, unexpected and an investigation of 
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this phenomenon would be of academic interest, at least. The fibrillary nature of 
poly4,5-diCl-OPD was only observed from one commercial source of the substrate. 
Identification of the substance(s) that caused this phenomenon might prove useful 
in developing an alternative to DAB at the light microscopic level. Product 
inhibition is the major restriction of the peroxidise/DAB system and has driven the 
development of both reporter and marker amplification technologies. These would 
be largely obviated should a living polymer be developed, and such a novel 
substrate could easily be incorporated into the high throughput systems that are 
used in both diagnostic histopathology and industry; all that would be required 
would be the manipulation of the incubation time for a given level of sensitivity. 
The investigations in Chapters 4 and 5 were based on the supposition that 
antibodies could penetrate acrylic resin sections. The evidence for this phenomenon 
(Newman and Hobot, 1987) remains controversial and the results of the brief 
investigation in Chapter 4 lend support to the generally held belief that antibodies 
are simply too large. The behaviour of LR White acrylic resin has changed slightly 
over the last couple of decades; early personal observations indicated that it swelled 
to a considerable extent when hydrated, but more recent formulations do not. The 
composition of the resin has not been altered (Dr. Brian Causton, London Resin 
Company, personal communication), but subtle variations in the composition, such 
as a change in the commercial source of one of the components or an improvement 
in purity, might alter the behaviour of the final resin. The lowicryl resin, K4M, also 
swells when hydrated (Newman and Hobot, 2001) and its composition, unlike that 
of the LR resins, is published (Carlemalm et al., 1982). It is not, however, 
compatible with the peroxidase/DAB system, suffering from serious background 
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staining (Newman and Hobot, 2001), but manipulation of its composition might 
overcome this drawback.  
Antibodies are probably too large to penetrate resin sections, and even the 
smallest active fragments are in the order of 15 kD (Sheriff and Constantine, 1996). 
The molecular weight cut-off of acrylic resins and tissues that are embedded therein 
is unknown, but manipulation of resin formulation may improve reporter 
penetration. Failing this, two approaches exist for preparing low molecular weight 
reporters, namely (1) design of ligands with a high specificity for selected epitopes 
and (2) synthesis of a scaffold with randomly attached functional groups followed 
by screening. The former technique requires detailed information concerning the 3-
dimensional structure of the target epitope, extensive mathematical modelling to 
determine an appropriate complementary structure and subsequent synthesis and 
evaluation. The latter approach mimics the process underlying antibody production 
in vivo. Both approaches would involve a huge amount of work. 
In Chapter 6, the possibility of depositing silver from a physical developer by 
the photoconversion process was explored. The results were extremely encouraging 
and raised questions regarding the nature of the photoconversion process, with 
particular regard to the polymerisation of DAB. Refinement of this technique, 
together with the application of appropriate methodologies for suppressing tissue 
autofluorescence, may well lead to an alternative approach for illustrating 
fluorochromes at the electron microscopic level and, ultimately, to the development 
of an AEMT marker, since metallic silver is inherently electron opaque and should 
produce a strong X-ray signal. 
Current technologies for CLEM exploit the photoconversion process to deposit 
electron-opaque markers for examination in the TEM. This might be circumvented, 
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and the problems associated with tissue and resin autofluorescence avoided, by the 
development of fluorescent reporters with catalytic properties. The introduction of 
such catalytic moieties into live cells would probably have unforeseen 
consequences, but the masking of such sites may overcome this. Such unmasking 
might be achieved by photoisomerisation of stilbene (Waldeck, 1991) and 
azobenzene compounds (Schultz et al., 2003). An additional advantage to this 
approach would be the avoidance of problems associated with overlapping 
excitation spectra of organic and inorganic fluorochromes. In the light microscope, 
a wide variety of optical and digital techniques exist for separating their emission 
spectra, but these cannot be applied, of course, to the photoconversion process. In 
some ways, this brings the thesis full-circle to the first experimental chapter where 
the catalytic action of polyDAB-metal complexes was empirically investigated. 
The characterisation of polyDAB was less extensive than initially hoped, but 
provided some useful insights into the direction that more fruitful investigation 
might be directed. The resolution of some of the conflicting results, together with 
the application of more informative technologies, should hopefully reveal the co-
ordination chemistry of polyDAB and thus lead to the development to novel 
catalytic markers. In addition, such techniques could aid an understanding of the 
polymerisation of the halogenated compounds. 
This thesis has focussed, primarily on the peroxidase/DAB system for 
generating markers, but this inevitably places constraints on the chemistries that 
might be available. There is no reason, in principle, why enzymes should not be 
replaced by more stable, non-enzymatic catalysts. This might not only allow for the 
rational development of new classes of markers, but also avoid the problems 
associated with existing immunohistochemical techniques e.g. endogenous 
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enzymatic and non-enzymatic activities. In addition, the coupling of non-enzymatic 
catalysts to antibodies would reduce the overall size of the molecule and would 
contribute to the development of penetrable reporters. 
The recent commercial introduction of SEM tomography (SEMT) (Zankel et 
al., 2009) represents an exciting development in 3-D reconstruction of biological 
samples, since mach larger specimens can be examined than in the TTEM. 
Currently, an ESEM is required to overcome the problems associated with 
electrostatic charging of uncoated, non-conducting resins. Electrically conducting 
resins are commercially available, but achieve conductivity by the incorporation of 
metal particles, which preclude ultramicrotomy. In addition, such particles would 
probably fail to penetrate biological samples and thus any advantage that such 
resins might offer would be lost. Electrostatic charging can be overcome by 
operating the SEM at low voltages e.g. 0.1 kV, but this restricts the technology to 
those laboratories with high vacuum SEMs fitted with field emission guns. An 
alternative approach would be the development of electrically conducting organic 
resins, since this would broaden the availability of SEMT to the majority of 
laboratories. An additional advantage of conducting resins would be improved 
stability in the TEM, which would be of particular importance in AEMT. 
 
  
460 
 
9.2 Summary and Conclusion 
The study of dynamic processes in live cells has led to the introduction of a 
wide range of cytochemical markers to exploit the numerous optical techniques that 
have been developed over the last couple of decades. In sharp contrast, 
immunohistochemical and CLEM marker chemistries have not progressed 
significantly since the 1980s, even though considerable advances have been made in 
both instrument design and capability. The rational design of novel marker 
chemistries for visualising the smallest amounts of target molecule at the light 
microscopic level and for discriminating marker deposits at the electron 
microscopic level is long overdue, and simplicity of application, to ensure the 
broadest applicability, should be the guiding principle. 
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